The DOI matches its Crossref record; 485 of the 485 references it cites were found in a registry or an index; 194 of the 435 sources its claims cite were checked for support.
Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies
Open accessAbstract
The prevalence of obesity in combination with sarcopenia (the age-related loss of muscle mass and strength or physical function) is increasing in adults aged 65 years and older. A major subset of adults over the age of 65 is now classified as having sarcopenic obesity, a high-risk geriatric syndrome predominantly observed in an ageing population that is at risk of synergistic complications from both sarcopenia and obesity. This Review discusses pathways and mechanisms leading to muscle impairment in older adults with obesity. We explore sex-specific hormonal changes, inflammatory pathways and myocellular mechanisms leading to the development of sarcopenic obesity. We discuss the evolution, controversies and challenges in defining sarcopenic obesity and present current body composition modalities used to assess this condition. Epidemiological surveys form the basis of defining its prevalence and consequences beyond comorbidity and mortality. Current treatment strategies, and the evidence supporting them, are outlined, with a focus on calorie restriction, protein supplementation and aerobic and resistance exercises. We also describe weight loss-induced complications in patients with sarcopenic obesity that are relevant to clinical management. Finally, we review novel and potential future therapies including testosterone, selective androgen receptor modulators, myostatin inhibitors, ghrelin analogues, vitamin K and mesenchymal stem cell therapy.The prevalence of obesity in combi…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
112 No full text of the sources · 92 Partly supported · 53 Supported · 25 No basis given · 21 Own interpretation · 12 Supported so far · 7 Not supported · 4 Couldn’t confirm · 3 Not checked yet · 1 Mixed support · 1 Sources not found · accuracy not yet measured
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“an association that was not observed with cardiovascular disease221”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Consequences of sarcopenic obesity > Comorbidities.
What the sources say
- Disputedcites [221] Atkins, J. L. et al. Sarcopenic obesity and risk of cardiovascular disease and mortality: a population-based cohort study of older men. J. Am. Geriatr. Soc. 62, 253–260 (2014). sourceExperimental — accuracy not yet measured
The Discussion (WC and MAMC Measurements; page unavailable) says sarcopenic obesity defined using grip strength predicted greater risk of CVD events—the opposite of the claimed lack of association. This paper's own null finding concerned obesity and low muscle mass defined using waist and midarm measurements, not BMI and handgrip strength (Methods, Anthropometric Measurements and Sarcopenic Obesity Definition; page unavailable). (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Aerobic exercise and resistance training are safe, even in patients who are at a high risk of falling275.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Treatments for sarcopenic obesity > Resistance training and aerobic exercise.
What the sources say
- Disputedcites [275] Gillespie, L. D. et al. Interventions for preventing falls in older people living in the community. Cochrane Database Syst. Rev. 9, CD007146 (2012). sourceExperimental — accuracy not yet measured
The Results (page not specified) report significantly more musculoskeletal injuries with resistance training than with control (18 versus 5), contrary to the unqualified claim that it is safe. The review reports no trials of endurance training alone, so it also does not establish the safety of aerobic exercise, including for people at high risk of falling. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“However, reductions in TNF and IL-6 observed in older men with hypogonadism can be reversed following testosterone treatment406.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Testosterone.
What the sources say
- Disputedcites [406] Corrales, J. J. et al. Androgen-replacement therapy depresses the ex vivo production of inflammatory cytokines by circulating antigen-presenting cells in aging type-2 diabetic men with partial androgen deficiency. J. Endocrinol. 189, 595–604 (2006). sourceExperimental — accuracy not yet measured
The Discussion says acute hypogonadism in elderly men increased circulating TNF and IL-6, rather than reducing them; subsequent testosterone treatment reduced TNF but not IL-6. The Results report that testosterone treatment suppressed spontaneous ex vivo production of both cytokines in the paper’s older diabetic men, not that it reversed reductions in them. Page numbers are unavailable in our copy. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Individuals with sarcopenia have elevated levels of myostatin443, a negative regulator of skeletal muscle growth development444.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Myostatin inhibitors.
What the sources say
- Disputedcites [443] Bergen, H. R. III et al. Myostatin as a mediator of sarcopenia versus homeostatic regulator of muscle mass: insights using a new mass spectrometry-based assay. Skelet. Muscle 5, 21 (2015). sourceExperimental — accuracy not yet measured
The citation is attached to the claim that people with sarcopenia have elevated myostatin. The Discussion reports no meaningful difference in myostatin concentrations between older subjects with and without sarcopenia in either sex. The Results also report that sarcopenic older women had absolute levels comparable to younger women, while sarcopenic older men had lower levels than younger men. The separate citation for myostatin’s regulatory role is not assessed here. (LLM, conf=0.89)
Checked by a reasoning model — may be wrong.
- Not checked — no full text of the sourcecites [444] McPherron, A. C., Lawler, A. M. & Lee, S. J. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 387, 83–90 (1997). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“A number of mechanisms might explain the reduction of muscle mass and strength in sarcopenic obesity, including type II muscle fibre atrophy, reduction in motor neurons, collagen deposition and fibre necrosis67–70.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Biological pathways to sarcopenic obesity > Myocellular mechanisms.
What the sources say
- Not checked — no full text of the sourcecites [67] Thomas, D. R. Loss of skeletal muscle mass in aging: examining the relationship of starvation, sarcopenia and cachexia. Clin. Nutr. 26, 389–399 (2007). source
- Not checked — no full text of the sourcecites [68] Nilwik, R. et al. The decline in skeletal muscle mass with aging is mainly attributed to a reduction in type II muscle fiber size. Exp. Gerontol. 48, 492–498 (2013). source
- Partly supportedcites [69] Delbono, O. Neural control of aging skeletal muscle. Aging Cell 2, 21–29 (2003). sourceExperimental — accuracy not yet measured
The Introduction links age-related muscle-mass loss to fibre atrophy, and ‘Neural influences on aging skeletal muscle’ describes motor-unit loss and denervation of fast fibres. The Conclusions also discuss possible motor-neurone loss and reduced muscle force. These passages concern aging muscle, not specifically sarcopenic obesity; they do not establish type II fibre atrophy, collagen deposition, or fibre necrosis. Page numbers are unavailable in our copy. (LLM, conf=0.88)
- Partly supportedcites [70] Stenholm, S. et al. Sarcopenic obesity: definition, cause and consequences. Curr. Opin. Clin. Nutr. Metab. Care 11, 693–700 (2008). sourceExperimental — accuracy not yet measured
In “Searching for a definition based on pathophysiology and associated risk” (page unavailable), the paper identifies reduced fibre size and number, increased collagen, and motor-unit changes as contributors to declining muscle quality. “Age-related changes in body composition” (page unavailable) also names loss of alpha-motor units. It does not specify type II fibre atrophy or identify fibre necrosis as a mechanism. (LLM, conf=0.88)
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Muscle injury activates satellite cells to regenerate muscle by releasing IGF1, fibroblast growth factor and mechano growth factor, all of which stimulate the differentiation and proliferation of muscle satellite cells112,113.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Biological pathways to sarcopenic obesity > The role of exercise.
What the sources say
- Partly supportedcites [112] Kang, J. S. & Krauss, R. S. Muscle stem cells in developmental and regenerative myogenesis. Curr. Opin. Clin. Nutr. Metab. Care 13, 243–248 (2010). sourceExperimental — accuracy not yet measured
The Satellite cell heterogeneity section (page unavailable) says muscle injury activates satellite cells to proliferate and differentiate during regeneration. It does not say injury releases IGF1, fibroblast growth factor, or mechano growth factor to stimulate those cells; its discussion of FGF concerns embryonic progenitors instead. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [113] Thornell, L. E. Sarcopenic obesity: satellite cells in the aging muscle. Curr. Opin. Clin. Nutr. Metab. Care 14, 22–27 (2011). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In sum, individuals with obesity are at risk of inflammation, which can lead to the preferential mobilization of muscle instead of fat91.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Biological pathways to sarcopenic obesity > Myocellular mechanisms.
What the sources say
- Partly supportedcites [91] Srikanthan, P., Hevener, A. L. & Karlamangla, A. S. Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia: findings from the National Health and Nutrition Examination Survey III. PLoS ONE 5, e10805 (2010). sourceExperimental — accuracy not yet measured
The Introduction (page not specified) says inflammation occurs in obesity and may accelerate muscle protein degradation. It does not say that inflammation causes muscle to be mobilized preferentially over fat; that comparison is unsupported. (LLM, conf=0.85)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Older adults (those ≥65 years) are at risk of developing anabolic resistance owing to reduced post-prandial amino acid availability, reduced muscle perfusion and a reduced digestive capacity resulting from splanchnic sequestration of amino acids71.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Biological pathways to sarcopenic obesity > Myocellular mechanisms.
What the sources say
- Partly supportedcites [71] Bauer, J. et al. Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. J. Am. Med. Dir. Assoc. 14, 542–559 (2013). This is a position paper from the PROT-Age study group that recommends an average daily intake of at least 1.0–1.2 g protein per kg body weight per day. sourceExperimental — accuracy not yet measured
The “Benefits of Higher Protein Intake for Older Adults” section (page unavailable) describes an impaired muscle anabolic response to meals in older adults and calls this anabolic resistance. It does not establish the claimed combination of reduced postprandial amino acid availability and reduced muscle perfusion as its causes. The “Protein DigestibilityeCorrected Amino Acid Score” section (page unavailable) says age-related gastrointestinal changes do not substantially impair amino acid availability from food, contrary to the claimed reduction in digestive capacity. (LLM, conf=0.88)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Aerobic exercise101, resistance training102–104 and their combination105 increase muscle protein synthesis in older adults despite age-related decreases in anabolic signalling106–109.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Biological pathways to sarcopenic obesity > The role of exercise.
What the sources say
- Not checked — no full text of the sourcecites [101] Short, K. R., Vittone, J. L., Bigelow, M. L., Proctor, D. N. & Nair, K. S. Age and aerobic exercise training effects on whole body and muscle protein metabolism. Am. J. Physiol. Endocrinol. Metab. 286, E92–E101 (2004). source
- Not checked — no full text of the sourcecites [102] Yarasheski, K. E., Zachwieja, J. J. & Bier, D. M. Acute effects of resistance exercise on muscle protein synthesis rate in young and elderly men and women. Am. J. Physiol. 265, E210–E214 (1993). source
- Not checked — no full text of the sourcecites [103] Yarasheski, K. E. et al. Resistance exercise training increases mixed muscle protein synthesis rate in frail women and men >/=76 yr old. Am. J. Physiol. 277, E118–E125 (1999). source
- Not checked — no full text of the sourcecites [104] Hasten, D. L., Pak-Loduca, J., Obert, K. A. & Yarasheski, K. E. Resistance exercise acutely increases MHC and mixed muscle protein synthesis rates in 78–84 and 23–32 yr olds. Am. J. Physiol. Endocrinol. Metab. 278, E620–E626 (2000). source
- Supportedcites [105] Villareal, D. T., Smith, G. I., Sinacore, D. R., Shah, K. & Mittendorfer, B. Regular multicomponent exercise increases physical fitness and muscle protein anabolism in frail, obese, older adults. Obesity (Silver Spring) 19, 312–318 (2011). This study demonstrates that a multicomponent exercise programme consisting of strength, endurance, flexibility and balance increases the basal rate of muscle protein synthesis without affecting the magnitude of the muscle protein anabolic response to feeding. source
Citation 105 is attached to the claim about combining aerobic and resistance exercise, not to the separate claims about each exercise type or age-related signalling. The Introduction describes a programme including strength and endurance exercise in frail, obese older adults; the Discussion reports that muscle protein synthesis was about 50% higher after training. (LLM, conf=0.93)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Further, whether the bioelectrical impedance prediction equations are valid when applied to different ethnic groups is unclear170, despite specific adaptations and adjustments171–173.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Assessing body composition
What the sources say
- Not checked — no full text of the sourcecites [170] Chumlea, W. C. et al. Body composition estimates from NHANES III bioelectrical impedance data. Int. J. Obes. Relat. Metab. Disord. 26, 1596–1609 (2002). This study presents normative bioelectrical impedance analysis equations validated using a population-based cohort of American adults. source
- Not checked — no full text of the sourcecites [171] Janssen, I., Heymsfield, S. B., Baumgartner, R. N. & Ross, R. Estimation of skeletal muscle mass by bioelectrical impedance analysis. J. Appl. Physiol. (1985) 89, 465–471 (2000). source
- Not checked — no full text of the sourcecites [172] Mally, K., Trentmann, J., Heller, M. & Dittmar, M. Reliability and accuracy of segmental bioelectrical impedance analysis for assessing muscle and fat mass in older Europeans: a comparison with dual-energy X-ray absorptiometry. Eur. J. Appl. Physiol. (1985) 111, 1879–1887 (2011). source
- Supportedcites [173] Yu, S. C., Powell, A., Khow, K. S. & Visvanathan, R. The performance of five bioelectrical impedance analysis prediction equations against dual x-ray absorptiometry in estimating appendicular skeletal muscle mass in an adult Australian population. Nutrients 8, 189 (2016). source
The Discussion (§4) reports that equations developed in Caucasian cohorts outperformed equations developed in other cohorts when tested in predominantly Caucasian Australians. The Conclusions (§5) call for validation in other ethnic groups, supporting the claim that validity across ethnic groups remains unclear. The separate clause about adaptations is cited to other sources, not this paper. (LLM, conf=0.93)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Muscle fascicle length and muscle tendon stiffness reportedly increased after strength training (leg press and extension) over 14 weeks in a cohort of men and women aged over 65 years140.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Biological pathways to sarcopenic obesity > The role of exercise.
What the sources say
- Partly supportedcites [140] Reeves, N. D., Maganaris, C. N. & Narici, M. V. Effect of strength training on human patella tendon mechanical properties of older individuals. J. Physiol. 548, 971–981 (2003). sourceExperimental — accuracy not yet measured
The Abstract and Results report increased patella tendon stiffness after 14 weeks of leg press and leg extension training; Methods identifies the training group as five women and four men, with a mean age of 74.3 years. The paper does not report an increase in muscle fascicle length: its Discussion mentions fascicle length in connection with another study, not as a measured outcome here. (LLM, conf=0.89)
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In a pre-frail and frail population, a strategy combining physical training and nutritional intervention was more likely to result in stable or reduced IL-6 levels in individuals who demonstrated improved physical performance than in those with lower physical performance149.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Biological pathways to sarcopenic obesity > Summary of mechanisms.
What the sources say
- Partly supportedcites [149] Haider, S. et al. Change in inflammatory parameters in prefrail and frail persons obtaining physical training and nutritional support provided by lay volunteers: a randomized controlled trial. PLoS ONE 12, e0185879 (2017). sourceExperimental — accuracy not yet measured
The Abstract and Results (Table 4; page not available) report that prefrail and frail participants whose physical performance improved were more likely to have stable or reduced IL-6 than participants whose performance did not improve. The comparison was based on improvement over time, not on having higher versus lower physical performance levels. (LLM, conf=0.84)
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Variable hydration status also impacts its accuracy167.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Assessing body composition
What the sources say
- Supportedcites [167] Bosy-Westphal, A. et al. Quantification of whole-body and segmental skeletal muscle mass using phase-sensitive 8-electrode medical bioelectrical impedance devices. Eur. J. Clin. Nutr. 71, 1061–1067 (2017). source
The Introduction says BIA assumes constant hydration and that this assumption is violated as adiposity changes the ratio of extracellular to intracellular water. The Discussion also links changes in regional water distribution with departures from BIA's assumptions that can increase measurement error. These passages support the general claim that variation in hydration affects accuracy. (LLM, conf=0.86)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Muscle protein synthesis is also improved by nutrient-stimulated vasodilation and nutrient transport to local muscle myofibrils112,124.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Biological pathways to sarcopenic obesity > The role of exercise.
What the sources say
- Could not verifycites [112] Kang, J. S. & Krauss, R. S. Muscle stem cells in developmental and regenerative myogenesis. Curr. Opin. Clin. Nutr. Metab. Care 13, 243–248 (2010). sourceExperimental — accuracy not yet measured
The Introduction and Conclusion describe muscle stem cells, development, and regeneration. A passage in “Satellite cell heterogeneity” discusses signaling between nearby cells and satellite cells, but not nutrient-stimulated vasodilation, nutrient transport to myofibrils, or muscle protein synthesis. Searches for those terms found no passage addressing the claimed mechanism; page numbers were not available in our copy. (LLM, conf=0.76)
- Not checked — no full text of the sourcecites [124] Marzetti, E. et al. Physical activity and exercise as countermeasures to physical frailty and sarcopenia. Aging Clin. Exp. Res. 29, 35–42 (2017). This study provides an overview of the interplay between physical activity, exercise and sarcopenia. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“With ageing, fat preferentially accumulates both viscerally and ectopically rather than as abdominal subcutaneous fat.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > An evolving definition
What the sources say
- Partly supportedcites [186] Villareal, D. T. et al. Obesity in older adults: technical review and position statement of the American Society for Nutrition and NAASO, The Obesity Society. Am. J. Clin. Nutr. 82, 923–934 (2005). This study highlights current guidelines for the management of older adults with obesity. sourceExperimental — accuracy not yet measured
The 'Changes in body weight and body composition with aging' section says intraabdominal fat increases more, in relative terms, than subcutaneous fat. It also reports increases in intramuscular and intrahepatic fat, but does not say those ectopic depots increase preferentially over abdominal subcutaneous fat; the 'Definition of obesity' section says abdominal subcutaneous fat also increases with aging. Page numbers were not available in our copy. (LLM, conf=0.86)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“instrumental activity of daily living disability (OR 1.36, 95% CI 1.05–1.76)”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Consequences of sarcopenic obesity > Disability or impairments.
What the sources say
- Supportedcites [204] Hirani, V. et al. Longitudinal associations between body composition, sarcopenic obesity and outcomes of frailty, disability, institutionalisation and mortality in community-dwelling older men: The Concord Health and Ageing in Men Project. Age Ageing 46, 413–420 (2017). source
The Abstract reports that, in fully adjusted analysis of community-dwelling men aged 70 or older, sarcopenic obesity was associated with IADL disability (OR 1.36, 95% CI 1.05–1.76). It specifies FNIH cut-points for low muscle mass and defines obesity as more than 30% body fat. (LLM, conf=0.95)
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Rapid accumulation of intra-abdominal fat is exacerbated by physical inactivity, hormonal changes, reduced responsiveness to thyroid hormone and leptin resistance186.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > An evolving definition
What the sources say
- Partly supportedcites [186] Villareal, D. T. et al. Obesity in older adults: technical review and position statement of the American Society for Nutrition and NAASO, The Obesity Society. Am. J. Clin. Nutr. 82, 923–934 (2005). This study highlights current guidelines for the management of older adults with obesity. sourceExperimental — accuracy not yet measured
The Pathogenesis section links declining physical activity and age-related hormonal changes, including reduced thyroid-hormone responsiveness and leptin resistance, to increasing body fat. The Changes in Body Weight and Body Composition with Aging section reports a greater relative increase in intra-abdominal fat. The paper does not specifically establish that each listed factor worsens intra-abdominal fat accumulation, and it describes the overall increase in body fat as gradual, not rapid. (LLM, conf=0.86)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“data from the UK Biobank study found an association between high BMI, low grip strength and reduced long-term physical activity211”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Consequences of sarcopenic obesity > Disability or impairments.
What the sources say
- Supportedcites [211] Kim, Y. et al. Adiposity and grip strength as long-term predictors of objectively measured physical activity in 93 015 adults: the UK Biobank study. Int. J. Obes. (Lond.) 41, 1361–1368 (2017). This study analyses data from the UK Biobank study and shows that advanced obesity and poor strength at baseline independently predict lower activities at follow-up. source
The Conclusion reports that baseline BMI and grip strength independently predicted physical activity after a median 5.7-year follow-up in the UK Biobank cohort. The Discussion says more obese participants had lower activity and less strong participants generally had lower activity, though the grip-strength association was less consistent in men with lower BMI. (LLM, conf=0.93)
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In another study, the authors identified individuals with a BMI ≥35 kg/m2 and evaluated the prevalence of sarcopenic obesity using DXA-defined body fat in 120 predominantly female adults (46.9 ± 11.0 years). The investigators reported rates that ranged from 0–84.5% in women to 0–100% in males depending upon the definition applied197.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Prevalence of sarcopenic obesity
What the sources say
- Partly supportedcites [197] Johnson Stoklossa, C. A. et al. Prevalence of sarcopenic obesity in adults with class II/III obesity using different diagnostic criteria. J. Nutr. Metab. 2017, 7307618 (2017). sourceExperimental — accuracy not yet measured
The Results report 120 participants (85.8% female) and sarcopenic-obesity prevalence of 0–84.5% in females and 0–100% in males across definitions. However, the reported mean age is 46.9 ± 11.1 years, not ± 11.0. The Results also describe the cohort’s obesity as BMI-defined; the Methods say DXA supplied body-composition measures, not that body fat defined obesity for every prevalence estimate. (LLM, conf=0.88)
plainn = 120- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“activity of daily living disability (OR 1.58, 95% CI 1.12–2.24)”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Consequences of sarcopenic obesity > Disability or impairments.
What the sources say
- Supportedcites [204] Hirani, V. et al. Longitudinal associations between body composition, sarcopenic obesity and outcomes of frailty, disability, institutionalisation and mortality in community-dwelling older men: The Concord Health and Ageing in Men Project. Age Ageing 46, 413–420 (2017). source
The Abstract (page not provided) defines low muscle mass using FNIH cut-points and obesity as more than 30% body fat. It reports that, in fully adjusted analysis, men with sarcopenic obesity had increased odds of ADL disability (OR 1.58, 95% CI 1.12–2.24). (LLM, conf=0.95)
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“High BMI and low muscle strength were related to limitation in mobility at 2-year follow-up (OR 3.88, 95% CI 1.08–13.91)212.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Consequences of sarcopenic obesity > Disability or impairments.
What the sources say
- Supportedcites [212] Jung, S. et al. Obesity and muscle weakness as risk factors for mobility limitation in community-dwelling older Japanese women: a two-year follow-up investigation. J. Nutr. Health Aging 20, 28–34 (2016). source
The Results (Table 4) report that participants with obesity and low hand-grip strength had higher odds of mobility limitation at two-year follow-up than those with normal weight and high hand-grip strength (adjusted OR 3.88, 95% CI 1.08–13.91). The study population was community-dwelling older Japanese women. (LLM, conf=0.94)
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“a combination of obesity, as defined by percentage of body fat, with low muscle mass represented odds ratios of difficulty ascending and descending stairs that were 2.60 and 2.35 higher, respectively”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Consequences of sarcopenic obesity > Disability or impairments.
What the sources say
- Supportedcites [203] Rolland, Y. et al. Difficulties with physical function associated with obesity, sarcopenia, and sarcopenic-obesity in community-dwelling elderly women: the EPIDOS (EPIDemiologie de l’OSteoporose) Study. Am. J. Clin. Nutr. 89, 1895–1900 (2009). source
The Results (pp. 1–3) report that, compared with women with a healthy body composition, sarcopenic-obese women had 2.60 higher odds of difficulty climbing stairs and 2.35 higher odds of difficulty going down stairs. The Abstract defines obesity by percentage body fat and identifies the group as women with both obesity and low muscle mass. (LLM, conf=0.94)
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Body fat has better predictive validity on the development of the metabolic syndrome192 and cardiovascular disease risk193 than BMI.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > An evolving definition
What the sources say
- Partly supportedcites [192] Fox, C. S. et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 116, 39–48 (2007). sourceExperimental — accuracy not yet measured
The Discussion reports that visceral adipose tissue (VAT), but not subcutaneous adipose tissue, provided information about cardiometabolic risk factors beyond BMI. This supports a narrower comparison than the claim: the study assessed associations cross-sectionally, not whether body fat generally predicts future cardiovascular disease better than BMI. The Conclusions call for prospective studies of MetS and CVD incidence. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [193] Despres, J. P. Body fat distribution and risk of cardiovascular disease: an update. Circulation 126, 1301–1313 (2012). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Ethnic-specific differences result in inaccurate prevalence estimates184.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > An evolving definition
What the sources say
- Partly supportedcites [184] Cruz-Jentoft, A. J. et al. Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing 43, 748–759 (2014). sourceExperimental — accuracy not yet measured
The Discussion > Prevalence passage says ethnicity may affect prevalence estimates, especially when the reference and study populations do not match. It does not establish that ethnic differences necessarily result in inaccurate estimates; the citing sentence states that possibility as a definite outcome. Page information is unavailable in our copy. (LLM, conf=0.86)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“sarcopenic obesity resulted in an increased risk of frailty (OR 2.00, 95% CI 1.42–2.82)”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Consequences of sarcopenic obesity > Disability or impairments.
What the sources say
- Supportedcites [204] Hirani, V. et al. Longitudinal associations between body composition, sarcopenic obesity and outcomes of frailty, disability, institutionalisation and mortality in community-dwelling older men: The Concord Health and Ageing in Men Project. Age Ageing 46, 413–420 (2017). source
The Abstract reports that, in fully adjusted analyses of older men, sarcopenic obesity was associated with frailty (OR 2.00, 95% CI 1.42–2.82). It defines low muscle mass using FNIH cut-points and obesity as greater than 30% body fat. (LLM, conf=0.94)
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“mobility disability trajectories and gait speed over 6 years were steepest in individuals with obesity as defined by BMI and low muscle strength200”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Consequences of sarcopenic obesity > Disability or impairments.
What the sources say
- Partly supportedcites [200] Stenholm, S. et al. The effect of obesity combined with low muscle strength on decline in mobility in older persons: results from the InCHIANTI study. Int. J. Obes. (Lond.) 33, 635–644 (2009). This study details data from the InCHIANTI study that prove that obesity combined with low muscle strength increases the risk of mobility disability with age. sourceExperimental — accuracy not yet measured
The Results (Change over time in walking speed) report the most prominent six-year decline in walking speed among participants aged 65–80 with obesity and low muscle strength. The Results (Risk of mobility disability) report a higher rate of new disability at six years, but do not describe disability trajectories as steepest; the walking-speed finding is also qualified by age. (LLM, conf=0.85)
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Data from the InCHIANTI study noted rates of 3.2–8.7% using the low knee extensor strength with either high BMI or waist circumferrence200.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Prevalence of sarcopenic obesity
What the sources say
- Partly supportedcites [200] Stenholm, S. et al. The effect of obesity combined with low muscle strength on decline in mobility in older persons: results from the InCHIANTI study. Int. J. Obes. (Lond.) 33, 635–644 (2009). This study details data from the InCHIANTI study that prove that obesity combined with low muscle strength increases the risk of mobility disability with age. sourceExperimental — accuracy not yet measured
The Methods (Measurement of muscle strength; page not provided) define low strength using knee extensor strength, and the Results (Risk of mobility disability; page not provided) describe analyses using BMI or waist circumference to define obesity. The passages in our copy do not report the claimed 3.2–8.7% rates, so the numerical range is unsupported. (LLM, conf=0.84)
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In a population-based cohort using National Health and Nutrition Examination Survey (NHANES) data that applied the aforementioned FNIH criteria for appendicular lean mass, rates of sarcopenic obesity were 12.6% in men and 33.5% in women.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Prevalence of sarcopenic obesity
What the sources say
- Supportedcites [198] Batsis, J. A., Mackenzie, T. A., Emeny, R. T., Lopez-Jimenez, F. & Bartels, S. J. Low lean mass with and without obesity, and mortality: results from the 1999–2004 National Health and Nutrition Examination Survey. J. Gerontol. A Biol. Sci. Med. Sci. 72, 1445–1451 (2017). This report details the definition of low lean mass determined by the Foundation of the National Institutes of Health, as well as the adverse association between low lean mass and mortality. source
The Methods describe an NHANES 1999–2004 sample of adults aged 60 and older and define low lean mass using FNIH appendicular lean mass cutoffs. Results Table 3 reports weighted prevalence of low lean mass with obesity, defined using body-fat cutoffs, as 12.6% in men and 33.5% in women. (LLM, conf=0.95)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“a combination of low knee extensor strength with high BMI was associated with reduced gait speed and reduced Late-Life Function and Disability Index and Short Form-12 scores207”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Consequences of sarcopenic obesity > Disability or impairments.
What the sources say
- Partly supportedcites [207] Batsis, J. A., Zbehlik, A. J., Pidgeon, D. & Bartels, S. J. Dynapenic obesity and the effect on long-term physical function and quality of life: data from the osteoarthritis initiative. BMC Geriatr. 15, 118 (2015). sourceExperimental — accuracy not yet measured
The Results report lower gait speed, LLFDI limitations-subscale scores, and SF-12 physical-component scores in the dynapenic obesity group compared with those with neither condition. The claim is broader than those findings: the Results report no difference in SF-12 mental-component scores, and do not establish reductions across all LLFDI components. (LLM, conf=0.86)
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“while data from FNIH classified 4.1% of men and 14.0% of women as having sarcopenic obesity using high BMI and low grip strength as measures of obesity and low muscle strength, respectively202.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Prevalence of sarcopenic obesity
What the sources say
- Partly supportedcites [202] Alley, D. E. et al. Grip strength cutpoints for the identification of clinically relevant weakness. J. Gerontol. A Biol. Sci. Med. Sci. 69, 559–566 (2014). sourceExperimental — accuracy not yet measured
Table 1 in the Results reports that 4.1% of obese men had weak grip strength, and the Results state that 14% of obese women were classified as weak. These percentages are among obese participants, not among all men and women; the paper also does not classify them as having “sarcopenic obesity.” (LLM, conf=0.90)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“a combination of weight loss and regular exercise improved physical function and ameliorated frailty more than either intervention alone246”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Treatments for sarcopenic obesity
What the sources say
- Supportedcites [246] Villareal, D. T. et al. Weight loss, exercise, or both and physical function in obese older adults. N. Engl. J. Med. 364, 1218–1229 (2011). This is a randomized trial of older adults with frailty and obesity that compares diet, exercise type and controls and demonstrates that physical function improves and muscle and bone loss is mitigated with concomitant exercise therapy. source
The Discussion states that, in obese older adults, weight loss plus exercise improved physical function and ameliorated frailty more than either intervention alone. It also describes the participants as having mild-to-moderate frailty and sarcopenic obesity. The supplied passages do not give page numbers. (LLM, conf=0.94)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“reduced leg isometric strength and increased waist circumference were associated with increased mortality232 (HR 2.46, 95% CI 1.34–4.52)”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Consequences of sarcopenic obesity > Mortality.
What the sources say
- Supportedcites [232] Rossi, A. P. et al. Dynapenic abdominal obesity as predictor of mortality and disability worsening in older adults: a 10-year prospective study. Clin. Nutr. 35, 199–204 (2016). source
The Abstract reports that leg isometric strength and waist circumference were measured and that participants with both low strength and abdominal obesity had an adjusted mortality HR of 2.46 (95% CI 1.34–4.52). The Discussion likewise identifies this group as having the highest all-cause mortality risk. (LLM, conf=0.94)
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“higher doses have recently demonstrated no changes in lean mass273”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Treatments for sarcopenic obesity > Dietary strategies: calorie restriction and protein supplementation.
What the sources say
- Supportedcites [273] Bhasin, S. et al. Effect of protein intake on lean body mass in functionally limited older men: a randomized clinical trial. JAMA Intern. Med. 178, 530–541 (2018). source
The Lean Body Mass section reports no significant effect of increasing protein intake from 0.8 to 1.3 g/kg/day on lean body mass over six months. This supports the claim as a statement about the effect of higher protein intake, not an assertion that no participant’s lean mass changed; the trial studied functionally limited older men. (LLM, conf=0.91)
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“investigators reported a 16% reduction in mortality (95% CI 0.71–0.99)243”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Treatments for sarcopenic obesity
What the sources say
- Partly supportedcites [243] Kritchevsky, S. B. et al. Intentional weight loss and all-cause mortality: a meta-analysis of randomized clinical trials. PLoS ONE 10, e0121993 (2015). This is an important meta-analysis that evaluates randomized controlled trials of weight loss interventions in older adults and their impact on mortality. sourceExperimental — accuracy not yet measured
The Results section (‘Sub-analyses: modifying effects of age, follow up duration, and magnitude of weight loss’) reports a 16% lower mortality estimate (RR 0.84; 95% CI 0.71–0.99) for trials with a mean participant age ≥55 years. Follow-up ≥4 years was a separate subgroup, with a different estimate (RR 0.85; 95% CI 0.72–1.00). The cited result therefore does not establish the claimed combined age-and-follow-up subgroup. (LLM, conf=0.90)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Early pilot studies demonstrate that meals enhanced with protein and coupled with a weight loss intervention improve physical function263.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Treatments for sarcopenic obesity > Dietary strategies: calorie restriction and protein supplementation.
What the sources say
- Supportedcites [263] Porter Starr, K. N. et al. Improved function with enhanced protein intake per meal: a pilot study of weight reduction in frail, obese older adults. J. Gerontol. A Biol. Sci. Med. Sci. 71, 1369–1375 (2016). source
The Results report that participants on the protein-enhanced weight-loss diet improved physical function more than those on the traditional weight-loss diet. The Discussion identifies this as a pilot trial in frail, obese older adults. (LLM, conf=0.93)
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Cutoffs specific to individuals from South Korea predicted higher mortality risk than the FNIH cut-off233.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Consequences of sarcopenic obesity > Mortality.
What the sources say
- Partly supportedcites [233] Moon, J. H. et al. Predictive values of the new sarcopenia index by the Foundation for the National Institutes of Health sarcopenia project for mortality among older Korean adults. PLoS ONE 11, e0166344 (2016). sourceExperimental — accuracy not yet measured
The Discussion reports that lowest-quintile cutoffs specific to the Korean study population predicted mortality more accurately than FNIH cutoffs. It also says these associations were observed only in men, not women, so the claim is broader than the finding. (LLM, conf=0.87)
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“a high- protein diet in conjunction with resistance training preserved appendicular lean mass during weight loss264”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Treatments for sarcopenic obesity > Dietary strategies: calorie restriction and protein supplementation.
What the sources say
- Partly supportedcites [264] Verreijen, A. M. et al. Effect of a high protein diet and/or resistance exercise on the preservation of fat free mass during weight loss in overweight and obese older adults: a randomized controlled trial. Nutr. J. 16, 10 (2017). sourceExperimental — accuracy not yet measured
The Discussion reports that only the combined high-protein and resistance-exercise group significantly increased fat-free mass during weight loss, while finding no significant interaction between the interventions. The Methods describe measurement of whole-body fat-free mass, not appendicular lean mass, so the cited paper does not establish preservation of that specific outcome. (LLM, conf=0.88)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“an elevated BMI is associated with admission to a nursing home240”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Consequences of sarcopenic obesity > Institutionalization and health-care utilization.
What the sources say
- Partly supportedcites [240] Zizza, C. A., Herring, A., Stevens, J. & Popkin, B. M. Obesity affects nursing-care facility admission among whites but not blacks. Obes. Res. 10, 816–823 (2002). sourceExperimental — accuracy not yet measured
The Results section reports increased nursing-home admission risk for white adults with BMI of 30 or higher, but not for those with BMI of 25 to under 30. It reports no significant increased risk among Black adults. The claim omits these limits and therefore overgeneralizes the association. (LLM, conf=0.89)
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Energy deficits created by acute calorie restriction could downregulate muscle protein synthesis and increase proteolysis, which contributes to reduced muscle mass247,253,254”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Treatments for sarcopenic obesity > Dietary strategies: calorie restriction and protein supplementation.
What the sources say
- Partly supportedcites [247] Villareal, D. T. et al. Aerobic or resistance exercise, or both in dieting obese older adults. N. Engl. J. Med. 376, 1943–1955 (2017). This is a randomized trial of older adults with obesity and frailty demonstrating that weight loss coupled with both aerobic and resistance activities is associated with improved physical function. sourceExperimental — accuracy not yet measured
The Results (Body Composition; page not available in our copy) report decreased lean mass during the six-month weight-loss intervention, supporting the reduced-mass portion of the claim. The Methods describe a sustained dietary energy deficit, but the paper does not report whether acute calorie restriction downregulates muscle protein synthesis or increases proteolysis. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [253] Areta, J. L. et al. Reduced resting skeletal muscle protein synthesis is rescued by resistance exercise and protein ingestion following short-term energy deficit. Am. J. Physiol. Endocrinol. Metab. 306, E989–E997 (2014). source
- Not checked — no full text of the sourcecites [254] Pasiakos, S. M. et al. Effects of high-protein diets on fat-free mass and muscle protein synthesis following weight loss: a randomized controlled trial. FASEB J. 27, 3837–3847 (2013). source
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Generally, 25.0–30.0 g of protein containing 2.5–2.8 g of leucine can slow frailty261,262.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Treatments for sarcopenic obesity > Dietary strategies: calorie restriction and protein supplementation.
What the sources say
- Partly supportedcites [261] Beasley, J. M. et al. Protein intake and incident frailty in the Women’s Health Initiative observational study. J. Am. Geriatr. Soc. 58, 1063–1071 (2010). sourceExperimental — accuracy not yet measured
The Results and Discussion report that higher protein intake was associated with lower incidence of frailty in older women. Our copy gives no 25.0–30.0 g protein or 2.5–2.8 g leucine recommendation (searched those amounts and leucine), and this observational association does not establish that such an intake slows frailty. (LLM, conf=0.89)
- Partly supportedcites [262] Tieland, M. et al. Protein supplementation improves physical performance in frail elderly people: a randomized, double-blind, placebo-controlled trial. J. Am. Med. Dir. Assoc. 13, 720–726 (2012). sourceExperimental — accuracy not yet measured
The indexed title reports that protein supplementation improved physical performance in frail elderly people. The retrieved passages do not establish that 25.0–30.0 g of protein containing 2.5–2.8 g of leucine slows frailty; searches for the amounts and for frailty progression found no supporting passage. (LLM, conf=0.72)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“participants with sarcopenic obesity undergoing a weight loss programme augmented by a high-protein diet showed improvements in muscle strength and Short Form-36 scores (REF265)”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Treatments for sarcopenic obesity > Dietary strategies: calorie restriction and protein supplementation.
What the sources say
- Partly supportedcites [265] Sammarco, R. et al. Evaluation of hypocaloric diet with protein supplementation in middle-aged sarcopenic obese women: a pilot study. Obes. Facts 10, 160–167 (2017). sourceExperimental — accuracy not yet measured
The Results (p. 5) report significantly improved muscle strength in the high-protein group. They report a significant improvement in only the general-health score of the SF-36; the other SF-36 categories did not change significantly, so the claim is too broad about SF-36 scores. (LLM, conf=0.87)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The rate of depression has been reported as being highest in patients with sarcopenic obesity (defined as low handgrip strength and obesity defined by BMI) (OR 1.79, 95% CI 1.10–2.89) over 4 years222”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Consequences of sarcopenic obesity > Comorbidities.
What the sources say
- Partly supportedcites [222] Hamer, M., Batty, G. D. & Kivimaki, M. Sarcopenic obesity and risk of new onset depressive symptoms in older adults: English Longitudinal Study of Ageing. Int. J. Obes. (Lond.) 39, 1717–1720 (2015). This study includes longitudinal data that suggest an association between sarcopenic obesity and depression. sourceExperimental — accuracy not yet measured
The Results report an adjusted OR of 1.79 (95% CI 1.10–2.89) for new-onset depressive symptoms in obese adults with low grip strength versus non-obese adults with high grip strength. However, the outcome was assessed at six-year follow-up; four years refers to the interval over which grip-strength change was measured in a separate analysis. (LLM, conf=0.90)
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Another study reported no differences in Short Form-36 scores, which provide a measure of quality of life235, between individuals with obesity and low handgrip strength and individuals with normal indices236.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Consequences of sarcopenic obesity > Quality of life.
What the sources say
- Partly supportedcites [236] Silva Neto, L. S., Karnikowiski, M. G., Tavares, A. B. & Lima, R. M. Association between sarcopenia, sarcopenic obesity, muscle strength and quality of life variables in elderly women. Rev. Bras. Fisioter. 16, 360–367 (2012). sourceExperimental — accuracy not yet measured
The Results (Table 3; page not available in our copy) report no statistically significant differences in SF-36 domains between older women classified with and without sarcopenic obesity. But classification was based on body-composition measures, not low handgrip strength; the comparison group was women without sarcopenic obesity, not necessarily women with normal indices. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“weight loss plus combined aerobic and resistance exercise was the most effective method for improving functional status of adults aged 65 years and older with obesity247”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Treatments for sarcopenic obesity
What the sources say
- Supportedcites [247] Villareal, D. T. et al. Aerobic or resistance exercise, or both in dieting obese older adults. N. Engl. J. Med. 376, 1943–1955 (2017). This is a randomized trial of older adults with obesity and frailty demonstrating that weight loss coupled with both aerobic and resistance activities is associated with improved physical function. source
The Abstract Conclusions state that, of the methods tested, weight loss plus combined aerobic and resistance exercise was most effective for improving functional status in obese older adults. The Discussion specifies that the trial involved adults aged 65 or older and found greater improvement in physical function than with either exercise type alone. (LLM, conf=0.94)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“the combination of obesity as defined by BMI and low handgrip strength suggested an increased risk of type 2 diabetes mellitus (OR 3.57, 95% CI 2.04–6.24)”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Consequences of sarcopenic obesity > Comorbidities.
What the sources say
- Could not verifycites [221] Atkins, J. L. et al. Sarcopenic obesity and risk of cardiovascular disease and mortality: a population-based cohort study of older men. J. Am. Geriatr. Soc. 62, 253–260 (2014). sourceExperimental — accuracy not yet measured
The Methods define obesity by waist circumference and sarcopenia by midarm muscle circumference, not BMI and handgrip strength. The Results report cardiovascular events and mortality; a search for type 2 diabetes and the stated OR and confidence interval found no matching result in our copy. (LLM, conf=0.76)
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“risk of falling was highest in individuals with low muscle mass and/or strength with obesity as defined by percentage of body fat219”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Consequences of sarcopenic obesity > Comorbidities.
What the sources say
- Partly supportedcites [219] Scott, D. et al. Sarcopenic obesity and dynapenic obesity: 5-year associations with falls risk in middle-aged and older adults. Obesity (Silver Spring) 22, 1568–1574 (2014). sourceExperimental — accuracy not yet measured
The Discussion reports that obesity combined with low muscle strength, but not low muscle mass, predicted an increased falls-risk score over five years in community-dwelling middle-aged and older adults. The Operational definitions section defines obesity by high DXA-assessed total or trunk fat mass, not percentage body fat; the study measured a risk score rather than observed falls. (LLM, conf=0.90)
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The EuroQOL score was dependent on cardiovascular fitness rather than sarcopenic obesity237.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Consequences of sarcopenic obesity > Quality of life.
What the sources say
- Partly supportedcites [237] Pedrero-Chamizo, R. et al. Higher levels of physical fitness are associated with a reduced risk of suffering sarcopenic obesity and better perceived health among the elderly: the EXERNET multi-center study. J. Nutr. Health Aging 19, 211–217 (2015). sourceExperimental — accuracy not yet measured
The Results (page unavailable) associate better EuroQol-rated perceived health with higher aerobic fitness, supporting the cardiovascular-fitness part of the claim. But Table 2 and the Statistical analysis section also report differences in health-related quality of life across sarcopenic-obesity groups; the paper does not establish that the score depends on fitness rather than sarcopenic obesity. (LLM, conf=0.86)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“High protein intake (1.2 g of protein per kg per day) during weight loss might eliminate the beneficial effect of weight loss on insulin sensitivity in skeletal muscle258.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Treatments for sarcopenic obesity > Dietary strategies: calorie restriction and protein supplementation.
What the sources say
- Supportedcites [258] Smith, G. I. et al. High-protein intake during weight loss therapy eliminates the weight-loss-induced improvement in insulin action in obese postmenopausal women. Cell Rep. 17, 849–861 (2016). source
The Discussion reports that participants receiving 1.2 g protein/kg/day during approximately 10% weight loss did not gain the improvement in muscle insulin action seen with the standard-protein diet. The study was conducted in postmenopausal women with obesity, and the citing sentence’s cautious “might” is consistent with that finding. (LLM, conf=0.94)
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Strategies that optimize protein anabolism during weight loss, such as consumption before exercise or spreading out of protein during the day, can prevent weight loss-induced sarcopenia247,250.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Treatments for sarcopenic obesity > Dietary strategies: calorie restriction and protein supplementation.
What the sources say
- Partly supportedcites [247] Villareal, D. T. et al. Aerobic or resistance exercise, or both in dieting obese older adults. N. Engl. J. Med. 376, 1943–1955 (2017). This is a randomized trial of older adults with obesity and frailty demonstrating that weight loss coupled with both aerobic and resistance activities is associated with improved physical function. sourceExperimental — accuracy not yet measured
The Discussion (page not provided) suggests improving the efficiency of protein intake as a possible future strategy to preserve lean mass during weight loss. It does not mention protein consumption before exercise or distributing protein across the day, and reports that lean-mass loss was attenuated, not prevented. (LLM, conf=0.88)
- Partly supportedcites [250] Batsis, J. A. et al. Weight loss interventions in older adults with obesity: a systematic review of randomized controlled trials since 2005. J. Am. Geriatr. Soc. 65, 257–268 (2017). This is a comprehensive systematic review of randomized trials in older adults with obesity highlighting the importance of the improvement in physical function through diet and exercise. sourceExperimental — accuracy not yet measured
The Discussion (page not provided) says that caloric reduction with appropriate protein supplementation and resistance exercise may prevent sarcopenia in older adults with obesity. It does not address consuming protein before exercise or spreading intake throughout the day, and its conclusion is more cautious than the claim’s “can prevent.” (LLM, conf=0.87)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“reduced muscle strength is associated with increased mortality (HR 1.30, 95% CI 1.09–1.54)228”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Consequences of sarcopenic obesity > Mortality.
What the sources say
- Partly supportedcites [228] Stenholm, S. et al. Obesity and muscle strength as long-term determinants of all-cause mortality — a 33-year follow-up of the Mini-Finland Health Examination Survey. Int. J. Obes. (Lond.) 38, 1126–1132 (2014). sourceExperimental — accuracy not yet measured
The Abstract Results report HR 1.30 (95% CI 1.09–1.54), but specifically for participants aged 70 or older with normal weight and low handgrip strength, compared with normal-weight participants with high handgrip strength. The citing sentence omits those age, weight, and comparator qualifications and presents the estimate as applying to reduced strength generally. (LLM, conf=0.90)
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Increased dietary protein stimulates muscle protein synthesis71,256.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Treatments for sarcopenic obesity > Dietary strategies: calorie restriction and protein supplementation.
What the sources say
- Supportedcites [71] Bauer, J. et al. Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. J. Am. Med. Dir. Assoc. 14, 542–559 (2013). This is a position paper from the PROT-Age study group that recommends an average daily intake of at least 1.0–1.2 g protein per kg body weight per day. source
The Protein or Amino Acid Supplementation section states that dietary protein supplementation promotes protein synthesis in older people. The Benefits of Higher Protein Intake for Older Adults section also describes sufficient protein intake as a way to maximize muscle protein anabolism. The paper supports the claim in its older-adult context. (LLM, conf=0.90)
- Not checked — no full text of the sourcecites [256] Wolfe, R. R., Miller, S. L. & Miller, K. B. Optimal protein intake in the elderly. Clin. Nutr. 27, 675–684 (2008). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“identified 33 trials that significantly improved physical abilities (standardized mean difference 0.14, 95% CI 0.05–0.22) in 2,172 participants”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Treatments for sarcopenic obesity > Resistance training and aerobic exercise.
What the sources say
- Supportedcites [281] Liu, C. J. & Latham, N. K. Progressive resistance strength training for improving physical function in older adults. Cochrane Database Syst. Rev. 3, CD002759 (2009). This is a systematic Cochrane review of randomized controlled trials reporting physical outcomes of progressive resistance therapy that demonstrates improved strength and performance. source
The Results, under “PRT versus control,” report a significant decrease in disability across 33 trials and 2,172 participants (SMD 0.14, 95% CI 0.05 to 0.22). The 33 trials are those pooled for this outcome, not all trials included in the review. (LLM, conf=0.95)
plaindirectn = 2,172- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Obesity is inversely related to BMD and fractures313 but might increase the fracture risk through bone quality314,315 or frailty132,316 independent of BMD.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Risks of weight loss in older adults
What the sources say
- Supportedcites [314] Nielson, C. M. et al. BMI and fracture risk in older men: the osteoporotic fractures in men study (MrOS). J. Bone Miner. Res. 26, 496–502 (2011). source
The Discussion reports that obesity was associated with greater fracture risk in older men after adjustment for BMD, partly explained by deficits in physical performance. This supports the hedged suggestion of a frailty-related pathway; the bone-quality portion of the citing sentence is attached to other citations. (LLM, conf=0.90)
- Partly supportedcites [315] Compston, J. E. et al. Obesity is not protective against fracture in postmenopausal women: GLOW. Am. J. Med. 124, 1043–1050 (2011). sourceExperimental — accuracy not yet measured
The Discussion reports more falls and several markers of frailty among obese women with fractures, and suggests these may help explain their fracture risk. It also cautions that higher BMD may not confer greater bone strength, but it does not establish that frailty increases fracture risk independently of BMD. The bone-quality portion of the citing sentence has separate citations. (LLM, conf=0.82)
- Partly supportedcites [132] Villareal, D. T., Banks, M., Siener, C., Sinacore, D. R. & Klein, S. Physical frailty and body composition in obese elderly men and women. Obes. Res. 12, 913–920 (2004). sourceExperimental — accuracy not yet measured
The Results report that 96% of the obese elderly subjects met the study’s frailty criteria, and the Discussion associates obesity with physical frailty despite greater bone mass than in the nonobese groups. The paper does not establish that frailty increases fracture risk independently of BMD; it says the implications of the greater bone mass for fracture risk are unknown. Bone quality is not the part of the citing sentence attributed to this source. (LLM, conf=0.85)
- Partly supportedcites [316] Ensrud, K. E. et al. A comparison of frailty indexes for the prediction of falls, disability, fractures, and mortality in older men. J. Am. Geriatr. Soc. 57, 492–498 (2009). sourceExperimental — accuracy not yet measured
The Results report that frail older men had higher age-adjusted nonspine fracture risk, and the multivariable prediction models included femoral-neck BMD. The paper does not show that obesity increases fracture risk through frailty, or establish frailty as a causal pathway independent of BMD; bone quality is associated with other citations in the citing sentence. (LLM, conf=0.85)
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“adding aerobic activity to calorie restriction increased serum concentrations of adiponectin (6.9 μg/ml for individuals in the group without aerobic activity versus 8.5 μg/ml for individuals in the group with aerobic activity (P < 0.001))305”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Treatments for sarcopenic obesity > Calorie restriction and physical activity.
What the sources say
- Partly supportedcites [305] Wang, X., You, T., Murphy, K., Lyles, M. F. & Nicklas, B. J. Addition of exercise increases plasma adiponectin and release from adipose tissue. Med. Sci. Sports Exerc. 47, 2450–2455 (2015). sourceExperimental — accuracy not yet measured
The Methods and Results describe overweight or obese postmenopausal women and support an increase in circulating adiponectin when aerobic exercise was added to caloric restriction. The Results report post-intervention plasma concentrations of 5.2 μg/ml without exercise and 7.6 μg/ml with exercise, not the claimed 6.9 and 8.5 μg/ml; the group-by-time interaction had P = 0.014, while the increase within the exercise group had P = 0.0001. The paper measured plasma, rather than serum, adiponectin. (LLM, conf=0.91)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“the short physical performance battery — an objective assessment tool for the evaluation of lower extremity function (higher score equals better function)284 — of patients with sarcopenia improved from 7.4 to 8.7 when compared with the successful ageing group285”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Treatments for sarcopenic obesity > Resistance training and aerobic exercise.
What the sources say
- Partly supportedcites [285] Liu, C. K. et al. The impact of sarcopenia on a physical activity intervention: the Lifestyle Interventions and Independence for Elders Pilot Study (LIFE-P). J. Nutr. Health Aging 18, 59–64 (2014). sourceExperimental — accuracy not yet measured
The Results section, “Analysis of SPPB” (page unavailable), reports a 12-month SPPB score of 8.7 for sarcopenic participants in the physical-activity group and compares that group with the successful-aging group. Our copy does not establish the claimed starting score of 7.4. The reported difference between groups at 12 months was not statistically significant. (LLM, conf=0.84)
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Adipose tissue has been shown to be inversely associated with bone material strength and positively associated with cortical porosity, indicating an adverse effect of adipose tissue on bone microstructure317.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Risks of weight loss in older adults
What the sources say
- Partly supportedcites [317] Sundh, D. et al. A high amount of local adipose tissue is associated with high cortical porosity and low bone material strength in older women. J. Bone Miner. Res. 31, 749–757 (2016). sourceExperimental — accuracy not yet measured
The Discussion (page not provided) reports that local tibial adipose tissue was inversely associated with bone material strength and positively associated with cortical porosity in older women. It describes a negative effect on cortical microstructure as possible, rather than establishing that adipose tissue has an adverse effect generally. (LLM, conf=0.86)
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Unopposed diet therapy without exercise in older frail adults ≥65 years with obesity (BMI ≥30 kg/m2) led to a marked loss of lean mass at 6 months and 1 year (−3.5 kg and −3.2 kg, respectively) compared with the diet and exercise group, where the loss of lean mass was partially mitigated (−1.7 kg and −1.8 kg, respectively)246.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Risks of weight loss in older adults
What the sources say
- Partly supportedcites [246] Villareal, D. T. et al. Weight loss, exercise, or both and physical function in obese older adults. N. Engl. J. Med. 364, 1218–1229 (2011). This is a randomized trial of older adults with frailty and obesity that compares diet, exercise type and controls and demonstrates that physical function improves and muscle and bone loss is mitigated with concomitant exercise therapy. sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“aquatic exercises are as effective as land-based exercises (standardized mean difference 0.39, 95% CI 0.12–0.66)”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Treatments for sarcopenic obesity > Resistance training and aerobic exercise.
What the sources say
- Supportedcites [294] Waller, B. et al. The effect of aquatic exercise on physical functioning in the older adult: a systematic review with meta-analysis. Age Ageing 45, 593–601 (2016). source
The Abstract reports an SMD of 0.39 (95% CI 0.12–0.66) for aquatic versus land-based exercise on physical functioning. The Discussion concludes that aquatic exercise appears at least as effective, while cautioning that the evidence has high heterogeneity and risk of bias. (LLM, conf=0.93)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“A meta-analysis of 18 trials (n = 3,824), including study participants greater than 65 years who participated in tai chi for a minimum of 4 weeks (range 1–12 months) 1–3 times per week, demonstrated a reduction in falls of 20% (relative risk (RR) 0.8, 95% CI 0.72–0.88)292.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Treatments for sarcopenic obesity > Resistance training and aerobic exercise.
What the sources say
- Partly supportedcites [292] Huang, Z. G., Feng, Y. H., Li, Y. H. & Lv, C. S. Systematic review and meta-analysis: Tai Chi for preventing falls in older adults. BMJ Open 7, e013661 (2017). sourceExperimental — accuracy not yet measured
The Abstract Results report 18 trials with 3,824 participants and RR 0.80 (95% CI 0.72–0.88), but the Results section specifies that this estimate for the number of fallers came from 16 studies with 3,539 participants. The Methods allowed participants over 60, or trials with an average age over 65, rather than requiring every participant to be over 65. The study-characteristics table also includes Tai Chi schedules longer than 12 months and more frequent than three times weekly, so the stated duration and frequency ranges do not describe all included trials. (LLM, conf=0.91)
boosteddirectn = 3,824- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In the Look AHEAD trial, total skeletal mass decreased in both of the intensive lifestyle groups and in the diabetes support and education group (−1.4 kg; P < 0.001).”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Risks of weight loss in older adults
What the sources say
- Partly supportedcites [310] Gallagher, D. et al. Changes in skeletal muscle and organ size after a weight-loss intervention in overweight and obese type 2 diabetic patients. Am. J. Clin. Nutr. 105, 78–84 (2017). sourceExperimental — accuracy not yet measured
The Abstract reports that total skeletal muscle decreased by 1.4 kg in both groups during year 1 (P < 0.001), and the SM section identifies those groups as ILI and DSE. The claim incorrectly describes two intensive lifestyle groups; the study reports one ILI group and one DSE group. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“demonstrated reduced persistent mobility disability (HR 0.72, 95% CI 0.57–0.91) compared with a health education programme”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Treatments for sarcopenic obesity > Resistance training and aerobic exercise.
What the sources say
- Supportedcites [282] Pahor, M. et al. Effect of structured physical activity on prevention of major mobility disability in older adults: the LIFE study randomized clinical trial. JAMA 311, 2387–2396 (2014). This study reports on a gold standard, structured, long-term physical activity intervention, consisting of 3–4 times of aerobic, resistance and flexibility training per week, that demonstrates improvements in mobility disability over a 2.6-year follow-up. source
The Results section (Major mobility disability) reports persistent mobility disability in 120/818 physical activity participants versus 162/817 health education participants, with HR 0.72 (95% CI 0.57–0.91). This directly supports the claimed reduction and comparator. (LLM, conf=0.95)
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“improvements in muscle strength (standardized mean difference 0.84, 95% CI 0.67–1.00) in 73 trials281 (3,059 participants)”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Treatments for sarcopenic obesity > Resistance training and aerobic exercise.
What the sources say
- Supportedcites [281] Liu, C. J. & Latham, N. K. Progressive resistance strength training for improving physical function in older adults. Cochrane Database Syst. Rev. 3, CD002759 (2009). This is a systematic Cochrane review of randomized controlled trials reporting physical outcomes of progressive resistance therapy that demonstrates improved strength and performance. source
The Results (‘Effects of interventions,’ Strength) report that 73 studies involving 3,059 participants found a beneficial effect of progressive resistance training on strength: SMD 0.84 (95% CI 0.67–1.00). The pooled measure was specifically strength of a lower-limb extensor muscle group. (LLM, conf=0.94)
plaindirectn = 3,059- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The addition of weight loss of 0.3 kg per week for 6 months to physical activity in older community-dwelling adults with obesity or overweight results in a greater reduction in serum levels of leptin and IL-6 than either physical activity alone or a successful ageing health education intervention308.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Treatments for sarcopenic obesity > Calorie restriction and physical activity.
What the sources say
- Supportedcites [308] Beavers, K. M., Ambrosius, W. T., Nicklas, B. J. & Rejeski, W. J. Independent and combined effects of physical activity and weight loss on inflammatory biomarkers in overweight and obese older adults. J. Am. Geriatr. Soc. 61, 1089–1094 (2013). source
Split into 2 atoms — 2 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“A meta-analysis of 28 studies demonstrated a positive effect of aquatic exercises on physical functioning (RR 0.70, 95% CI 0.48–0.92) compared with no training (control group)294.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Treatments for sarcopenic obesity > Resistance training and aerobic exercise.
What the sources say
- Partly supportedcites [294] Waller, B. et al. The effect of aquatic exercise on physical functioning in the older adult: a systematic review with meta-analysis. Age Ageing 45, 593–601 (2016). sourceExperimental — accuracy not yet measured
The Abstract (p. 1) reports a positive effect of aquatic exercise versus control of 0.70 (95% CI 0.48–0.92), also reported in Results under “Aquatic exercise compared to control.” However, 28 studies were included in the systematic review, only 24 in the meta-analysis, and the effect measure was a standardised mean difference, not a risk ratio (RR). (LLM, conf=0.94)
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“two versus three training sessions per week for 12 weeks of high-speed resistance training were equally effective for improving physical performance and quality of life288”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Treatments for sarcopenic obesity > Resistance training and aerobic exercise.
What the sources say
- Partly supportedcites [288] Ramirez-Campillo, R. et al. Effects of different doses of high-speed resistance training on physical performance and quality of life in older women: a randomized controlled trial. Clin. Interv. Aging 11, 1797–1804 (2016). sourceExperimental — accuracy not yet measured
The Discussion states that two and three HSRT sessions per week were equally effective for physical performance and quality of life, and the Methods specify a 12-week intervention. The Conclusion limits that finding to older women when training volume and intensity were equated; the citing sentence omits those conditions and reads more broadly. (LLM, conf=0.85)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“the positive effects on circulating cytokines, adiponectin and TNF were due to diet and not exercise301”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Treatments for sarcopenic obesity > Calorie restriction and physical activity.
What the sources say
- Supportedcites [301] Bouchonville, M. et al. Weight loss, exercise or both and cardiometabolic risk factors in obese older adults: results of a randomized controlled trial. Int. J. Obes. (Lond.) 38, 423–431 (2014). source
The Abstract (Results) reports similar improvements in adiponectin and the TNF-related measure in the diet and diet-exercise groups, with no changes in the exercise-only group. The Results (Adipocytokines) identify the TNF-related measure more precisely as soluble TNF receptor 1 (sTNF R1). (LLM, conf=0.92)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“levels of C-reactive protein and IL-6 decreased in older adults (age ≥65 years) with obesity (BMI ≥30 kg/m2) compared with controls (−2.5 versus 0.8 mg/l (P < 0.05) and −2.4 versus 1.6 pg/ml (P < 0.05), respectively)300”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Treatments for sarcopenic obesity > Calorie restriction and physical activity.
What the sources say
- Supportedcites [300] Villareal, D. T. et al. Effect of lifestyle intervention on metabolic coronary heart disease risk factors in obese older adults. Am. J. Clin. Nutr. 84, 1317–1323 (2006). source
Split into 2 atoms — 2 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The addition of pharmacotherapy, such as testosterone supplementation, to progressive resistance training augmented the improvements in body composition, including reduced fat mass and improved lean mass357.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Exercise and combined interventions.
What the sources say
- Supportedcites [357] Hildreth, K. L. et al. Effects of testosterone and progressive resistance exercise in healthy, highly functioning older men with low-normal testosterone levels. J. Clin. Endocrinol. Metab. 98, 1891–1900 (2013). source
The Body composition results report that, among men assigned to progressive resistance training, those receiving testosterone had a greater reduction in fat mass and a greater increase in fat-free mass than those receiving placebo. The Body composition discussion explicitly states that testosterone plus training produced greater improvements in both measures than placebo plus training. The study population was generally healthy older men with low-normal testosterone levels. (LLM, conf=0.94)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Summative effects of the combination of whole body vibration therapy and resistance exercises374–377 or of whole-body vibration therapy and vitamin D367 are mixed.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Whole-body vibration therapy.
What the sources say
- Not checked — no full text of the sourcecites [374] Bemben, D. A., Palmer, I. J., Bemben, M. G. & Knehans, A. W. Effects of combined whole-body vibration and resistance training on muscular strength and bone metabolism in postmenopausal women. Bone 47, 650–656 (2010). source
- Not checked — no full text of the sourcecites [375] Fjeldstad, C., Palmer, I. J., Bemben, M. G. & Bemben, D. A. Whole-body vibration augments resistance training effects on body composition in postmenopausal women. Maturitas 63, 79–83 (2009). source
- Not checked — no full text of the sourcecites [376] Machado, A., Garcia-Lopez, D., Gonzalez-Gallego, J. & Garatachea, N. Whole-body vibration training increases muscle strength and mass in older women: a randomized-controlled trial. Scand. J. Med. Sci. Sports 20, 200–207 (2010). source
- Not checked — no full text of the sourcecites [377] von Stengel, S., Kemmler, W., Engelke, K. & Kalender, W. A. Effect of whole-body vibration on neuromuscular performance and body composition for females 65 years and older: a randomized-controlled trial. Scand. J. Med. Sci. Sports 22, 119–127 (2012). source
- Partly supportedcites [367] Verschueren, S. M. et al. The effects of whole-body vibration training and vitamin D supplementation on muscle strength, muscle mass, and bone density in institutionalized elderly women: a 6-month randomized, controlled trial. J. Bone Miner. Res. 26, 42–49 (2011). sourceExperimental — accuracy not yet measured
The Interaction effects section (page unavailable) reports no evidence of an interactive effect between whole-body vibration and vitamin D for any outcome. This supports a lack of additional benefit from the combination in this trial, but the paper does not itself report mixed effects of that combination. The resistance-exercise clause is attributed to other citations, not this source. (LLM, conf=0.78)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“Studies emphasize exercise training during calorie restriction to prevent an increase in bone turn-over327 and an increase in serum levels of sclerostin328, thus minimizing bone loss.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Risks of weight loss in older adults
What the sources say
- Supportedcites [327] Shah, K. et al. Exercise training in obese older adults prevents increase in bone turnover and attenuates decrease in hip bone mineral density induced by weight loss despite decline in bone-active hormones. J. Bone Miner. Res. 26, 2851–2859 (2011). source
The Results report that bone-turnover markers increased with diet alone but did not significantly change with diet plus exercise. The Discussion reports that exercise attenuated the weight-loss-induced decrease in hip BMD. In the citing sentence, this paper is cited for bone turnover (327); the sclerostin claim has a separate citation (328). (LLM, conf=0.93)
- Supportedcites [328] Armamento-Villareal, R. et al. Weight loss in obese older adults increases serum sclerostin and impairs hip geometry but both are prevented by exercise training. J. Bone Miner. Res. 27, 1215–1221 (2012). source
The Discussion reports that adding exercise training to diet prevented the weight-loss-induced rise in sclerostin and attenuated bone loss in obese older adults. It also states that exercise prevented an increase in bone-turnover markers, while noting that this result had been reported previously. (LLM, conf=0.92)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“These findings suggest that BMD and markers of bone turnover following long-term calorie restriction show larger changes in patients than in healthy control participants advised to continue their current diet322.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Risks of weight loss in older adults
What the sources say
- Partly supportedcites [322] Villareal, D. T. et al. Effect of two-year caloric restriction on bone metabolism and bone mineral density in non-obese younger adults: a randomized clinical trial. J. Bone Miner. Res. 31, 40–51 (2016). This is a 2-year randomized trial of caloric restriction, which had been previously shown to lead to bone loss at important sites of osteoporotic fractures as represented by reductions in BMD. sourceExperimental — accuracy not yet measured
The Abstract reports greater BMD changes after 24 months of calorie restriction than with an ad libitum diet, and greater changes in several bone-turnover markers at 12 months; at 24 months, only BSAP differed between groups. The Methods (Participants and Study Design; page unavailable) say both groups were healthy volunteers and the controls were advised to continue their current diets, so describing the restriction group as “patients” is misleading. (LLM, conf=0.87)
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Furthermore, trabecular geometry, cortical geometry and strength were no different in individuals undergoing intentional weight loss through calorie restriction or weight maintenance for 6 months324, which suggests that calorie restriction has protective effects on bone quality.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Risks of weight loss in older adults
What the sources say
- Supportedcites [324] Pop, L. C. et al. Moderate weight loss in obese and overweight men preserves bone quality. Am. J. Clin. Nutr. 101, 659–667 (2015). source
The tibia Results (page not specified) report no significant changes in trabecular variables and generally no changes in cortical variables between the weight-loss and weight-maintenance groups over six months. The Discussion likewise reports no changes in cortical or trabecular bone variables in the men studied. The statement about protective effects follows the citation as the citing authors’ inference; the source establishes preservation, not an improvement in bone quality. (LLM, conf=0.87)
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In one study, the authors reported that trabecular bone microarchitecture was no different in calorie- restricted participants (~35% less calories than controls) than in middle-aged individuals eating a Western diet323.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Risks of weight loss in older adults
What the sources say
- Supportedcites [323] Villareal, D. T. et al. Reduced bone mineral density is not associated with significantly reduced bone quality in men and women practicing long-term calorie restriction with adequate nutrition. Aging Cell 10, 96–102 (2011). source
The Discussion reports that distal-radius trabecular bone microarchitecture, assessed by composite hr-MRI measures, was not significantly different between the calorie-restricted and Western-diet groups. The Abstract identifies the participants as middle-aged and reports that the calorie-restricted group consumed about 35% fewer calories than controls. (LLM, conf=0.92)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Periodized resistance training in older adults demonstrated equal efficacy in physical function and physiological outcomes when compared with non-periodized resistance training360.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Periodization strategies.
What the sources say
- Supportedcites [360] Conlon, J. A. et al. Periodization strategies in older adults: impact on physical function and health. Med. Sci. Sports Exerc. 48, 2426–2436 (2016). source
The Abstract reports that periodized and non-periodized resistance training produced improvements in physical function and physiological health outcomes with no between-group differences. Its conclusion calls the approaches equally effective in the studied population of apparently healthy, previously untrained older adults. (LLM, conf=0.94)
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Supplementing vitamin D in patients with sarcopenic obesity can potentially influence and improve muscle function331 and proximal muscle weakness332 through the actions ofvitamin D metabolites333.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Risks of weight loss in older adults > Supplementation with calcium and vitamin D.
What the sources say
- Partly supportedcites [331] Hassan-Smith, Z. K. et al. 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 exert distinct effects on human skeletal muscle function and gene expression. PLoS ONE 12, e0170665 (2017). sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) links vitamin D metabolites to muscle function and gene expression, supporting the mechanism attributed to this source. But the study was cross-sectional in healthy volunteers; it did not test supplementation in patients with sarcopenic obesity or establish that supplementation improves muscle function or proximal weakness. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [332] Beaudart, C. et al. The effects of vitamin D on skeletal muscle strength, muscle mass, and muscle power: a systematic review and meta-analysis of randomized controlled trials. J. Clin. Endocrinol. Metab. 99, 4336–4345 (2014). source
- Not checked — no full text of the sourcecites [333] Malafarina, V., Uriz-Otano, F., Malafarina, C., Martinez, J. A. & Zulet, M. A. Effectiveness of nutritional supplementation on sarcopenia and recovery in hip fracture patients. A multi-centre randomized trial. Maturitas 101, 42–50 (2017). source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Older adults often receive gold standard imaging, which can accurately ascertain muscle and fat content, for indications other than sarcopenic obesity, such as abdominal pain or back pain342,343.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Integrating methods for analysing body composition into clinical practice.
What the sources say
- Not checked — no full text of the sourcecites [342] Maddalo, M. et al. Validation of a free software for unsupervised assessment of abdominal fat in MRI. Phys. Med. 37, 24–31 (2017). source
- Partly supportedcites [343] van Vugt, J. L. A. et al. A comparative study of software programmes for cross-sectional skeletal muscle and adipose tissue measurements on abdominal computed tomography scans of rectal cancer patients. J. Cachexia Sarcopenia Muscle 8, 285–297 (2017). sourceExperimental — accuracy not yet measured
The Materials and Methods (Patients; page unavailable) say the abdominal CT scans were routinely obtained for rectal-cancer workup or treatment assessment, not for body-composition assessment. The Abstract (Conclusions; page unavailable) reports excellent agreement in muscle and fat measurements across software and observers. The paper does not establish that older adults often receive such imaging for abdominal or back pain, or that it is a gold-standard measure of accuracy. (LLM, conf=0.87)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Whole-body vibration therapy uses the transmission of mechanical stimuli through the person’s body365,366 to activate the primary ends of muscle spindles, which leads to neuromuscular activation367–369.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Whole-body vibration therapy.
What the sources say
- Partly supportedcites [365] Rogan, S., Hilfiker, R., Herren, K., Radlinger, L. & de Bruin, E. D. Effects of whole-body vibration on postural control in elderly: a systematic review and meta-analysis. BMC Geriatr. 11, 72 (2011). sourceExperimental — accuracy not yet measured
The Discussion says vibration delivers energy to the body and identifies reflex muscle contraction during WBV as a possible stimulus to the muscle–nerve system. It does not identify activation of the primary endings of muscle spindles as the mechanism; the passages have no page numbers. (LLM, conf=0.84)
- Partly supportedcites [366] Rogan, S. et al. Feasibility and effects of applying stochastic resonance whole-body vibration on untrained elderly: a randomized crossover pilot study. BMC Geriatr. 15, 25 (2015). sourceExperimental — accuracy not yet measured
The Background and Methods > Protocol describe participants standing on vibrating platforms and receiving whole-body vibration, supporting the mechanical-stimulation part of the claim. The cited paper does not describe activation of muscle-spindle primary endings or establish that mechanism for neuromuscular activation; the citing sentence places separate citations after that clause. No page numbers are available in our copy. (LLM, conf=0.82)
- Supportedcites [367] Verschueren, S. M. et al. The effects of whole-body vibration training and vitamin D supplementation on muscle strength, muscle mass, and bone density in institutionalized elderly women: a 6-month randomized, controlled trial. J. Bone Miner. Res. 26, 42–49 (2011). source
The Introduction states that vibrations from the platform transmit mechanical stimuli to the body, stimulating the primary endings of muscle spindles and resulting in neuronal activation and muscle contractions. This supports the claimed mechanism; the paper does not give a page number in the supplied passage. (LLM, conf=0.94)
- Supportedcites [368] Cardim, A. B. et al. Does whole-body vibration improve the functional exercise capacity of subjects with COPD? A meta-analysis. Respir. Care 61, 1552–1559 (2016). source
The citation is attached to the transmission of mechanical stimuli through the body. The Introduction (page not specified) describes a vibrating platform whose oscillations are transmitted to the body; it also says they stimulate muscle spindles to produce contractions. (LLM, conf=0.92)
- Supportedcites [369] Burke, D. & Schiller, H. H. Discharge pattern of single motor units in the tonic vibration reflex of human triceps surae. J. Neurol. Neurosurg. Psychiatry 39, 729–741 (1976). source
The Working Hypothesis and Its Implications section (page not provided) says vibration produces group Ia spindle-afferent activity that excites motoneurones. The Muscle Vibration section (page not provided) reports vibration-induced motor-unit discharges. These passages support the spindle-to-neuromuscular-activation mechanism for which this citation is offered. (LLM, conf=0.85)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Loss of BMD in older adults with obesity seems to continue during long-term lifestyle change in the opposite direction to the weight changes321.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Risks of weight loss in older adults
What the sources say
- Supportedcites [321] Waters, D. L. et al. Long-term maintenance of weight loss after lifestyle intervention in frail, obese older adults. J. Nutr. Health Aging 17, 3–7 (2013). source
The Results (page unavailable) report a progressive decline in total-hip BMD over 30 months. The Discussion (page unavailable) reports that weight loss was about 10% at 12 months but 7% at 30 months, indicating some weight regain while hip BMD continued to fall. The finding concerns hip BMD, not whole-body or lumbar-spine BMD. (LLM, conf=0.88)
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“However, 2017 data from the Look AHEAD trial showed that long-term intentional weight loss was associated with a 39% increased risk of fragility fractures325.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Risks of weight loss in older adults
What the sources say
- Partly supportedcites [325] Johnson, K. C. et al. The effect of intentional weight loss on fracture risk in persons with diabetes: results from the Look AHEAD randomized clinical trial. J. Bone Miner. Res. 32, 2278–2287 (2017). sourceExperimental — accuracy not yet measured
The Results report a 39% higher risk of frailty fracture in the intensive lifestyle intervention group than in the diabetes support and education group. The Methods define that endpoint by fracture site—hip, pelvis, upper arm, or shoulder—not as fragility fractures, so the cited figure does not establish the claim for fragility fractures. (LLM, conf=0.86)
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“For instance, leucine-rich protein can activate metabolic pathways involved in testosterone and IGF1 homeostasis348–351.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Dietary composition and restriction.
What the sources say
- Partly supportedcites [348] Witard, O. C., McGlory, C., Hamilton, D. L. & Phillips, S. M. Growing older with health and vitality: a nexus of physical activity, exercise and nutrition. Biogerontology 17, 529–546 (2016). sourceExperimental — accuracy not yet measured
The section “Optimizing the quality and utilization of protein intake on a per meal basis” (page unavailable) says leucine-rich protein can activate mTOR signaling involved in muscle protein synthesis. It does not link that activation to testosterone or IGF1 homeostasis; its separate mention of testosterone concerns pharmaceutical therapy. (LLM, conf=0.87)
- Could not verifycites [349] Garatachea, N. et al. Exercise attenuates the major hallmarks of aging. Rejuvenation Res. 18, 57–89 (2015). sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) says resistance exercise acutely raises testosterone and IGF-1 and activates amino-acid-sensing pathways. Searches for “leucine-rich protein,” leucine, and testosterone found no passage saying that leucine-rich protein activates pathways involved in homeostasis of those hormones. The exercise findings do not establish the protein-specific claim. (LLM, conf=0.76)
- Not checked — no full text of the sourcecites [350] Emmelot-Vonk, M. H. et al. Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial. JAMA 299, 39–52 (2008). source
- Not checked — no full text of the sourcecites [351] Travison, T. G. et al. Clinical meaningfulness of the changes in muscle performance and physical function associated with testosterone administration in older men with mobility limitation. J. Gerontol. A Biol. Sci. Med. Sci. 66, 1090–1099 (2011). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In patients with sarcopenic obesity (defined using handgrip strength and BMI), no differences were observed in strength, power or short performance physical battery following a 10-week periodization strategy of strength and endurance training with concentric and eccentric movements290.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Periodization strategies.
What the sources say
- Partly supportedcites [290] Vasconcelos, K. S. et al. Effects of a progressive resistance exercise program with high-speed component on the physical function of older women with sarcopenic obesity: a randomized controlled trial. Braz. J. Phys. Ther. 20, 432–440 (2016). sourceExperimental — accuracy not yet measured
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Furthermore, trabecular geometry, cortical geometry and strength were no different in individuals undergoing intentional weight loss through calorie restriction or weight maintenance for 6 months324, which suggests that calorie restriction has protective effects on bone quality.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Risks of weight loss in older adults
What the sources say
- Supportedcites [324] Pop, L. C. et al. Moderate weight loss in obese and overweight men preserves bone quality. Am. J. Clin. Nutr. 101, 659–667 (2015). source
The Abstract describes a six-month comparison of calorie-restricted weight loss and weight maintenance in overweight and obese men. The tibia Results report no significant trabecular changes and no significant between-group differences in the main cortical analysis, though cortical thickness and area showed trends. The Discussion reports little or no change in geometry or strength with weight loss. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“increased differences were reported in the disposition index (an index of insulin secretion after correction for insulin resistance) in the diet–exercise group (92.4 ± 11.4%) compared with the diet-only group (61.9 ± 15.3%) at 12 months320.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Risks of weight loss in older adults
What the sources say
- Supportedcites [320] Colleluori, G., Napoli, N., Phadnis, U., Armamento-Villareal, R. & Villareal, D. T. Effect of weight loss, exercise, or both on undercarboxylated osteocalcin and insulin secretion in frail, obese older adults. Oxid. Med. Cell. Longev. 2017, 4807046 (2017). source
Results §3.3 reports that at 12 months the disposition index increased more in the diet–exercise group (92.4 ± 11.4%) than in the diet-only group (61.9 ± 15.3%; P = 0.04). The same passage describes the index as adjusting insulin secretion for changes in insulin sensitivity. (LLM, conf=0.95)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Periodization, which is a systematic variation in physical training specificity, intensity and volume within periods, has emerged as a potential strategy to improve muscle performance358.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Periodization strategies.
What the sources say
- Supportedcites [358] Strohacker, K., Fazzino, D., Breslin, W. L. & Xu, X. The use of periodization in exercise prescriptions for inactive adults: a systematic review. Prev. Med. Rep. 2, 385–396 (2015). source
The Introduction (page not specified) defines periodization as systematic variation in training specificity, intensity and volume. The Discussion (page not specified) reports significant improvements in muscular fitness in all included studies that measured it, supporting the claim that periodization is a potential strategy to improve muscle performance. (LLM, conf=0.91)
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In the ‘Testosterone Trials’, treatment with testosterone improved participants’ results in the 6 min walk test compared with placebo (20.5% versus 12.6%; P = 0.003)53.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Testosterone.
What the sources say
- Partly supportedcites [53] Snyder, P. J. et al. Effects of testosterone treatment in older men. N. Engl. J. Med. 374, 611–624 (2016). This is a randomized trial of testosterone therapy in symptomatic older men that demonstrates no benefit in vitality or walking distance following supplementation. sourceExperimental — accuracy not yet measured
The Results > Efficacy section reports improved 6-minute walking outcomes with testosterone versus placebo among participants across all three Testosterone Trials, including P = 0.003 for the proportion whose walking distance increased by at least 50 m. Our copy does not give the cited 20.5% versus 12.6% figures. It also reports no significant difference for that outcome among participants in the Physical Function Trial alone. (LLM, conf=0.88)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“in men over 60 years with low testosterone, gains in lean mass following testosterone supplementation ranged from 1.6 kg to 6.20 kg (REF407).”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Testosterone.
What the sources say
- Supportedcites [407] Neto, W. K. et al. Effects of testosterone on lean mass gain in elderly men: systematic review with meta-analysis of controlled and randomized studies. Age (Dordr.) 37, 9742 (2015). This is a meta-analysis demonstrating that testosterone supplementation in elderly men leads to increases in lean mass and potentially reductions in fat mass. source
The Study selection criteria specify men over 60 with total testosterone levels ≤550 ng/dl. Data synthesis and sensitivity analysis reports lean-body-mass gains ranging from 1.65 to 6.20 kg with androgen therapy; the claim’s 1.6 kg is an approximate rendering of the lower bound. The paper reports substantial heterogeneity across trials. (LLM, conf=0.88)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Elsewhere, testosterone-associated increases in lean mass were accompanied by improvements in handgrip strength, knee extension and leg press and chest press exercises415,416.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Testosterone.
What the sources say
- Not checked — no full text of the sourcecites [415] Srinivas-Shankar, U. et al. Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study. J. Clin. Endocrinol. Metab. 95, 639–650 (2010). source
- Partly supportedcites [416] Page, S. T. et al. Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T. J. Clin. Endocrinol. Metab. 90, 1502–1510 (2005). sourceExperimental — accuracy not yet measured
The Strength section (p. 3) reports improved handgrip strength with testosterone, and the paper reports increased lean body mass. But knee strength did not differ significantly from placebo; the paper does not report improvements in leg-press or chest-press exercises. (LLM, conf=0.90)
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Improvements in lean mass do not directly result in improved function after testosterone therapy409.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Testosterone.
What the sources say
- Partly supportedcites [409] Schroeder, E. T. et al. Value of measuring muscle performance to assess changes in lean mass with testosterone and growth hormone supplementation. Eur. J. Appl. Physiol. 112, 1123–1131 (2012). sourceExperimental — accuracy not yet measured
The Discussion reports that large lean-mass gains at week 8 were not accompanied by large improvements in muscle function, supporting the point that the gains did not immediately translate into functional improvement. But it also reports more substantial strength and muscle-performance gains by week 17, so the claim is too broad without a timing qualifier. (LLM, conf=0.85)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Orlistat promotes the weight loss via fat and visceral adipose tissue loss but minimally changes lean mass389–391.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Weight loss medications.
What the sources say
- Partly supportedcites [389] Kujawska-Luczak, M. et al. The effect of orlistat versus metformin on body composition and insulin resistance in obese premenopausal women: 3-month randomized prospective open-label study. Arch. Med. Sci. 13, 725–731 (2017). sourceExperimental — accuracy not yet measured
The Results (Body composition measurements, Table II; page unavailable) report weight and total-fat loss with orlistat. They do not report lean-mass changes, and orlistat's absolute android fat change was small; the Methods describe regional fat measurements rather than a direct measurement of visceral adipose tissue. Thus, this paper supports weight and fat loss, but not the specific claims of visceral adipose tissue loss and minimal lean-mass change. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [390] Smith, S. R. et al. Orlistat 60 mg reduces visceral adipose tissue: a 24-week randomized, placebo-controlled, multicenter trial. Obesity (Silver Spring) 19, 1796–1803 (2011). source
- Not checked — no full text of the sourcecites [391] Smith, T. J. et al. Efficacy of orlistat 60 mg on weight loss and body fat mass in US Army soldiers. J. Acad. Nutr. Diet. 112, 533–540 (2012). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“There are conflicting data on the effect of testosterone supplementation on muscle strength and function50,51,357,414.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Testosterone.
What the sources say
- Not checked — no full text of the sourcecites [50] Urban, R. J. et al. Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis. Am. J. Physiol. 269, E820–E826 (1995). source
- Not checked — no full text of the sourcecites [51] Snyder, P. J. et al. Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. J. Clin. Endocrinol. Metab. 84, 2647–2653 (1999). source
- Supportedcites [357] Hildreth, K. L. et al. Effects of testosterone and progressive resistance exercise in healthy, highly functioning older men with low-normal testosterone levels. J. Clin. Endocrinol. Metab. 98, 1891–1900 (2013). source
The paper describes mixed findings in older men: the Abstract says most studies found little or no effect on strength or physical function, while the Muscle strength and power section reports an upper-body strength benefit from testosterone alone. The Body composition section also says favorable changes have not reliably translated into strength or functional gains. (LLM, conf=0.89)
- Not checked — no full text of the sourcecites [414] Bhasin, S. et al. Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle. J. Clin. Endocrinol. Metab. 90, 678–688 (2005). This is a randomized trial of dose-dependent testosterone supplementation that demonstrates that older men are as responsive as young men to the anabolic effects of testosterone; however, older men have lower testosterone clearance rates, higher increments in haemoglobin and a higher frequency of adverse effects. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In select older men over the age of 60 years with testosterone deficiency and frailty, body composition and quality of life improved following supplementation with testosterone409–411.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Testosterone.
What the sources say
- Partly supportedcites [409] Schroeder, E. T. et al. Value of measuring muscle performance to assess changes in lean mass with testosterone and growth hormone supplementation. Eur. J. Appl. Physiol. 112, 1123–1131 (2012). sourceExperimental — accuracy not yet measured
The Results (‘Changes in body composition’; page not provided) report increased lean mass in older men receiving testosterone, supporting the body-composition portion. The Methods (‘Study participants’; page not provided) specify men aged 65–90 with testosterone in the lower portion of the adult range, but do not establish that they were frail or testosterone-deficient. The paper does not report an improvement in quality of life. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [410] Hyde, Z. et al. Low free testosterone predicts frailty in older men: the health in men study. J. Clin. Endocrinol. Metab. 95, 3165–3172 (2010). source
- Partly supportedcites [411] Krasnoff, J. B. et al. Free testosterone levels are associated with mobility limitation and physical performance in community-dwelling men: the Framingham Offspring Study. J. Clin. Endocrinol. Metab. 95, 2790–2799 (2010). sourceExperimental — accuracy not yet measured
The Discussion (page unavailable in our copy) says testosterone administration is associated with increased skeletal muscle mass, supporting the body-composition part of the claim. It does not report improved quality of life after supplementation in men over 60 with both testosterone deficiency and frailty; it notes that most earlier trials enrolled healthy older men without functional limitations. (LLM, conf=0.86)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“To date, the American Association of Clinical Endocrinologists187, the Endocrine Society425 and the Obesity Society186 have not recommended testosterone supplementation as a treatment for sarcopenia or obesity.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Testosterone.
What the sources say
- Not checked — no full text of the sourcecites [187] Garvey, W. T. et al. American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr. Pract. 22 (Suppl. 3), 1–203 (2016). Guidelines for the management of obesity by the AACE/ACE. source
- Not checked — no full text of the sourcecites [425] Bhasin, S. et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 95, 2536–2559 (2010). source
- Could not verifycites [186] Villareal, D. T. et al. Obesity in older adults: technical review and position statement of the American Society for Nutrition and NAASO, The Obesity Society. Am. J. Clin. Nutr. 82, 923–934 (2005). This study highlights current guidelines for the management of older adults with obesity. sourceExperimental — accuracy not yet measured
The Treatment options and Pharmacotherapy sections discuss obesity treatments, and the Future Research Directions section discusses sarcopenic obesity. None states whether the Obesity Society recommends testosterone supplementation for sarcopenia or obesity. A treatment list that omits testosterone does not establish the claimed non-recommendation. (LLM, conf=0.72)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“SARMs indirectly affect nonmuscle androgen receptor pathways mediated by muscle fibroblasts426.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Selective androgen receptor modulators.
What the sources say
- Partly supportedcites [426] Dubois, V., Laurent, M., Boonen, S., Vanderschueren, D. & Claessens, F. Androgens and skeletal muscle: cellular and molecular action mechanisms underlying the anabolic actions. Cell. Mol. Life Sci. 69, 1651–1667 (2012). sourceExperimental — accuracy not yet measured
The Introduction describes SARMs as tissue-selective androgen receptor ligands and says non-genomic pathways may play a role in their action. It does not establish that SARMs indirectly affect nonmuscle androgen receptor pathways through muscle fibroblasts; the Introduction instead treats indirect androgen action through other cells as an open question. (LLM, conf=0.82)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Enobosarm significantly increased lean mass compared with baseline (1.0 kg, 95% CI −4.8 to 11.5; P = 0.046) versus controls (0.02 kg, 95% CI −5.8 to 6.7; P = 0.88).”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Selective androgen receptor modulators.
What the sources say
- Partly supportedcites [429] Dalton, J. T. et al. The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial. J. Cachexia Sarcopenia Muscle 2, 153–161 (2011). sourceExperimental — accuracy not yet measured
The Results (Table 2; page unavailable) support an increase in lean body mass with enobosarm, but not the quoted estimates, confidence intervals, or P values. The 3-mg group gained 1.246 kg from baseline, versus a 0.073-kg decrease with placebo; the reported P value for the treatment-versus-placebo comparison is <0.001. (LLM, conf=0.88)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“An early human study suggests a role for mesenchymal stem cells in managing frailty468.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Mesenchymal stem cells.
What the sources say
- Supportedcites [468] Tompkins, B. A. et al. Allogeneic mesenchymal stem cells ameliorate aging frailty: a phase ii randomized, double-blind, placebo-controlled clinical trial. J. Gerontol. A Biol. Sci. Med. Sci. 72, 1513–1522 (2017). source
The paper’s Abstract Conclusion reports that intravenous allogeneic human mesenchymal stem cells were safe in people with aging frailty and that treated groups improved on physical-performance and inflammatory measures. It calls for larger trials to establish efficacy, consistent with the citing sentence’s cautious wording. (LLM, conf=0.93)
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Its deficiency has been associated with increased risk of fragility fractures452–455, particularly in patients who are malnourished456,457.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Vitamin K.
What the sources say
- Not checked — no full text of the sourcecites [452] Hart, J. P. et al. Electrochemical detection of depressed circulating levels of vitamin K1 in osteoporosis. J. Clin. Endocrinol. Metab. 60, 1268–1269 (1985). source
- Not checked — no full text of the sourcecites [453] Bitensky, L. et al. Circulating vitamin K levels in patients with fractures. J. Bone Joint Surg. Br. 70, 663–664 (1988). source
- Not checked — no full text of the sourcecites [454] Hodges, S. J., Akesson, K., Vergnaud, P., Obrant, K. & Delmas, P. D. Circulating levels of vitamins K1 and K2 decreased in elderly women with hip fracture. J. Bone Miner. Res. 8, 1241–1245 (1993). source
- Not checked — no full text of the sourcecites [455] Hodges, S. J. et al. Depressed levels of circulating menaquinones in patients with osteoporotic fractures of the spine and femoral neck. Bone 12, 387–389 (1991). source
- Partly supportedcites [456] Binkley, N. et al. Vitamin K treatment reduces undercarboxylated osteocalcin but does not alter bone turnover, density, or geometry in healthy postmenopausal North American women. J. Bone Miner. Res. 24, 983–991 (2009). sourceExperimental — accuracy not yet measured
The Introduction and Discussion report associations between low vitamin K status and increased hip fracture risk. But the Discussion (p. 989) does not establish a stronger association specifically in malnourished patients; it suggests that general undernutrition or frailty, rather than vitamin K inadequacy itself, may explain the observed fracture risk. The study did not evaluate fractures as an endpoint. (LLM, conf=0.84)
- Not checked — no full text of the sourcecites [457] Binkley, N. C. & Suttie, J. W. Vitamin K nutrition and osteoporosis. J. Nutr. 125, 1812–1821 (1995). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“Lack of functional improvements were also observed in patients with unresectable non-small-cell lung cancer442.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Anamorelin.
What the sources say
- Supportedcites [442] Katakami, N. et al. Anamorelin (ONO-7643) for the treatment of patients with non-small cell lung cancer and cachexia: results from a randomized, double-blind, placebo-controlled, multicenter study of Japanese patients (ONO-7643-04). Cancer 124, 606–616 (2018). source
The Discussion reports no improvement in motor function after anamorelin, including on handgrip-strength and six-minute-walk measures. The Methods describe the study population as patients with stage III or IV non-small-cell lung cancer who were not to undergo an operation. Page numbers are unavailable in our copy. (LLM, conf=0.93)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“SARM treatment in older women with low lean mass, a self-reported mobility disability and a short physical performance battery score between 4 and 9 provided improvements in muscle mass without benefits of improved strength430.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Selective androgen receptor modulators.
What the sources say
- Supportedcites [430] Papanicolaou, D. A. et al. A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia. J. Nutr. Health Aging 17, 533–543 (2013). source
The Participants section describes women aged 65 or older with low appendicular lean mass, limited self-reported mobility, and an initial SPPB eligibility range of 4–9; the range was later expanded to include some lower scores. The Discussion reports increased lean body mass with MK-0773 versus placebo, but no strength improvement beyond that seen with placebo. (LLM, conf=0.89)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Other studies showed increases in lean mass without improvements in strength or physical performance in patients with sarcopenia428,430.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Selective androgen receptor modulators.
What the sources say
- Partly supportedcites [428] Dobs, A. S. et al. Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial. Lancet Oncol. 14, 335–345 (2013). sourceExperimental — accuracy not yet measured
The Results report increased lean body mass and no significant improvement in hand-grip strength, supporting those parts of the claim. But the Results and Discussion report significant improvements in stair-climb power, a measure of physical function—the opposite of the claimed lack of improvement. The trial studied patients with cancer-induced muscle wasting, not a general sarcopenia population. (LLM, conf=0.90)
- Supportedcites [430] Papanicolaou, D. A. et al. A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia. J. Nutr. Health Aging 17, 533–543 (2013). source
The Discussion reports that six months of MK-0773 increased lean body mass in women with sarcopenia-induced mobility disability, but gains in strength and physical function did not exceed those in the placebo group. Thus, the claim is supported when “without improvements” means without improvements relative to placebo; both groups improved from baseline. (LLM, conf=0.92)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Early data suggest improved physical function in patients with non-small-cell lung cancer427.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Myostatin inhibitors.
What the sources say
- Partly supportedcites [427] Crawford, J. et al. Study design and rationale for the phase 3 clinical development program of enobosarm, a selective androgen receptor modulator, for the prevention and treatment of muscle wasting in cancer patients (POWER Trials). Curr. Oncol. Rep. 18, 37 (2016). sourceExperimental — accuracy not yet measured
The Design of the POWER Trials section reports that enobosarm improved physical function in a preceding phase 2b trial involving patients with non-small-cell lung cancer. But the Novel Drug: Enobosarm section identifies it as a selective androgen receptor modulator, not a myostatin inhibitor. The verbatim citing sentence is supported; the supplied paraphrase adds an unsupported drug classification. (LLM, conf=0.88)
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The prevalence of obesity in combination with sarcopenia (the age-related loss of muscle mass and strength or physical function) is increasing in adults aged 65 years and older.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Abstract
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: unclear — It is unclear why the paper says it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“A major subset of adults over the age of 65 is now classified as having sarcopenic obesity, a high-risk geriatric syndrome predominantly observed in an ageing population that is at risk of synergistic complications from both sarcopenia and obesity.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Abstract
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: unclear — It is unclear why the paper says it holds.
In the paper
“This reduction in IGF1, along with the age-related reductions in testosterone, increases the likelihood of incident frailty62.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Biological pathways to sarcopenic obesity > Inflammatory pathways.
What the sources say
- Not checked — no full text of the sourcecites [62] Yeap, B. B. et al. Associations of insulin-like growth factor-I and its binding proteins and testosterone with frailty in older men. Clin. Endocrinol. (Oxf.) 78, 752–759 (2013). source
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Pro-inflammatory lipids also secrete paracrine hormones and cytokines that promote a feedforward cycle by producing intramyocellular lipids.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Biological pathways to sarcopenic obesity > Myocellular mechanisms.
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Ageing leads to reduced cardiopulmonary status owing to inefficient oxygen extraction and a concomitant reduction in metabolically active muscle mass128.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Biological pathways to sarcopenic obesity > The role of exercise.
What the sources say
- Not checked — no full text of the sourcecites [128] Lambert, C. P. & Evans, W. J. Adaptations to aerobic and resistance exercise in the elderly. Rev. Endocr. Metab. Disord. 6, 137–143 (2005). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Myocyte apoptosis can be abrogated by physical activity125,126, while mechanisms of cellular quality control, including autophagy, mitophagy and mitochondriogenesis127, contribute to the development of sarcopenic obesity and could be potential targets for therapy.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Biological pathways to sarcopenic obesity > The role of exercise.
What the sources say
- Not checked — no full text of the sourcecites [125] Hood, D. A. Mechanisms of exercise-induced mitochondrial biogenesis in skeletal muscle. Appl. Physiol. Nutr. Metab. 34, 465–472 (2009). source
- Not checked — no full text of the sourcecites [126] Mooren, F. C. & Kruger, K. Exercise, autophagy, and apoptosis. Prog. Mol. Biol. Transl Sci. 135, 407–422 (2015). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Muscle satellite cells located between myofibres and their surrounding basal lamina are recruited into existing muscle fibres by physical activity110,111.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Biological pathways to sarcopenic obesity > The role of exercise.
What the sources say
- Not checked — no full text of the sourcecites [110] Dreyer, H. C., Blanco, C. E., Sattler, F. R., Schroeder, E. T. & Wiswell, R. A. Satellite cell numbers in young and older men 24 hours after eccentric exercise. Muscle Nerve 33, 242–253 (2006). source
- Not checked — no full text of the sourcecites [111] Petrella, J. K., Kim, J. S., Mayhew, D. L., Cross, J. M. & Bamman, M. M. Potent myofiber hypertrophy during resistance training in humans is associated with satellite cell-mediated myonuclear addition: a cluster analysis. J. Appl. Physiol. (1985) 104, 1736–1742 (2008). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Resistance training has also been shown to reduce levels of cytokines, such as resistin, leptin and IL-6 (REF142).”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Biological pathways to sarcopenic obesity > The role of exercise.
What the sources say
- Not matchedcites REF142
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In tandem, crosstalk with biologically active muscle tissue leads to a negative feedback cycle that promotes progressive gain in fat mass and loss of lean mass and muscle strength.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Biological pathways to sarcopenic obesity > Summary of mechanisms.
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: unclear — It is unclear why the paper says it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The core biological factors that underlie sarcopenic obesity are age-related changes in metabolism and body composition and the presence of concurrent environmental obesogenic factors and physical illnesses that develop with the ageing process.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Biological pathways to sarcopenic obesity > Summary of mechanisms.
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“In a study of eight young adults (aged 18–29 years) and seven older adults (aged 67–81 years), isometric knee extension at varying degrees of maximal voluntary contraction followed by a 6-week resistance programme demonstrated early increases of isometric knee extensor maximal force (which is a marker of voluntary muscle contraction) and increases in motor unit discharge rates (which is a magn”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Biological pathways to sarcopenic obesity > The role of exercise.
What the sources say
- Not checked — no full text of the sourcecites [141] Kamen, G. & Knight, C. A. Training-related adaptations in motor unit discharge rate in young and older adults. J. Gerontol. A Biol. Sci. Med. Sci. 59, 1334–1338 (2004). source
boosteddirectn = 8- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Gold standard methods to assess body composition, including CT and MRI, allow clinicians to accurately analyse adipose tissue and muscle mass150 (FIG. 2).”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Assessing body composition
What the sources say
- Not checked — no full text of the sourcecites [150] Woodrow, G. Body composition analysis techniques in the aged adult: indications and limitations. Curr. Opin. Clin. Nutr. Metab. Care 12, 8–14 (2009). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Thus, an overestimation of the total volume of water and extracellular fluid in the body leads to aberrant values.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Assessing body composition
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: For bioelectrical impedance to be valid, tissue hydration must be constant and the body must be cylindrical.
In the paper
“Separately, resistance exercises resulted in increased TNF mRNA and protein from skeletal muscle biopsy samples in frail adults134.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Biological pathways to sarcopenic obesity > The role of exercise.
What the sources say
- Not checked — no full text of the sourcecites [134] Greiwe, J. S., Cheng, B., Rubin, D. C., Yarasheski, K. E. & Semenkovich, C. F. Resistance exercise decreases skeletal muscle tumor necrosis factor alpha in frail elderly humans. FASEB J. 15, 475–482 (2001). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Without a consistent definition of sarcopenia, investigators are limited in their ability to identify participants for interventional research.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > An evolving definition
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Others applied mathematical body fat thresholds of reference populations to provide sufficient power that might not be based on distal outcomes190,191.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > An evolving definition
What the sources say
- Not checked — no full text of the sourcecites [190] Baumgartner, R. N. et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am. J. Epidemiol. 147, 755–763 (1998). This is a landmark study that demonstrates the prevalence of sarcopenia in a cohort of older adults in the New Mexico Elder Health Survey. source
- Not checked — no full text of the sourcecites [191] Baumgartner, R. N. et al. Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly. Obes. Res. 12, 1995–2004 (2004). This study highlights the synergistic problems of sarcopenia and obesity that lead to impairments in instrumental activities of daily living. source
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“abdominal visceral fat and quadriceps muscle area served as markers for central obesity and sarcopenia, respectively, and were associated with postural instability213”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Consequences of sarcopenic obesity > Disability or impairments.
What the sources say
- Not checked — no full text of the sourcecites [213] Ochi, M. et al. Quadriceps sarcopenia and visceral obesity are risk factors for postural instability in the middle-aged to elderly population. Geriatr. Gerontol. Int. 10, 233–243 (2010). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“individuals with sarcopenic obesity were at an increased risk of dyslipidaemia (OR 2.82, 95% CI 1.76–4.51)214”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Consequences of sarcopenic obesity > Metabolic impairments.
What the sources say
- Not checked — no full text of the sourcecites [214] Baek, S. J. et al. Sarcopenia and sarcopenic obesity and their association with dyslipidemia in Korean elderly men: the 2008–2010 Korea National Health and Nutrition Examination Survey. J. Endocrinol. Invest. 37, 247–260 (2014). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“did not demonstrate differences in disability compared with controls205”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Consequences of sarcopenic obesity > Disability or impairments.
What the sources say
- Not checked — no full text of the sourcecites [205] Zoico, E. et al. Physical disability and muscular strength in relation to obesity and different body composition indexes in a sample of healthy elderly women. Int. J. Obes. Relat. Metab. Disord. 28, 234–241 (2004). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Overlap using different diagnostic criteria of sarcopenic obesity is limited183 but ranges from 2.1% to 4.1%.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Prevalence of sarcopenic obesity
What the sources say
- Not checked — no full text of the sourcecites [183] Kemmler, W. et al. Prevalence of sarcopenia and sarcopenic obesity in older German men using recognized definitions: high accordance but low overlap! Osteoporos. Int. 28, 1881–1891 (2017). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“A comparison of the rates of sarcopenic obesity using bioelectrical impedance to define sarcopenia and percentage of body fat to define obesity showed increasing rates with age196.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Prevalence of sarcopenic obesity
What the sources say
- Not checked — no full text of the sourcecites [196] Kemmler, W., von Stengel, S., Engelke, K., Sieber, C. & Freiberger, E. Prevalence of sarcopenic obesity in Germany using established definitions: baseline data of the FORMOsA study. Osteoporos. Int. 27, 275–281 (2016). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“An increase in mobility disability and risk of hospitalization (OR 2.10, 95% CI 1.14–3.88) was associated with low muscle strength and abdominal obesity in an 11-year follow-up study”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Consequences of sarcopenic obesity > Disability or impairments.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“A shortcoming in ascertaining accurate prevalence rates for sarcopenic obesity is the lack of a consistent definition for either sarcopenia or obesity.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Prevalence of sarcopenic obesity
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Low handgrip strength and elevated BMI were strongly associated with an increased risk of functional decline210.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Consequences of sarcopenic obesity > Disability or impairments.
What the sources say
- Not checked — no full text of the sourcecites [210] Yang, M., Jiang, J., Hao, Q., Luo, L. & Dong, B. Dynapenic obesity and lower extremity function in elderly adults. J. Am. Med. Dir. Assoc. 16, 31–36 (2015). source
boostedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Muscle strength is a stronger predictor of long-term functional decline than muscle mass206.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Consequences of sarcopenic obesity > Disability or impairments.
What the sources say
- Not checked — no full text of the sourcecites [206] Schaap, L. A., Koster, A. & Visser, M. Adiposity, muscle mass, and muscle strength in relation to functional decline in older persons. Epidemiol. Rev. 35, 51–65 (2013). This is a meta-analysis that proves the longitudinal impact of BMI on incident loss of muscle mass and muscle strength. source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“These findings are also observed when evaluating the overlap of sarcopenia-only definitions, which is less than 50%183.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Prevalence of sarcopenic obesity
What the sources say
- Not checked — no full text of the sourcecites [183] Kemmler, W. et al. Prevalence of sarcopenia and sarcopenic obesity in older German men using recognized definitions: high accordance but low overlap! Osteoporos. Int. 28, 1881–1891 (2017). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“A review of eight definitions for sarcopenic obesity noted a 19-fold to 26-fold variation in sex-specific rates178.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Prevalence of sarcopenic obesity
What the sources say
- Not checked — no full text of the sourcecites [178] Batsis, J. A. et al. Variation in the prevalence of sarcopenia and sarcopenic obesity in older adults associated with different research definitions: dual-energy X-ray absorptiometry data from the National Health and Nutrition Examination Survey 1999–2004. J. Am. Geriatr. Soc. 61, 974–980 (2013). This study applies multiple definitions of sarcopenic obesity on a cohort of American adults and emphasizes the varied prevalences of this disorder. source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Feasible anthropometric indices as surrogates for adiposity, including BMI and waist circumference, have poor sensitivity.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > An evolving definition
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“The analysis showed that definitions for sarcopenia were highly dependent on mathematical thresholds, reference populations and muscle mass definitions.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Prevalence of sarcopenic obesity
What the sources say
- Not checked — no full text of the sourcecites [178] Batsis, J. A. et al. Variation in the prevalence of sarcopenia and sarcopenic obesity in older adults associated with different research definitions: dual-energy X-ray absorptiometry data from the National Health and Nutrition Examination Survey 1999–2004. J. Am. Geriatr. Soc. 61, 974–980 (2013). This study applies multiple definitions of sarcopenic obesity on a cohort of American adults and emphasizes the varied prevalences of this disorder. source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“sarcopenic obesity was associated with a relative risk of incident disability over 8 years that was 2.63 (95% CI 1.19–5.85)”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Consequences of sarcopenic obesity > Disability or impairments.
What the sources say
- Not checked — no full text of the sourcecites [191] Baumgartner, R. N. et al. Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly. Obes. Res. 12, 1995–2004 (2004). This study highlights the synergistic problems of sarcopenia and obesity that lead to impairments in instrumental activities of daily living. source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“low muscle strength (as defined by the FNIH criteria) with an elevated BMI was not associated with differences in metabolic components among groups of postmenopausal women aged 55–75 years217”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Consequences of sarcopenic obesity > Metabolic impairments.
What the sources say
- Not checked — no full text of the sourcecites [217] Aubertin-Leheudre, M., Lord, C., Goulet, E. D., Khalil, A. & Dionne, I. J. Effect of sarcopenia on cardiovascular disease risk factors in obese postmenopausal women. Obesity (Silver Spring) 14, 2277–2283 (2006). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Sarcopenic obesity (as defined by low appendicular lean mass normalized for height2 and increased BMI) was associated with unfavourable scores on the Medical Outcomes Survey234.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Consequences of sarcopenic obesity > Quality of life.
What the sources say
- Not checked — no full text of the sourcecites [234] Messier, V. et al. Metabolic profile and quality of life in class I sarcopenic overweight and obese postmenopausal women: a MONET study. Appl. Physiol. Nutr. Metab. 34, 18–24 (2009). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“muscle strength with waist circumference (HR 1.23, 95% CI 1.09–1.38)230”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Consequences of sarcopenic obesity > Mortality.
What the sources say
- Not checked — no full text of the sourcecites [230] Tian, S. & Xu, Y. Association of sarcopenic obesity with the risk of all-cause mortality: a meta-analysis of prospective cohort studies. Geriatr. Gerontol. Int. 16, 155–166 (2016). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“a recent meta-analysis found that mortality was highest in patients with sarcopenic obesity (HR 1.24, 95% CI 1.12–1.37) compared with healthy individuals”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Consequences of sarcopenic obesity > Mortality.
What the sources say
- Not checked — no full text of the sourcecites [230] Tian, S. & Xu, Y. Association of sarcopenic obesity with the risk of all-cause mortality: a meta-analysis of prospective cohort studies. Geriatr. Gerontol. Int. 16, 155–166 (2016). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“had significant positive associations with insulin resistance as defined by HOMA scores and triglycerides215”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Consequences of sarcopenic obesity > Metabolic impairments.
What the sources say
- Not checked — no full text of the sourcecites [215] Chung, J. Y., Kang, H. T., Lee, D. C., Lee, H. R. & Lee, Y. J. Body composition and its association with cardiometabolic risk factors in the elderly: a focus on sarcopenic obesity. Arch. Gerontol. Geriatr. 56, 270–278 (2013). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“spine and total BMD were lower in individuals who were sarcopenic obese and dynapenic obese than in individuals with obesity alone220”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Consequences of sarcopenic obesity > Comorbidities.
What the sources say
- Not checked — no full text of the sourcecites [220] Scott, D. et al. Associations of sarcopenic obesity and dynapenic obesity with bone mineral density and incident fractures over 5–10 years in community-dwelling older adults. Calcif. Tissue Int. 99, 30–42 (2016). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Sarcopenic obesity (defined by muscle mass assessed by bioelectrical impedance and percentage of body fat) was associated with an increased mortality (HR 1.29, 95% CI 1.03–1.60)230.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Consequences of sarcopenic obesity > Mortality.
What the sources say
- Not checked — no full text of the sourcecites [230] Tian, S. & Xu, Y. Association of sarcopenic obesity with the risk of all-cause mortality: a meta-analysis of prospective cohort studies. Geriatr. Gerontol. Int. 16, 155–166 (2016). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Individuals with sarcopenic obesity have a higher risk (OR 3.51, 95% CI 2.15–5.75) of radiographic knee osteoarthritis218 than individuals in the non-sarcopenic obesity group.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Consequences of sarcopenic obesity > Comorbidities.
What the sources say
- Not checked — no full text of the sourcecites [218] Lee, S., Kim, T. N. & Kim, S. H. Sarcopenic obesity is more closely associated with knee osteoarthritis than is nonsarcopenic obesity: a cross-sectional study. Arthritis Rheum. 64, 3947–3954 (2012). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“mortality was significantly elevated in people with sarcopenic obesity, which was defined using mid-arm circumference (HR 1.46, 95% CI 1.23–1.73)”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Consequences of sarcopenic obesity > Mortality.
What the sources say
- Not checked — no full text of the sourcecites [230] Tian, S. & Xu, Y. Association of sarcopenic obesity with the risk of all-cause mortality: a meta-analysis of prospective cohort studies. Geriatr. Gerontol. Int. 16, 155–166 (2016). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“low quadriceps strength was associated with increased mortality231”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Consequences of sarcopenic obesity > Mortality.
What the sources say
- Not checked — no full text of the sourcecites [231] Newman, A. B. et al. Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort. J. Gerontol. A Biol. Sci. Med. Sci. 61, 72–77 (2006). This study demonstrates the importance of muscle strength as opposed to muscle mass as a key determinant of mortality. source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“low handgrip strength and high waist circumference and/or BMI were significantly associated with elevated levels of IL-6, C-reactive protein and IL-1 (REF57)”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Consequences of sarcopenic obesity > Metabolic impairments.
What the sources say
- Not checked — no full text of the sourcecites [57] Schrager, M. A. et al. Sarcopenic obesity and inflammation in the InCHIANTI study. J. Appl. Physiol. (1985) 102, 919–925 (2007). This is an epidemiological study that shows that obesity directly affects inflammation and negatively affects muscle strength. source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“individuals in the resistance training group had the greatest improvements in strength”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Treatments for sarcopenic obesity
What the sources say
- Not checked — no full text of the sourcecites [248] Chen, H. T., Chung, Y. C., Chen, Y. J., Ho, S. Y. & Wu, H. J. Effects of different types of exercise on body composition, muscle strength, and IGF-1 in the elderly with sarcopenic obesity. J. Am. Geriatr. Soc. 65, 827–832 (2017). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“A population-based cohort study that defined sarcopenia using the EWGSOP criteria found an increased incidence of long-term care certification in patients with sarcopenia239.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Consequences of sarcopenic obesity > Institutionalization and health-care utilization.
What the sources say
- Not checked — no full text of the sourcecites [239] Akune, T. et al. Incidence of certified need of care in the long-term care insurance system and its risk factors in the elderly of Japanese population-based cohorts: the ROAD study. Geriatr. Gerontol. Int. 14, 695–701 (2014). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“High-speed circuit training was associated with nonsignificant improvements between groups in short performance physical battery (mean difference 1.1, 95% CI–0.1 to 2.4; P = 0.08)”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Treatments for sarcopenic obesity > Resistance training and aerobic exercise.
What the sources say
- Not checked — no full text of the sourcecites [289] Balachandran, A., Krawczyk, S. N., Potiaumpai, M. & Signorile, J. F. High-speed circuit training versus hypertrophy training to improve physical function in sarcopenic obese adults: a randomized controlled trial. Exp. Gerontol. 60, 64–71 (2014). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“power (mean difference 158 W, 95% CI 2–315; P = 0.01)”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Treatments for sarcopenic obesity > Resistance training and aerobic exercise.
What the sources say
- Not checked — no full text of the sourcecites [289] Balachandran, A., Krawczyk, S. N., Potiaumpai, M. & Signorile, J. F. High-speed circuit training versus hypertrophy training to improve physical function in sarcopenic obese adults: a randomized controlled trial. Exp. Gerontol. 60, 64–71 (2014). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These data suggest that improved insulin sensitivity is due, in part, to the distribution of adiponectin across various tissues and an upregulation in the expression of its receptor.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Treatments for sarcopenic obesity > Calorie restriction and physical activity.
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“High-intensity resistance training combined with short resting intervals improves body composition, muscle and functional performance in men aged 68 ± 4.1 years286.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Treatments for sarcopenic obesity > Resistance training and aerobic exercise.
What the sources say
- Not checked — no full text of the sourcecites [286] Villanueva, M. G., Lane, C. J. & Schroeder, E. T. Short rest interval lengths between sets optimally enhance body composition and performance with 8 weeks of strength resistance training in older men. Eur. J. Appl. Physiol. 115, 295–308 (2015). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Increased muscle mass and reduced total and visceral fat over an 8-week intervention were observed in predominantly female individuals, whose mean age was 69 years, with sarcopenic obesity engaged in resistance training248.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Treatments for sarcopenic obesity > Calorie restriction and physical activity.
What the sources say
- Not checked — no full text of the sourcecites [248] Chen, H. T., Chung, Y. C., Chen, Y. J., Ho, S. Y. & Wu, H. J. Effects of different types of exercise on body composition, muscle strength, and IGF-1 in the elderly with sarcopenic obesity. J. Am. Geriatr. Soc. 65, 827–832 (2017). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“High-speed resistance training over 12 weeks induced greater improvements in muscle power and functional capacity than low-speed training287.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Treatments for sarcopenic obesity > Resistance training and aerobic exercise.
What the sources say
- Not checked — no full text of the sourcecites [287] Ramirez-Campillo, R. et al. High-speed resistance training is more effective than low-speed resistance training to increase functional capacity and muscle performance in older women. Exp. Gerontol. 58, 51–57 (2014). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Percent weight loss from appendicular lean mass dropped markedly more in the low-fat and no exercise group than in the other groups, suggesting that this intervention has a detrimental effect on appendicular lean mass312.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Risks of weight loss in older adults
What the sources say
- Not checked — no full text of the sourcecites [312] Wood, R. J. et al. Preservation of fat-free mass after two distinct weight loss diets with and without progressive resistance exercise. Metab. Syndr. Relat. Disord. 10, 167–174 (2012). source
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Calorie restriction alters bone metabolism, resulting in the loss of BMD in the hip without effects on lumbar spine318, even after a 4-month restriction319.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Risks of weight loss in older adults
What the sources say
- Not checked — no full text of the sourcecites [318] Zibellini, J. et al. Does diet-induced weight loss lead to bone loss in overweight or obese adults? A systematic review and meta-analysis of clinical trials. J. Bone Miner. Res. 30, 2168–2178 (2015). source
- Not checked — no full text of the sourcecites [319] Soltani, S., Hunter, G. R., Kazemi, A. & Shab-Bidar, S. The effects of weight loss approaches on bone mineral density in adults: a systematic review and meta-analysis of randomized controlled trials. Osteoporos. Int. 27, 2655–2671 (2016). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Levels of adiponectin were also elevated following a multicomponent, randomized lifestyle intervention study that investigated the mRNA expression of adiponectin and its receptor in skeletal muscle in adults with impaired glucose tolerance who were aged ≥60 years and had a BMI of 30–40 kg/m2 (REF306).”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Treatments for sarcopenic obesity > Calorie restriction and physical activity.
What the sources say
- Not checked — no full text of the sourcecites [306] O’Leary, V. B. et al. Enhanced adiponectin multimer ratio and skeletal muscle adiponectin receptor expression following exercise training and diet in older insulin-resistant adults. Am. J. Physiol. Endocrinol. Metab. 293, E421–E427 (2007). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“A review of 52 studies reported that loss of fat-free mass as a proportion of overall weight was attenuated after combining exercise with calorie restriction298.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Risks of weight loss in older adults
What the sources say
- Not checked — no full text of the sourcecites [298] Weinheimer, E. M., Sands, L. P. & Campbell, W. W. A systematic review of the separate and combined effects of energy restriction and exercise on fat-free mass in middle-aged and older adults: implications for sarcopenic obesity. Nutr. Rev. 68, 375–388 (2010). This is a systematic review assessing the effects of energy restriction and exercise on fat-free mass and suggests that exercise is an effective tool in combating sarcopenia-induced weight loss. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“A meta-analysis showed that aerobic exercise and resistance were useful tools to preserve fat-free mass in adults aged ≥50 years who were engaged in a moderate energy restriction-induced weight loss programme298.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Treatments for sarcopenic obesity > Calorie restriction and physical activity.
What the sources say
- Not checked — no full text of the sourcecites [298] Weinheimer, E. M., Sands, L. P. & Campbell, W. W. A systematic review of the separate and combined effects of energy restriction and exercise on fat-free mass in middle-aged and older adults: implications for sarcopenic obesity. Nutr. Rev. 68, 375–388 (2010). This is a systematic review assessing the effects of energy restriction and exercise on fat-free mass and suggests that exercise is an effective tool in combating sarcopenia-induced weight loss. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Percent weight loss from appendicular lean mass dropped markedly more in the low-fat and no exercise group than in the other groups, suggesting that this intervention has a detrimental effect on appendicular lean mass312.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Risks of weight loss in older adults
What the sources say
- Not checked — no full text of the sourcecites [312] Wood, R. J. et al. Preservation of fat-free mass after two distinct weight loss diets with and without progressive resistance exercise. Metab. Syndr. Relat. Disord. 10, 167–174 (2012). source
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“yoga has been shown to improve mobility in participants 60 years of age and older, with no restriction on their characteristics, whose follow-up ranged from 8 to 24 weeks (total duration 8–36 hours of yoga)293”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Treatments for sarcopenic obesity > Resistance training and aerobic exercise.
What the sources say
- Not checked — no full text of the sourcecites [293] Youkhana, S., Dean, C. M., Wolff, M., Sherrington, C. & Tiedemann, A. Yoga-based exercise improves balance and mobility in people aged 60 and over: a systematic review and meta-analysis. Age Ageing 45, 21–29 (2016). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“in patients with knee osteoarthritis, weight training combined with walking three times a week for 1 hour does not have any significant effect on levels of TNF, IL-6 or C-reactive protein307”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Treatments for sarcopenic obesity > Calorie restriction and physical activity.
What the sources say
- Not checked — no full text of the sourcecites [307] Nicklas, B. J. et al. Diet-induced weight loss, exercise, and chronic inflammation in older, obese adults: a randomized controlled clinical trial. Am. J. Clin. Nutr. 79, 544–551 (2004). This is an early trial suggesting that resistance training is important for improving body composition and muscle strength in elderly individuals who are obese, an effect which is improved with caloric restriction. source
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Conventional strategies to minimize the effect of weight loss on bone metabolism, including up to 1,200 mg supplemental calcium per day and 800–1,000 international units (IU) per day of vitamin D3, are needed to minimize the risk of weight loss-induced BMD reduction329.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Risks of weight loss in older adults > Supplementation with calcium and vitamin D.
What the sources say
- Not checked — no full text of the sourcecites [329] Moyer, V. A. Vitamin D and calcium supplementation to prevent fractures in adults: U.S. Preventive Services Task Force recommendation statement. Ann. Intern. Med. 158, 691–696 (2013). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Three years of testosterone administration in patients with low levels of testosterone resulted in an increase in lean mass (0.9 kg, 95% CI 0.5–1.4; P < 0.001)412.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Testosterone.
What the sources say
- Not checked — no full text of the sourcecites [412] Storer, T. W. et al. Effects of testosterone supplementation for 3 years on muscle performance and physical function in older men. J. Clin. Endocrinol. Metab. 102, 583–593 (2017). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Augmenting existing squatting exercises with whole-body vibration therapy failed to improve muscle mass in younger men aged 18–30 years379.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Whole-body vibration therapy.
What the sources say
- Not checked — no full text of the sourcecites [379] Lamont, H. S. et al. Effects of a 6-week periodized squat training with or without whole-body vibration upon short-term adaptations in squat strength and body composition. J. Strength Cond. Res. 25, 1839–1848 (2011). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Supplementation with testosterone promotes IGF1 mRNA and protein expression, leading to increased lean mass through increased muscle protein synthesis52.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Testosterone.
What the sources say
- Not checked — no full text of the sourcecites [52] Ferrando, A. A. et al. Testosterone administration to older men improves muscle function: molecular and physiological mechanisms. Am. J. Physiol. Endocrinol. Metab. 282, E601–E607 (2002). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Its safety and efficacy in sarcopenic obesity is unknown other than one study that evaluated the influence of sarcopenic obesity on gastric bypass and sleeve gastrectomy results393.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Bariatric surgery.
What the sources say
- Not checked — no full text of the sourcecites [393] Mastino, D. et al. Bariatric surgery outcomes in sarcopenic obesity. Obes. Surg. 26, 2355–2362 (2016). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Phentermine minimally alters lean mass386.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Weight loss medications.
What the sources say
- Not checked — no full text of the sourcecites [386] Cordero-MacIntyre, Z. R. et al. Effect of a weight-reduction program on total and regional body composition in obese postmenopausal women. Ann. NY Acad. Sci. 904, 526–535 (2000). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Another trial of testosterone treatment found improved stair-climbing power and strength351.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Testosterone.
What the sources say
- Not checked — no full text of the sourcecites [351] Travison, T. G. et al. Clinical meaningfulness of the changes in muscle performance and physical function associated with testosterone administration in older men with mobility limitation. J. Gerontol. A Biol. Sci. Med. Sci. 66, 1090–1099 (2011). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Healthy men with reduced levels of testosterone had no improvements in muscle strength or mobility after 6 months of supplementation350.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Testosterone.
What the sources say
- Not checked — no full text of the sourcecites [350] Emmelot-Vonk, M. H. et al. Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial. JAMA 299, 39–52 (2008). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Androgen therapy also reduces fat mass (−1.78%).”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Testosterone.
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“With ageing, muscle strength often drops before muscle mass73.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Testosterone.
What the sources say
- Not checked — no full text of the sourcecites [73] Goodpaster, B. H. et al. The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J. Gerontol. A Biol. Sci. Med. Sci. 61, 1059–1064 (2006). This study shows that loss of strength with ageing is much more rapid than the concomitant loss of muscle mass, suggesting a decline in muscle quality. source
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“When compared with controls, patients treated with lorcaserin had greater fat mass loss than lean mass loss382.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Weight loss medications.
What the sources say
- Not checked — no full text of the sourcecites [382] Apovian, C., Palmer, K., Fain, R., Perdomo, C. & Rubino, D. Effects of lorcaserin on fat and lean mass loss in obese and overweight patients without and with type 2 diabetes mellitus: the BLOSSOM and BLOOM-DM studies. Diabetes Obes. Metab. 18, 945–948 (2016). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Testosterone potentially augments diet-induced loss of fat mass in individuals with BMI ≥30 kg/m2 and low testosterone levels.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Testosterone.
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Therapy with testosterone and GH in older men aged 65–80 years with normal testosterone levels resulted in greater improvements in lean mass with both treatments than with either alone56,408.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Testosterone.
What the sources say
- Not checked — no full text of the sourcecites [56] Giannoulis, M. G., Martin, F. C., Nair, K. S., Umpleby, A. M. & Sonksen, P. Hormone replacement therapy and physical function in healthy older men. Time to talk hormones? Endocr. Rev. 33, 314–377 (2012). source
- Not checked — no full text of the sourcecites [408] Giannoulis, M. G. et al. The effects of growth hormone and/or testosterone in healthy elderly men: a randomized controlled trial. J. Clin. Endocrinol. Metab. 91, 477–484 (2006). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The nonlinear relationship between mass and function suggests that hypertrophy rather than muscle fibre hyperplasia materializes without neuronal plasticity.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Testosterone.
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Testosterone deficiency can impair muscle adaptation to exercise owing to reduced expression of IGF1 and increased inflammatory cytokines.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Testosterone.
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Anamorelin, an oral ghrelin analogue, is effective for improving appetite in patients with cancer cachexia and might hold promise in patients with sarcopenic obesity.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Anamorelin.
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Adverse effects are no different than with placebo.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Anamorelin.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Vitamin K might have a role in mitigating bone loss following intentional weight loss by inhibiting bone resorption450 and osteoclast formation451.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Vitamin K.
What the sources say
- Not checked — no full text of the sourcecites [450] Sato, Y., Honda, Y., Kuno, H. & Oizumi, K. Menatetrenone ameliorates osteopenia in disuse-affected limbs of vitamin D− and K-deficient stroke patients. Bone 23, 291–296 (1998). source
- Not checked — no full text of the sourcecites [451] Schurgers, L. J. & Vermeer, C. Determination of phylloquinone and menaquinones in food. Effect of food matrix on circulating vitamin K concentrations. Haemostasis 30, 298–307 (2000). source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- It may state two separate claims as one. 119
- Probably not a substantial claim. 48
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Leptin upregulates the pro-inflammatory cytokines IL-6 and TNF, which results in a reduction in the anabolic actions of insulinlike growth factor 1 (IGF1)61.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Biological pathways to sarcopenic obesity > Inflammatory pathways.
What the sources say
- Disputedcites [61] Hamrick, M. W. Role of the cytokine-like hormone leptin in muscle-bone crosstalk with aging. J. Bone Metab. 24, 1–8 (2017). sourceExperimental — accuracy not yet measured
The section “The Anabolic Effects of Leptin on Skeletal Muscle” (page unavailable) says leptin treatment increases IGF-1 and that IGF-1 likely mediates leptin’s anabolic effects—the opposite of the claimed reduction. The passages found do not describe leptin upregulating IL-6 or TNF. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Disputed
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Peak oxygen consumption is potentially inversely related to frailty129,130, suggesting that improvements in VO2 max following aerobic training counteract frailty131,132.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Biological pathways to sarcopenic obesity > The role of exercise.
What the sources say
- Not checked — no full text of the sourcecites [129] Moayedi, Y. et al. The prognostic significance of frailty compared to peak oxygen consumption and B-type natriuretic peptide in patients with advanced heart failure. Clin. Transplant. https://doi.org/10.1111/ctr.13158 (2018). source
- Disputedcites [130] Jones, S. et al. Assessment of exercise capacity and oxygen consumption using a 6 min stepper test in older adults. Front. Physiol. 8, 408 (2017). sourceExperimental — accuracy not yet measured
The Results (Effect of endurance training; page unavailable) report that cardiopulmonary peak VO₂ did not change after training, contrary to the attributed improvement. Post-exercise muscle oxygen consumption increased, but that is a different measure. The paper does not assess frailty or whether a change in VO₂ max counteracts it. (LLM, conf=0.83)
Checked by a reasoning model — may be wrong.
- Not checked — no full text of the sourcecites [131] Binder, E. F. et al. Effects of exercise training on frailty in community-dwelling older adults: results of a randomized, controlled trial. J. Am. Geriatr. Soc. 50, 1921–1928 (2002). This is a randomized controlled trial demonstrating that intensive exercise training can improve measures of physical function. source
- Supportedcites [132] Villareal, D. T., Banks, M., Siener, C., Sinacore, D. R. & Klein, S. Physical frailty and body composition in obese elderly men and women. Obes. Res. 12, 913–920 (2004). source
The Results (page not available) report lower VO₂ peak in the frail groups than in the nonfrail group, supporting the potential inverse relationship cited to this paper. The aerobic-training inference has separate citations in the citing sentence and is not attributed to this source. (LLM, conf=0.90)
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Obesity is inversely related to BMD and fractures313 but might increase the fracture risk through bone quality314,315 or frailty132,316 independent of BMD.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Risks of weight loss in older adults
What the sources say
- Disputedcites [313] Tang, X. et al. Obesity and risk of hip fracture in adults: a meta-analysis of prospective cohort studies. PLoS ONE 8, e55077 (2013). sourceExperimental — accuracy not yet measured
The Discussion (page not provided) says BMD is positively correlated with BMI and that many obese individuals have higher BMD—the opposite of an inverse relationship. It does support an inverse association between obesity and hip-fracture risk in adults, but not the claimed inverse association with BMD. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Disputed
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“In vitro trials demonstrate that myostatin inhibitors increase muscle mass and strength446, suppress irisin, downregulate inflammatory cytokines and improve insulin resistance447.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Myostatin inhibitors.
What the sources say
- Not checked — no full text of the sourcecites [446] Camporez, J. P. et al. Anti-myostatin antibody increases muscle mass and strength and improves insulin sensitivity in old mice. Proc. Natl Acad. Sci. USA 113, 2212–2217 (2016). This study evaluates a treatment consisting of anti-myostatin antibody administration for 4 weeks, showing improved muscle mass and strength in young and old mice. source
- Disputedcites [447] Dong, J. et al. Inhibition of myostatin in mice improves insulin sensitivity via irisin-mediated cross talk between muscle and adipose tissues. Int. J. Obes. (Lond.) 40, 434–442 (2016). sourceExperimental — accuracy not yet measured
The Results section, “Myostatin inhibition increases irisin expression” (page unavailable), reports increased irisin after myostatin knockdown in cultured muscle cells—the opposite of the claimed suppression. The Discussion (page unavailable) supports reduced inflammation and improved insulin resistance after myostatin inhibition, but reports the insulin-resistance finding in high-fat-diet-fed mice, not as an in vitro trial. The muscle-mass and strength clause carries a different citation and is not judged here. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Obesity activates macrophages, mast cells and T lymphocytes, promoting a low-level inflammation that results in the secretion of tumour necrosis factor (TNF), leptin and growth hormone (GH)57–59.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Biological pathways to sarcopenic obesity > Inflammatory pathways.
What the sources say
- Not checked — no full text of the sourcecites [57] Schrager, M. A. et al. Sarcopenic obesity and inflammation in the InCHIANTI study. J. Appl. Physiol. (1985) 102, 919–925 (2007). This is an epidemiological study that shows that obesity directly affects inflammation and negatively affects muscle strength. source
- Partly supportedcites [58] Forsythe, L. K., Wallace, J. M. & Livingstone, M. B. Obesity and inflammation: the effects of weight loss. Nutr. Res. Rev. 21, 117–133 (2008). sourceExperimental — accuracy not yet measured
The Introduction describes obesity as low-grade systemic inflammation and identifies TNF-α and leptin as adipose-tissue secretory products. It mentions macrophages and mast cells as possible contributors to inflammation, but does not establish their activation; the passages do not support the added claims about T lymphocytes or growth hormone. Page numbers were not available in our copy. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [59] Park, H. S., Park, J. Y. & Yu, R. Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. Diabetes Res. Clin. Pract. 69, 29–35 (2005). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Elevated cytokine levels observed in hypogonadal states are associated with truncal obesity, which exacerbates the development of sarcopenia44,45.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Biological pathways to sarcopenic obesity > Inflammatory pathways.
What the sources say
- Partly supportedcites [44] Kadi, F. Cellular and molecular mechanisms responsible for the action of testosterone on human skeletal muscle. A basis for illegal performance enhancement. Br. J. Pharmacol. 154, 522–528 (2008). sourceExperimental — accuracy not yet measured
The section “Testosterone, muscle strength and mass” (page unavailable) reports that suppressing testosterone in young men increased adiposity and decreased muscle strength. It does not report elevated cytokines, specify truncal obesity, or establish that obesity exacerbates sarcopenia. (LLM, conf=0.78)
- Not checked — no full text of the sourcecites [45] Bondanelli, M. et al. Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone-releasing hormone. Neuroendocrinology 77, 380–387 (2003). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Obesity also induces leptin resistance, promoting reduced muscle fatty oxidation and ectopic fat deposition65,66.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Biological pathways to sarcopenic obesity > Inflammatory pathways.
What the sources say
- Partly supportedcites [65] Cartwright, M. J., Tchkonia, T. & Kirkland, J. L. Aging in adipocytes: potential impact of inherent, depot-specific mechanisms. Exp. Gerontol. 42, 463–471 (2007). sourceExperimental — accuracy not yet measured
The paper’s discussion of age-related fat redistribution says fat can accumulate in muscle and other non-adipose tissues. It does not say that obesity induces leptin resistance or that leptin resistance reduces muscle fatty-acid oxidation and thereby causes ectopic fat deposition; the leptin-resistance mention found in our copy is a reference-list title about aging. (LLM, conf=0.84)
- Not checked — no full text of the sourcecites [66] Shulman, G. I. Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. N. Engl. J. Med. 371, 1131–1141 (2014). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Exercise can affect hormonal balance, reduce oxidative stress, induce mitochondrial synthesis, alter immunological and motor function and improve muscle oxidative capacity92–95.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Biological pathways to sarcopenic obesity > The role of exercise.
What the sources say
- Not checked — no full text of the sourcecites [92] Joseph, A. M., Adhihetty, P. J. & Leeuwenburgh, C. Beneficial effects of exercise on age-related mitochondrial dysfunction and oxidative stress in skeletal muscle. J. Physiol. 594, 5105–5123 (2016). source
- Not checked — no full text of the sourcecites [93] Schubert, M. M., Sabapathy, S., Leveritt, M. & Desbrow, B. Acute exercise and hormones related to appetite regulation: a meta-analysis. Sports Med. 44, 387–403 (2014). source
- Partly supportedcites [94] Roque, F. R. et al. Aerobic exercise reduces oxidative stress and improves vascular changes of small mesenteric and coronary arteries in hypertension. Br. J. Pharmacol. 168, 686–703 (2013). sourceExperimental — accuracy not yet measured
The Discussion reports that low-intensity aerobic exercise reduced oxidative stress in spontaneously hypertensive rats. The Methods identify soleus citrate synthase activity as a marker of muscle oxidative activity, and the Results report higher activity in trained rats. The paper does not establish the claimed effects on hormonal balance, mitochondrial synthesis, or immunological and motor function. (LLM, conf=0.90)
- Not checked — no full text of the sourcecites [95] Kumaraguru, U., Nandakumar, S., Chi, D., Stone, M. & Krishnaswamy, G. Resistance training and aerobic exercise alters immune function (87.25). J. Immunol. 184, 87.25 (2010). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The regeneration potential of muscle is impaired, which might promote fibrosis, thereby promoting insulin resistance76–79, partially owing to impaired mitochondrial fatty acid oxidation and increased lipolysis76,80.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Biological pathways to sarcopenic obesity > Myocellular mechanisms.
What the sources say
- Not checked — no full text of the sourcecites [76] Kalinkovich, A. & Livshits, G. Sarcopenic obesity or obese sarcopenia: a cross talk between age-associated adipose tissue and skeletal muscle inflammation as a main mechanism of the pathogenesis. Ageing Res. Rev. 35, 200–221 (2017). source
- Not checked — no full text of the sourcecites [77] Kob, R. et al. Sarcopenic obesity: molecular clues to a better understanding of its pathogenesis? Biogerontology 16, 15–29 (2015). source
- Not checked — no full text of the sourcecites [78] Stinkens, R., Goossens, G. H., Jocken, J. W. & Blaak, E. E. Targeting fatty acid metabolism to improve glucose metabolism. Obes. Rev. 16, 715–757 (2015). source
- Partly supportedcites [79] Aon, M. A., Bhatt, N. & Cortassa, S. C. Mitochondrial and cellular mechanisms for managing lipid excess. Front. Physiol. 5, 282 (2014). sourceExperimental — accuracy not yet measured
The ‘Mitochondria, lipids, and insulin resistance’ section discusses impaired fat oxidation as one proposed contributor to skeletal-muscle insulin resistance, while noting that this explanation is debated. The ‘Concluding remarks’ link excessive lipolysis to insulin resistance. Neither section connects impaired muscle regeneration or fibrosis to those mechanisms; page numbers are not available in our copy. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [80] Bruce, C. R. et al. Muscle oxidative capacity is a better predictor of insulin sensitivity than lipid status. J. Clin. Endocrinol. Metab. 88, 5444–5451 (2003). source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Elevated TNF directly inhibits adiponectin63, arresting muscle protein synthesis and mitochondrial processes64.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Biological pathways to sarcopenic obesity > Inflammatory pathways.
What the sources say
- Could not verifycites [63] Wang, Y. et al. Adiponectin inhibits tumor necrosis factor-alpha-induced vascular inflammatory response via caveolin-mediated ceramidase recruitment and activation. Circ. Res. 114, 792–805 (2014). sourceExperimental — accuracy not yet measured
Citation 63 is attached to the assertion that elevated TNF directly inhibits adiponectin; the muscle-process assertion has a separate citation. The Results section describes adiponectin inhibiting TNFα-induced inflammation in endothelial cells, but the passages found when searching for TNF suppression of adiponectin do not address whether TNF directly inhibits adiponectin. No page number is available in our copy. (LLM, conf=0.74)
- Not checked — no full text of the sourcecites [64] Lang, C. H., Frost, R. A., Nairn, A. C., MacLean, D. A. & Vary, T. C. TNF-alpha impairs heart and skeletal muscle protein synthesis by altering translation initiation. Am. J. Physiol. Endocrinol. Metab. 282, E336–E347 (2002). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“While muscle cells can regenerate through satellite mesenchymal progenitor cells, their numbers decline with age, which contributes to reduced muscle function88,89.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Biological pathways to sarcopenic obesity > Myocellular mechanisms.
What the sources say
- Partly supportedcites [88] Shefer, G., Rauner, G., Stuelsatz, P., Benayahu, D. & Yablonka-Reuveni, Z. Moderate-intensity treadmill running promotes expansion of the satellite cell pool in young and old mice. FEBS J. 280, 4063–4073 (2013). sourceExperimental — accuracy not yet measured
The Introduction describes satellite cells as myogenic progenitors essential for skeletal-muscle repair and reports an age-associated decline in their numbers. It says this decline *may* contribute to muscle deterioration, rather than establishing that it does; it also calls the cells myogenic, not mesenchymal. (LLM, conf=0.88)
- Partly supportedcites [89] Zwetsloot, K. A., Childs, T. E., Gilpin, L. T. & Booth, F. W. Non-passaged muscle precursor cells from 32-month old rat skeletal muscle have delayed proliferation and differentiation. Cell Prolif. 46, 45–57 (2013). sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) says satellite cells are muscle progenitor cells involved in skeletal-muscle repair and growth, and that their dysfunction could contribute to sarcopenia. The Discussion (page unavailable) reports delayed proliferation of precursor cells from old rats, but our copy does not establish that satellite-cell numbers decline with age or that a decline in numbers causes reduced muscle function. (LLM, conf=0.87)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Increased muscle protein synthesis with exercise sensitizes muscle insulin action and promotes anabolism96–100.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Biological pathways to sarcopenic obesity > The role of exercise.
What the sources say
- Not checked — no full text of the sourcecites [96] Carraro, F., Stuart, C. A., Hartl, W. H., Rosenblatt, J. & Wolfe, R. R. Effect of exercise and recovery on muscle protein synthesis in human subjects. Am. J. Physiol. 259, E470–E476 (1990). source
- Partly supportedcites [97] Drummond, M. J. et al. Rapamycin administration in humans blocks the contraction-induced increase in skeletal muscle protein synthesis. J. Physiol. 587, 1535–1546 (2009). sourceExperimental — accuracy not yet measured
The Results (Muscle protein synthesis; page not provided) report an approximately 40% post-exercise increase in muscle protein synthesis in the control group, and the Discussion links post-exercise synthesis to muscle protein anabolism. The paper does not show that increased protein synthesis sensitizes muscle insulin action; its insulin discussion concerns blood insulin concentrations, not insulin sensitivity. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [98] Fujita, S. et al. Aerobic exercise overcomes the age-related insulin resistance of muscle protein metabolism by improving endothelial function and Akt/mammalian target of rapamycin signaling. Diabetes 56, 1615–1622 (2007). source
- Not checked — no full text of the sourcecites [99] Levenhagen, D. K. et al. Postexercise nutrient intake timing in humans is critical to recovery of leg glucose and protein homeostasis. Am. J. Physiol. Endocrinol. Metab. 280, E982–E993 (2001). source
- Not checked — no full text of the sourcecites [100] Sheffield-Moore, M. et al. Postexercise protein metabolism in older and younger men following moderate-intensity aerobic exercise. Am. J. Physiol. Endocrinol. Metab. 287, E513–E522 (2004). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Potential mechanisms explaining these changes include age-related reductions in protea some activity, deficiencies in ubiquitylation and autophagy and impairments in removing degraded proteins and end products82–84.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Biological pathways to sarcopenic obesity > Myocellular mechanisms.
What the sources say
- Partly supportedcites [82] Carnio, S. et al. Autophagy impairment in muscle induces neuromuscular junction degeneration and precocious aging. Cell Rep. 8, 1509–1521 (2014). sourceExperimental — accuracy not yet measured
The Results section, “Autophagy Declines during Aging” (page unavailable), reports reduced autophagy markers in aged mice and elderly sedentary people. The Discussion (page unavailable) says autophagy clears damaged proteins and organelles and that its failure contributes to aging. The paper does not establish the claimed age-related reduction in proteasome activity or deficiency in ubiquitylation. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [83] Marcell, T. J. Sarcopenia: causes, consequences, and preventions. J. Gerontol. A Biol. Sci. Med. Sci. 58, M911–M916 (2003). source
- Partly supportedcites [84] Wohlgemuth, S. E., Seo, A. Y., Marzetti, E., Lees, H. A. & Leeuwenburgh, C. Skeletal muscle autophagy and apoptosis during aging: effects of calorie restriction and life-long exercise. Exp. Gerontol. 45, 138–148 (2010). sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) links declining autophagy with accumulation of damaged cellular components, and the Discussion (page unavailable) says age-impaired quality-control pathways may allow damaged proteins to accumulate. However, the Introduction explicitly says it is unclear whether proteasome activity increases or decreases with age in skeletal muscle, and the copy does not establish a specific age-related deficiency in ubiquitylation. (LLM, conf=0.86)
plainconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The synthesis of mitochondria in myocytes is upregulated to meet the demands associated with an increase in capillary density, which in turn leads to increased oxygen extraction and metabolism122 through the induction of calcium and metabolic signalling pathways such as those involving 5’-AMP-activated serine/threonine-protein kinase (AMPK) and sirtuins123.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Biological pathways to sarcopenic obesity > The role of exercise.
What the sources say
- Not checked — no full text of the sourcecites [122] Marzetti, E. et al. Modulation of age-induced apoptotic signaling and cellular remodeling by exercise and calorie restriction in skeletal muscle. Free Radic. Biol. Med. 44, 160–168 (2008). source
- Partly supportedcites [123] Canto, C. et al. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 458, 1056–1060 (2009). sourceExperimental — accuracy not yet measured
The passages labelled Abstract (page unavailable) link AMPK and SIRT1 activity to mitochondrial gene expression and oxygen consumption in myotubes and skeletal muscle. They do not establish calcium signalling or say that increased capillary density drives mitochondrial synthesis; the paper measures cellular oxygen consumption, not oxygen extraction associated with capillary density. (LLM, conf=0.85)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This lipotoxicity impairs muscle fibre contractility and interferes with muscle protein synthesis, exacerbating sarcopenia82–84.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Biological pathways to sarcopenic obesity > Myocellular mechanisms.
What the sources say
- Partly supportedcites [82] Carnio, S. et al. Autophagy impairment in muscle induces neuromuscular junction degeneration and precocious aging. Cell Rep. 8, 1509–1521 (2014). sourceExperimental — accuracy not yet measured
The Discussion reports that oxidative stress impairs acto-myosin function and muscle force, supporting the contractility component. The Results section ‘Autophagy Declines during Aging’ says age-related muscle loss is believed to involve reduced protein synthesis, but our copy does not link either effect to lipotoxicity or show that lipotoxicity exacerbates sarcopenia. No page numbers are available in our copy. (LLM, conf=0.78)
- Not checked — no full text of the sourcecites [83] Marcell, T. J. Sarcopenia: causes, consequences, and preventions. J. Gerontol. A Biol. Sci. Med. Sci. 58, M911–M916 (2003). source
- Could not verifycites [84] Wohlgemuth, S. E., Seo, A. Y., Marzetti, E., Lees, H. A. & Leeuwenburgh, C. Skeletal muscle autophagy and apoptosis during aging: effects of calorie restriction and life-long exercise. Exp. Gerontol. 45, 138–148 (2010). sourceExperimental — accuracy not yet measured
The Introduction links muscle loss to an imbalance between protein synthesis and degradation, while the Discussion reports lipid-peroxidation markers in aged rat muscle. Neither passage says that lipotoxicity impairs fibre contractility or interferes with protein synthesis. Searches for lipotoxicity, intramuscular fat, and those proposed effects found no passage addressing that causal claim; page numbers were unavailable. (LLM, conf=0.76)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Myocyte apoptosis can be abrogated by physical activity125,126, while mechanisms of cellular quality control, including autophagy, mitophagy and mitochondriogenesis127, contribute to the development of sarcopenic obesity and could be potential targets for therapy.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Biological pathways to sarcopenic obesity > The role of exercise.
What the sources say
- Partly supportedcites [127] Wohlgemuth, S. E. et al. An exploratory analysis of the effects of a weight loss plus exercise program on cellular quality control mechanisms in older overweight women. Rejuvenation Res. 14, 315–324 (2011). sourceExperimental — accuracy not yet measured
The Introduction links declining cellular quality control to age-related muscle loss and describes the importance of removing damaged mitochondria and generating new ones. The Discussion suggests that improved cellular quality control may benefit muscle function after weight loss and exercise. But the Abstract explicitly says it remains undetermined whether impaired cellular quality control contributes to sarcopenia; the paper does not establish that these mechanisms cause sarcopenic obesity or identify all three as therapeutic targets. No page numbers are available in our copy. (LLM, conf=0.88)
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The FNIH suggested testing for low lean mass using DXA (defined using appendicular lean mass) and reduced muscle function using handgrip strength.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > An evolving definition
What the sources say
- Supportedcites [182] Studenski, S. A. et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J. Gerontol. A Biol. Sci. Med. Sci. 69, 547–558 (2014). This report details recommendations from the Foundation of the National Institutes on Health Sarcopenia Project, which aggregated multiple cohorts of older adults and created cut-off points to permit identification of low muscle mass and low muscle strength. source
The Methods (Measures; page unavailable) define appendicular lean mass as the sum of arm and leg lean mass and describe its measurement using DXA in the main study datasets. The Results (Table 3; page unavailable) recommend BMI-adjusted appendicular lean mass for low lean mass and handgrip-strength cutpoints for weakness. The paper notes that two contributing datasets used other body-composition methods. (LLM, conf=0.92)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Investigators assigned participants to partake in varying intensities of resistance exercises. The investigators reported no alterations in concentrations of leptin, but participants had intensity-dependent changes in adiponectin139,145 — high-intensity resistance training led to an increase in the concentrations of adiponectin for 24 hours after exercise in inactive adults who were overweight139.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Biological pathways to sarcopenic obesity > The role of exercise.
What the sources say
- Supportedcites [139] Fatouros, I. G. et al. Intensity of resistance exercise determines adipokine and resting energy expenditure responses in overweight elderly individuals. Diabetes Care 32, 2161–2167 (2009). source
Split into 2 atoms — 2 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
- Not checked — no full text of the sourcecites [145] Fatouros, I. G. et al. Leptin and adiponectin responses in overweight inactive elderly following resistance training and detraining are intensity related. J. Clin. Endocrinol. Metab. 90, 5970–5977 (2005). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Dual-energy X-ray absorptiometry (DXA) is recommended for the assessment of appendicular lean mass in the diagnosis of sarcopenia156 owing to its affordability, availability and diagnostic accuracy157.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Assessing body composition
What the sources say
- Supportedcites [156] Cruz-Jentoft, A. J. et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 39, 412–423 (2010). source
The citation to this paper (156) supports the recommendation to use DXA, not the subsequent rationale cited to 157. In the Assessment techniques section, the paper calls DXA the preferred alternative for research and clinical use, and Table 5 lists DXA measurements of appendicular lean mass for diagnosing sarcopenia. Page numbers are not provided in the supplied passages. (LLM, conf=0.91)
- Not checked — no full text of the sourcecites [157] Kendler, D. L. et al. The Official Positions of the International Society for Clinical Densitometry: indications of use and reporting of DXA for body composition. J. Clin. Densitom. 16, 496–507 (2013). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The Foundation for the National Institutes of Health (FNIH) Sarcopenia Project182 suggested a causal, indirect relationship between muscle mass and function in their definition of sarcopenia.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > An evolving definition
What the sources say
- Supportedcites [182] Studenski, S. A. et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J. Gerontol. A Biol. Sci. Med. Sci. 69, 547–558 (2014). This report details recommendations from the Foundation of the National Institutes on Health Sarcopenia Project, which aggregated multiple cohorts of older adults and created cut-off points to permit identification of low muscle mass and low muscle strength. source
The passage labeled Abstract > Conclusions describes an indirect pathway: some adults have functional limitations because they are weak, and are weak in part because they have low muscle mass. The Discussion says the project links lean mass to weakness and weakness to mobility impairment. The paper cautions that this is not a direct, strong causal pathway for everyone. (LLM, conf=0.87)
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Resistance training seems to be more efficient in reducing leptin levels than aerobic training alone146, though conflicting evidence exists147.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Biological pathways to sarcopenic obesity > The role of exercise.
What the sources say
- Supportedcites [146] Rostas, I. et al. In middle-aged and old obese patients, training intervention reduces leptin level: a meta-analysis. PLoS ONE 12, e0182801 (2017). source
The Discussion reports that resistance or strength training produced greater leptin suppression than aerobic training for the same amount of fat loss. The Results (Additional analyses) likewise report a steeper relationship between fat loss and leptin reduction for resistance or mixed training than for aerobic training. The separate statement about conflicting evidence is attached to citation 147, not this source. (LLM, conf=0.92)
- Not checked — no full text of the sourcecites [147] Nikseresht, M., Sadeghifard, N., Agha-Alinejad, H. & Ebrahim, K. Inflammatory markers and adipocytokine responses to exercise training and detraining in men who are obese. J. Strength Cond. Res. 28, 3399–3410 (2014). source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Following a 12-week diet–exercise intervention in male and female frail adults with obesity aged 69 ± 1 years, investigators reported reduced skeletal muscle levels of mRNA for TLR4, IL6 and TNF, increased mechano growth factor mRNA and increased fat-free mass in the exercise group, and these results were independent of weight loss133.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Biological pathways to sarcopenic obesity > The role of exercise.
What the sources say
- Partly supportedcites [133] Lambert, C. P., Wright, N. R., Finck, B. N. & Villareal, D. T. Exercise but not diet-induced weight loss decreases skeletal muscle inflammatory gene expression in frail obese elderly persons. J. Appl. Physiol. (1985) 105, 473–478 (2008). sourceExperimental — accuracy not yet measured
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Expression of skeletal muscle TNF, IL-1β and nitric oxide synthase, inducible in patients with heart failure was reduced following aerobic training, suggesting that aerobic exercise has anti-inflammatory effects135.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Biological pathways to sarcopenic obesity > The role of exercise.
What the sources say
- Supportedcites [135] Gielen, S. et al. Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure. J. Am. Coll. Cardiol. 42, 861–868 (2003). source
The Discussion reports that six months of aerobic endurance training reduced skeletal-muscle TNF-alpha, IL-1-beta, and iNOS expression in patients with stable chronic heart failure. It explicitly describes these as local anti-inflammatory effects. (LLM, conf=0.95)
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Assessments of lean mass are highly reproducible and can be used for clinical monitoring, while a detailed assessment of visceral fat is not as accurate150,161–163.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Assessing body composition
What the sources say
- Not checked — no full text of the sourcecites [150] Woodrow, G. Body composition analysis techniques in the aged adult: indications and limitations. Curr. Opin. Clin. Nutr. Metab. Care 12, 8–14 (2009). source
- Not checked — no full text of the sourcecites [161] Park, Y. W., Heymsfield, S. B. & Gallagher, D. Are dual-energy X-ray absorptiometry regional estimates associated with visceral adipose tissue mass? Int. J. Obes. Relat. Metab. Disord. 26, 978–983 (2002). source
- Partly supportedcites [162] Kaul, S. et al. Dual-energy X-ray absorptiometry for quantification of visceral fat. Obesity 20, 1313–1318 (2012). sourceExperimental — accuracy not yet measured
The Abstract (page unavailable) says DXA measures body composition with high precision, which broadly supports the lean-mass reproducibility claim, but the paper does not establish its use for clinical monitoring. The Discussion (page unavailable) reports strong agreement between DXA and CT visceral-fat measurements, rather than finding detailed visceral-fat assessment less accurate. (LLM, conf=0.82)
- Partly supportedcites [163] Micklesfield, L. K., Goedecke, J. H., Punyanitya, M., Wilson, K. E. & Kelly, T. L. Dual-energy X-ray performs as well as clinical computed tomography for the measurement of visceral fat. Obesity 20, 1109–1114 (2012). sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) says DXA cannot measure visceral fat directly and that modelling it introduces estimation errors. It does not establish that lean-mass assessments are highly reproducible or suitable for clinical monitoring, or compare their accuracy with visceral-fat assessments. The study also reports that DXA visceral-fat measurements performed comparably to clinical CT. (LLM, conf=0.82)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The European Working Group for the Study of Sarcopenia (EWGSOP)156 identified sarcopenia cut-off points and tools for its measurement. They recognized the lack of diagnostic criteria for sarcopenia but integrated low muscle mass and function (strength or performance) in their terminology, believing that the relationship between these two measures is not linear nor bidirectional73,156,181.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > An evolving definition
What the sources say
- Partly supportedcites [156] Cruz-Jentoft, A. J. et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 39, 412–423 (2010). sourceExperimental — accuracy not yet measured
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
- Not checked — no full text of the sourcecites [73] Goodpaster, B. H. et al. The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J. Gerontol. A Biol. Sci. Med. Sci. 61, 1059–1064 (2006). This study shows that loss of strength with ageing is much more rapid than the concomitant loss of muscle mass, suggesting a decline in muscle quality. source
- Not checked — no full text of the sourcecites [181] Janssen, I., Baumgartner, R. N., Ross, R., Rosenberg, I. H. & Roubenoff, R. Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women. Am. J. Epidemiol. 159, 413–421 (2004). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“EWGSOP recommended that muscle mass is assessed by DXA or bioelectrical impedance, using mathematical thresholds and formulas presented in their consensus document.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > An evolving definition
What the sources say
- Supportedcites [156] Cruz-Jentoft, A. J. et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 39, 412–423 (2010). source
The Assessment techniques section recommends DXA for research and clinical use and describes BIA as a portable alternative. Tables 4 and 5 list both methods for muscle-mass assessment and give indices, formulas, and cut-off points; the supplied passages do not specify page numbers. (LLM, conf=0.92)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Resistance exercise increases the number and size of fast twitching muscle fibres (IIA and IIX), which improve glucose metabolism in muscle and muscle protein synthesis102,103,137–139.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Biological pathways to sarcopenic obesity > The role of exercise.
What the sources say
- Not checked — no full text of the sourcecites [102] Yarasheski, K. E., Zachwieja, J. J. & Bier, D. M. Acute effects of resistance exercise on muscle protein synthesis rate in young and elderly men and women. Am. J. Physiol. 265, E210–E214 (1993). source
- Not checked — no full text of the sourcecites [103] Yarasheski, K. E. et al. Resistance exercise training increases mixed muscle protein synthesis rate in frail women and men >/=76 yr old. Am. J. Physiol. 277, E118–E125 (1999). source
- Not checked — no full text of the sourcecites [137] Andersen, L. L. et al. Changes in the human muscle force-velocity relationship in response to resistance training and subsequent detraining. J. Appl. Physiol. (1985) 99, 87–94 (2005). source
- Not checked — no full text of the sourcecites [138] Englund, D. A., Sharp, R. L., Selsby, J. T., Ganesan, S. S. & Franke, W. D. Resistance training performed at distinct angular velocities elicits velocity-specific alterations in muscle strength and mobility status in older adults. Exp. Gerontol. 91, 51–56 (2017). source
- Partly supportedcites [139] Fatouros, I. G. et al. Intensity of resistance exercise determines adipokine and resting energy expenditure responses in overweight elderly individuals. Diabetes Care 32, 2161–2167 (2009). sourceExperimental — accuracy not yet measured
The Conclusions (page not available in our copy) say chronic resistance exercise can add muscle mass and that muscle protein turnover may remain elevated after heavy exercise. They do not identify increases in the number or size of type IIA or IIX fibres, or say that such changes improve muscle glucose metabolism and protein synthesis. The study examined acute responses in overweight older adults, not those fibre changes. (LLM, conf=0.84)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The International Working Group for the Study of Sarcopenia (IWGS) provided a consensus definition for sarcopenia180 as the combination of low whole-body or appendicular lean mass and poor physical functioning (gait speed ≤1 m/s).”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > An evolving definition
What the sources say
- Partly supportedcites [180] Fielding, R. A. et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J. Am. Med. Dir. Assoc. 12, 249–256 (2011). This is a consensus statement from the International Working Group on Sarcopenia that presents evidence and a definition for the identification of sarcopenia. sourceExperimental — accuracy not yet measured
The Current Consensus Definition section defines sarcopenia using low whole-body or appendicular fat-free mass combined with poor physical functioning. It specifies gait speed of less than 1.0 m/s, however, whereas the citing sentence says ≤1 m/s; the paper's threshold does not include exactly 1.0 m/s. No page number is available in our copy. (LLM, conf=0.86)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“A study into the effects of aerobic activity in patients who had recovered from breast cancer reported that individuals who were randomized to the aerobic exercise group demonstrated reductions in insulin and leptin and increases in the adiponectin:leptin ratio but no significant changes in adiponectin compared with participants in the usual activity group148.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Biological pathways to sarcopenic obesity > The role of exercise.
What the sources say
- Partly supportedcites [148] Friedenreich, C. M. et al. Changes in insulin resistance indicators, IGFs, and adipokines in a year-long trial of aerobic exercise in postmenopausal women. Endocr. Relat. Cancer 18, 357–369 (2011). sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Further validation of bioelectrical impedance results is needed in individuals aged ≥80 years, as they are at increased risk of sarcopenic obesity177,178.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Assessing body composition
What the sources say
- Partly supportedcites [177] Batsis, J. A., Mackenzie, T. A., Lopez-Jimenez, F. & Bartels, S. J. Sarcopenia, sarcopenic obesity, and functional impairments in older adults: National Health and Nutrition Examination Surveys 1999–2004. Nutr. Res. 35, 1031–1039 (2015). sourceExperimental — accuracy not yet measured
The Results report that sarcopenic obesity prevalence increased with age, supporting the concern about older individuals. The Methods say body composition was measured with DEXA, and the Discussion mentions bioelectrical impedance only as an approach used elsewhere; neither section calls for further validation of its results in people aged ≥80 years. Page numbers are unavailable in our copy. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [178] Batsis, J. A. et al. Variation in the prevalence of sarcopenia and sarcopenic obesity in older adults associated with different research definitions: dual-energy X-ray absorptiometry data from the National Health and Nutrition Examination Survey 1999–2004. J. Am. Geriatr. Soc. 61, 974–980 (2013). This study applies multiple definitions of sarcopenic obesity on a cohort of American adults and emphasizes the varied prevalences of this disorder. source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. It may state two separate claims as one.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Furthermore, a 12-week aerobic and resistance programme increased serum levels of ghrelin and adiponectin by 47% and 55%, respectively, and reduced circulating levels of CD14+ and CD16+ inflammatory monocytes, adding additional evidence to the anti-inflammatory effects of exercise136.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Biological pathways to sarcopenic obesity > The role of exercise.
What the sources say
- Supportedcites [136] Markofski, M. M. et al. Exercise training modifies ghrelin and adiponectin concentrations and is related to inflammation in older adults. J. Gerontol. A Biol. Sci. Med. Sci. 69, 675–681 (2014). source
The paper reports that 12 weeks of combined aerobic and resistance training increased ghrelin and adiponectin by 47% and 55%, respectively (opening summary). The Discussion reports a concomitant reduction in circulating CD14+CD16+ inflammatory monocytes and presents the findings as evidence relevant to exercise’s anti-inflammatory effects. Page numbers are not available in the supplied passages. (LLM, conf=0.91)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This algorithm was meant for clinical application using gait speed (<0.8 m/s) before muscle mass or strength measurement.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > An evolving definition
What the sources say
- Partly supportedcites [156] Cruz-Jentoft, A. J. et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 39, 412–423 (2010). sourceExperimental — accuracy not yet measured
The ‘Sarcopenia screening and assessment’ section says the EWGSOP algorithm was intended for clinical practice and begins with gait-speed measurement, supporting the stated sequence. But that section gives a risk cut-off of >0.8 m/s, not <0.8 m/s. The ‘Assessment techniques’ table lists <0.8 m/s as a gait-speed cut-off without explicitly tying it to the algorithm. (LLM, conf=0.84)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The rates of sarcopenic obesity increased with age, reaching 48.0% and 27.5% in females and males, respectively, in those aged over 80 years198.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Prevalence of sarcopenic obesity
What the sources say
- Supportedcites [198] Batsis, J. A., Mackenzie, T. A., Emeny, R. T., Lopez-Jimenez, F. & Bartels, S. J. Low lean mass with and without obesity, and mortality: results from the 1999–2004 National Health and Nutrition Examination Survey. J. Gerontol. A Biol. Sci. Med. Sci. 72, 1445–1451 (2017). This report details the definition of low lean mass determined by the Foundation of the National Institutes of Health, as well as the adverse association between low lean mass and mortality. source
Table 3 in the Results reports that low lean mass with obesity increased across age groups in both sexes. In the 80+ group, prevalence was 48.0% for females and 27.5% for males. (LLM, conf=0.95)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“FNIH deliberately avoided the term sarcopenia to differentiate between qualitative (strength) and quantitative (mass) components.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > An evolving definition
What the sources say
- Supportedcites [182] Studenski, S. A. et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J. Gerontol. A Biol. Sci. Med. Sci. 69, 547–558 (2014). This report details recommendations from the Foundation of the National Institutes on Health Sarcopenia Project, which aggregated multiple cohorts of older adults and created cut-off points to permit identification of low muscle mass and low muscle strength. source
In the passage labelled Abstract > Conclusions (no page number available), the authors say they decided to avoid the term “sarcopenia” because its meaning was confused, using “low lean mass” and “weakness” instead. That supports the claim that FNIH deliberately used separate terms for mass and strength. (LLM, conf=0.91)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“FNIH stated that sex-specific cut-off points could be adjusted for BMI.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > An evolving definition
What the sources say
- Supportedcites [182] Studenski, S. A. et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J. Gerontol. A Biol. Sci. Med. Sci. 69, 547–558 (2014). This report details recommendations from the Foundation of the National Institutes on Health Sarcopenia Project, which aggregated multiple cohorts of older adults and created cut-off points to permit identification of low muscle mass and low muscle strength. source
The Results (Table 3) give separate cutoffs for men and women using BMI-adjusted appendicular lean mass, and also list BMI-adjusted grip-strength cutoffs as an alternative. This supports the statement that FNIH presented sex-specific cutoffs adjusted for BMI. (LLM, conf=0.93)
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Investigators from the Cardiovascular Health Study used low grip strength and high waist circumference to define low muscle strength and obesity. Rates approached 11.1%201, while data from FNIH classified 4.1% of men and 14.0% of women as having sarcopenic obesity using high BMI and low grip strength as measures of obesity and low muscle strength, respectively202.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Prevalence of sarcopenic obesity
What the sources say
- Supportedcites [201] Stephen, W. C. & Janssen, I. Sarcopenic-obesity and cardiovascular disease risk in the elderly. J. Nutr. Health Aging 13, 460–466 (2009). source
The Measurements section says waist circumference and grip strength were used to classify participants. The Results (Subject Characteristics) report that 11.1% were sarcopenic-obese under the obesity-by-muscle-strength classification; the Discussion specifies high waist circumference and low hand-grip strength. (LLM, conf=0.92)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The separate criteria for muscle mass and strength implied the need to target interventions for individuals with low mass or low strength.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > An evolving definition
What the sources say
- Partly supportedcites [182] Studenski, S. A. et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J. Gerontol. A Biol. Sci. Med. Sci. 69, 547–558 (2014). This report details recommendations from the Foundation of the National Institutes on Health Sarcopenia Project, which aggregated multiple cohorts of older adults and created cut-off points to permit identification of low muscle mass and low muscle strength. sourceExperimental — accuracy not yet measured
The Conclusions distinguish weakness from low muscle mass and suggest that people whose low mass contributes to weakness may benefit from muscle-mass interventions, while people weak for other reasons may need different interventions. The Discussion proposes trials for people with varying degrees of weakness and low lean mass. It does not establish a need to target interventions at everyone with low mass or low strength; it says low mass alone is not consistently associated with adverse outcomes. (LLM, conf=0.85)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In one study, BMI correctly classified 41.0% of men and 45.1% of women as being obese and waist circumference correctly classified 64.2% of men and 81.0% ofwomen as being obese194.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > An evolving definition
What the sources say
- Partly supportedcites [194] Batsis, J. A. et al. Diagnostic accuracy of body mass index to identify obesity in older adults: NHANES 1999–2004. Int. J. Obes. (Lond.) 40, 761–767 (2016). This study emphasizes the challenges of using BMI as a marker for obesity. BMI has a poor sensitivity in ascertaining body fat-defined obesity that worsens with age. sourceExperimental — accuracy not yet measured
The Abstract Results report that BMI ≥30 kg/m² correctly classified 41.0% of obese men and 45.1% of obese women. The Results say Table 2B assesses waist circumference, but the passages available in our copy do not give the claimed 64.2% and 81.0% figures, so that part is not verified. (LLM, conf=0.83)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Obesity is defined as an unhealthy excess body fat that increases the risk of medical illness and mortality186.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > An evolving definition
What the sources say
- Supportedcites [186] Villareal, D. T. et al. Obesity in older adults: technical review and position statement of the American Society for Nutrition and NAASO, The Obesity Society. Am. J. Clin. Nutr. 82, 923–934 (2005). This study highlights current guidelines for the management of older adults with obesity. source
The “Definition of Obesity” section directly defines obesity as an unhealthy excess of body fat that increases the risk of medical illness and premature mortality. The citing sentence closely paraphrases that definition. (LLM, conf=0.95)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Aerobic exercise improves cardiorespiratory fitness and has beneficial effects on mortality276–278.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Treatments for sarcopenic obesity > Resistance training and aerobic exercise.
What the sources say
- Supportedcites [276] Lin, X. et al. Effects of exercise training on cardiorespiratory fitness and biomarkers of cardiometabolic health: a systematic review and meta-analysis of randomized controlled trials. J. Am. Heart Assoc. 4, e002014 (2015). source
The Abstract’s Methods and Results report that exercise significantly increased cardiorespiratory fitness. The Conclusions also report better survival after exercise interventions in secondary-prevention studies; mortality was not an outcome measured by this meta-analysis. (LLM, conf=0.87)
- Not checked — no full text of the sourcecites [277] Hwang, C. L., Wu, Y. T. & Chou, C. H. Effect of aerobic interval training on exercise capacity and metabolic risk factors in people with cardiometabolic disorders: a meta-analysis. J. Cardiopulm. Rehabil. Prev. 31, 378–385 (2011). source
- Not checked — no full text of the sourcecites [278] Sui, X. M. et al. Cardiorespiratory fitness and adiposity as mortality predictors in older adults. JAMA 298, 2507–2516 (2007). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“intentional weight loss in older adults improves morbidity and physical function186”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Treatments for sarcopenic obesity
What the sources say
- Partly supportedcites [186] Villareal, D. T. et al. Obesity in older adults: technical review and position statement of the American Society for Nutrition and NAASO, The Obesity Society. Am. J. Clin. Nutr. 82, 923–934 (2005). This study highlights current guidelines for the management of older adults with obesity. sourceExperimental — accuracy not yet measured
The Physical function and quality of life section reports improved physical function in obese older adults when moderate weight loss was combined with exercise. The Medical complications section reports improvements in obesity-related metabolic abnormalities, but says most studies of these effects were conducted in middle-aged adults; it does not establish improved morbidity in older adults. The claim also omits the exercise component of the physical-function finding. (LLM, conf=0.86)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“chronic calorie restriction does not seem to reduce muscle protein synthesis, but it might increase it105,255”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Treatments for sarcopenic obesity > Dietary strategies: calorie restriction and protein supplementation.
What the sources say
- Could not verifycites [105] Villareal, D. T., Smith, G. I., Sinacore, D. R., Shah, K. & Mittendorfer, B. Regular multicomponent exercise increases physical fitness and muscle protein anabolism in frail, obese, older adults. Obesity (Silver Spring) 19, 312–318 (2011). This study demonstrates that a multicomponent exercise programme consisting of strength, endurance, flexibility and balance increases the basal rate of muscle protein synthesis without affecting the magnitude of the muscle protein anabolic response to feeding. sourceExperimental — accuracy not yet measured
The Methods (Experimental protocol; page unavailable) say participants were counseled to maintain a weight-maintaining diet, not to restrict calories. The Results (Muscle protein synthesis rate; page unavailable) report increased synthesis after exercise training. The copy therefore does not address whether chronic calorie restriction reduces or increases muscle protein synthesis; I searched for calorie restriction, energy restriction, and weight loss. (LLM, conf=0.76)
- Partly supportedcites [255] Campbell, W. W. et al. Resistance training preserves fat-free mass without impacting changes in protein metabolism after weight loss in older women. Obesity (Silver Spring) 17, 1332–1339 (2009). sourceExperimental — accuracy not yet measured
The Results (Muscle protein synthesis; page unavailable) report that postabsorptive and total muscle protein synthesis increased after weight loss, while postprandial synthesis did not change. But the Discussion says measurements were made after energy balance was restored, not during calorie restriction, and that the study could not separate the effects of restriction from weight loss. The broader claim about chronic calorie restriction therefore goes beyond this finding in older women. (LLM, conf=0.86)
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Distributing protein intake throughout the day259 or pulse feeding at main meals260 could be beneficial for the stimulation of muscle protein synthesis in patients with sarcopenic obesity.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Treatments for sarcopenic obesity > Dietary strategies: calorie restriction and protein supplementation.
What the sources say
- Partly supportedcites [259] Deutz, N. E. et al. Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN Expert Group. Clin. Nutr. 33, 929–936 (2014). These are the European Society for Clinical Nutrition and Metabolism workshop recommendations on protein requirements in elderly individuals. sourceExperimental — accuracy not yet measured
The “Protein intake pattern” section says pulse feeding may improve feeding-induced protein synthesis in older adults. The “Sarcopenic obesity and protein intake” section recommends increased protein intake for sarcopenic obesity, but does not specifically recommend pulse feeding or establish its benefit for protein synthesis in those patients. Page numbers were not available in our copy. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [260] Bouillanne, O. et al. Impact of protein pulse feeding on lean mass in malnourished and at-risk hospitalized elderly patients: a randomized controlled trial. Clin. Nutr. 32, 186–192 (2013). source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The findings demonstrated increases in physical performance test scores (higher score equals higher level of function), more so in the combined aerobic and resistance exercise group (27.9 to 33.4 points (21% increase)) than in the aerobic (29.3 to 33.2 points (14% increase)) or resistance group (28.8 to 32.7 points (14% increase)) alone.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Treatments for sarcopenic obesity > Calorie restriction and physical activity.
What the sources say
- Supportedcites [247] Villareal, D. T. et al. Aerobic or resistance exercise, or both in dieting obese older adults. N. Engl. J. Med. 376, 1943–1955 (2017). This is a randomized trial of older adults with obesity and frailty demonstrating that weight loss coupled with both aerobic and resistance activities is associated with improved physical function. source
Split into 2 atoms — 2 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“patients in the intervention group regained appendicular lean mass during the second year and that weight loss was 5.2 kg less in the intervention group than in participants in the control group, whose weight did not markedly change after the second year310”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Risks of weight loss in older adults
What the sources say
- Supportedcites [310] Gallagher, D. et al. Changes in skeletal muscle and organ size after a weight-loss intervention in overweight and obese type 2 diabetic patients. Am. J. Clin. Nutr. 105, 78–84 (2017). source
Split into 2 atoms — 2 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Adipose tissue has been shown to be inversely associated with bone material strength and positively associated with cortical porosity, indicating an adverse effect of adipose tissue on bone microstructure317.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Risks of weight loss in older adults
What the sources say
- Partly supportedcites [317] Sundh, D. et al. A high amount of local adipose tissue is associated with high cortical porosity and low bone material strength in older women. J. Bone Miner. Res. 31, 749–757 (2016). sourceExperimental — accuracy not yet measured
The Results report that local tibial adipose tissue was inversely correlated with bone material strength index and positively correlated with cortical porosity in older women. The Discussion describes an adverse effect on cortical bone microstructure as possible, whereas the citing sentence presents it without that qualification and does not specify the studied population. (LLM, conf=0.85)
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Although the LIFE study is considered a standard for physical activity in older adults282, we acknowledge its lack of evidence in sarcopenic obesity and the lack of power in this pilot trial.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Treatments for sarcopenic obesity > Resistance training and aerobic exercise.
What the sources say
- Supportedcites [282] Pahor, M. et al. Effect of structured physical activity on prevention of major mobility disability in older adults: the LIFE study randomized clinical trial. JAMA 311, 2387–2396 (2014). This study reports on a gold standard, structured, long-term physical activity intervention, consisting of 3–4 times of aerobic, resistance and flexibility training per week, that demonstrates improvements in mobility disability over a 2.6-year follow-up. source
The citation is attached to the identification of the LIFE study as a physical-activity study in older adults. The Abstract’s Design, Setting, and Participants section describes a randomized trial of 1,635 sedentary adults aged 70–89. The statements about sarcopenic obesity and the citing authors’ pilot trial are not attributed to this citation. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Weight loss in younger adults (age 45–65 years) led to loss of lean mass after calorie restriction (4% reduction in lean mass; P < 0.0001), which was partially lessened by augmentation with aerobic activity (2% reduction in lean mass in participants who had augmented weight loss with aerobic activity; P = 0.05)311.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Risks of weight loss in older adults
What the sources say
- Supportedcites [311] Weiss, E. P., Jordan, R. C., Frese, E. M., Albert, S. G. & Villareal, D. T. Effects of weight loss on lean mass, strength, bone, and aerobic capacity. Med. Sci. Sports Exerc. 49, 206–217 (2017). source
The Methods identify participants as sedentary adults aged 45–65. The Abstract Results report that lower-extremity lean mass fell about 4% with calorie restriction (p<0.0001) and about 2% with calorie restriction plus exercise (p=0.05). The percentages refer specifically to lower-extremity lean mass, rather than whole-body lean mass. (LLM, conf=0.94)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“A combined treatment of diet and exercise improved physical function in frail older men with obesity aged ≥65 years for 1 year, despite resulting in a reduction in oestradiol levels and only a modest increase in testosterone levels299.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Treatments for sarcopenic obesity > Calorie restriction and physical activity.
What the sources say
- Supportedcites [299] Armamento-Villareal, R., Aguirre, L. E., Qualls, C. & Villareal, D. T. Effect of lifestyle intervention on the hormonal profile of frail, obese older men. J. Nutr. Health Aging 20, 334–340 (2016). source
The Methods specify men aged ≥65 years with obesity and frailty in a 52-week study. The Results report improved physical performance in the diet–exercise group over one year, alongside decreased estradiol and a modest increase in testosterone. (LLM, conf=0.94)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“levels of adiponectin increased in individuals with overweight or obesity compared with controls (diet resulted in 9.5% increase in adiponectin (P < 0.001), and diet and exercise resulted in a 6.6% increase in adiponectin (P < 0.001)). Furthermore, levels of leptin in individuals with obesity or overweight decreased by 27.1% in the diet group and 40.1% in the diet and exercise group302.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Treatments for sarcopenic obesity > Calorie restriction and physical activity.
What the sources say
- Partly supportedcites [302] Abbenhardt, C. et al. Effects of individual and combined dietary weight loss and exercise interventions in postmenopausal women on adiponectin and leptin levels. J. Intern. Med. 274, 163–175 (2013). sourceExperimental — accuracy not yet measured
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“2 days of high-resistance concentric exercise with one bout of low-resistance exercise increased muscle expression of pro-inflammatory cytokine receptors, maximized muscle mass and total lean mass and improved knee extension283”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Treatments for sarcopenic obesity > Resistance training and aerobic exercise.
What the sources say
- Partly supportedcites [283] Stec, M. J. et al. Randomized, four-arm, dose-response clinical trial to optimize resistance exercise training for older adults with age-related muscle atrophy. Exp. Gerontol. 99, 98–109 (2017). sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Energy restriction with a hypocaloric diet with or without exercise results in the loss of approximately one-quarter of lean mass per unit weight, which could worsen sarcopenia and osteopenia154.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Risks of weight loss in older adults
What the sources say
- Partly supportedcites [154] Heymsfield, S. B., Gonzalez, M. C., Shen, W., Redman, L. & Thomas, D. Weight loss composition is one-fourth fat-free mass: a critical review and critique of this widely cited rule. Obes. Rev. 15, 310–321 (2014). sourceExperimental — accuracy not yet measured
The Introduction describes fat-free-mass loss during hypocaloric dieting as a clinical risk, and the Conclusions identify one-quarter of weight loss as fat-free mass as an approximation, not a fixed result. The “With Diet” section reports that adding exercise can reduce fat-free-mass losses. The copy does not specifically link these losses to worsening osteopenia. (LLM, conf=0.87)
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“individuals in the physical activity group had reductions in IL-8 but no differences in other inflammatory markers303”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Treatments for sarcopenic obesity > Calorie restriction and physical activity.
What the sources say
- Partly supportedcites [303] Beavers, K. M. et al. Long-term physical activity and inflammatory biomarkers in older adults. Med. Sci. Sports Exerc. 42, 2189–2196 (2010). sourceExperimental — accuracy not yet measured
The Abstract Results report that IL-8 was the only biomarker affected in the main analysis, with a 9.9% lower adjusted level in the physical-activity group at 12 months. But they also report reduced IL-15 in participants with high baseline IL-15, and say neither association remained significant after accounting for multiple comparisons. The claim omits those qualifications. (LLM, conf=0.86)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“A 12-week aerobic exercise regime in combination with a low glycaemic index diet or high glycaemic index diet resulted in reductions in leptin levels in two groups of participants who had elevated levels of adiponectin, suggesting that the reductions in leptin were a result of exercise training and independent of dietary glycaemic index304.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Treatments for sarcopenic obesity > Calorie restriction and physical activity.
What the sources say
- Supportedcites [304] Kelly, K. R. et al. Lifestyle-induced decrease in fat mass improves adiponectin secretion in obese adults. Med. Sci. Sports Exerc. 46, 920–926 (2014). source
Split into 2 atoms — 2 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
hedgeddirectn = 2- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Whole-body vibration therapy was as efficient as a fitness programme at increasing knee extension and lower leg muscle mass in non-institutionalized men aged 60–80 years old372 and improved quality of life and functional measures373.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Whole-body vibration therapy.
What the sources say
- Not checked — no full text of the sourcecites [372] Bogaerts, A. et al. Impact of whole-body vibration training versus fitness training on muscle strength and muscle mass in older men: a 1-year randomized controlled trial. J. Gerontol. A Biol. Sci. Med. Sci. 62, 630–635 (2007). source
- Supportedcites [373] Chang, S. F., Lin, P. C., Yang, R. S. & Yang, R. J. The preliminary effect of whole-body vibration intervention on improving the skeletal muscle mass index, physical fitness, and quality of life among older people with sarcopenia. BMC Geriatr. 18, 17 (2018). source
Citation 373 is attached to the claim that whole-body vibration improved quality of life and functional measures, not to the preceding comparison with a fitness programme. The Discussion reports a significant increase in the quality-of-life index and significant improvements in physical fitness after the 12-week intervention. (LLM, conf=0.92)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Widespread availability of DXA even in low-resource areas344 permits this evaluation.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Integrating methods for analysing body composition into clinical practice.
What the sources say
- Partly supportedcites [344] Curtis, J. R. et al. The geographic availability and associated utilization of dual-energy X-ray absorptiometry (DXA) testing among older persons in the United States. Osteoporos. Int. 20, 1553–1561 (2009). sourceExperimental — accuracy not yet measured
The Results report that 75.4% of rural Medicare beneficiaries lived within five miles of a DXA provider, supporting availability in many rural US areas. But the paper does not establish availability in low-resource areas as such; its Discussion also notes that rural access is more vulnerable to provider closures. The cited paper studies access to DXA testing, not its use to evaluate muscle mass. (LLM, conf=0.84)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Hengting Chen and colleagues370 identified 10 randomized trials of whole-body vibration therapy showing its usefulness in younger adults (difference (d) = 0.35 (95% CI 0.05–0.64; P = 0.02)), but this usefulness was not seen in older adults (d = −0.04 (95% CI −0.28 to 0.21; P = 0.78)).”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Whole-body vibration therapy.
What the sources say
- Partly supportedcites [370] Chen, H., Ma, J., Lu, B. & Ma, X. L. The effect of whole-body vibration training on lean mass: a PRISMA-compliant meta-analysis. Medicine (Baltimore) 96, e8390 (2017). sourceExperimental — accuracy not yet measured
The Abstract (Results) identifies 10 randomized trials, and the Results (Main analysis) report the quoted effect sizes and confidence intervals: a significant improvement in young adults but not in older adults. The measured outcome was muscle or lean mass, however, so the unqualified claim that therapy was generally “useful” extends beyond what the review established. The quoted P = 0.78 for older adults does not appear in the available Results passage. (LLM, conf=0.82)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The introduction in 2016 of an International Classification of Diseases 10 code for sarcopenia (M62.84) will permit clinical recognition and promote its diagnosis, classification and drug development339,340.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Harmonizing a definition.
What the sources say
- Supportedcites [339] Anker, S. D., Morley, J. E. & von Haehling, S. Welcome to the ICD-10 code for sarcopenia. J. Cachexia Sarcopenia Muscle 7, 512–514 (2016). sourceExperimental — accuracy not yet measured
The Abstract says sarcopenia received ICD-10-CM code M62.84 in September 2016, marking its recognition as a disease entity. It also predicts greater physician interest in diagnosis, more diagnostic tools, and accelerated drug development; the code supplies the classification described in the claim. (LLM, conf=0.91)
- Could not verifycites [340] Cao, B. Future healthy life expectancy among older adults in the US: a forecast based on cohort smoking and obesity history. Popul. Health Metr. 14, 23 (2016). sourceExperimental — accuracy not yet measured
The Data and Results sections discuss obesity, smoking and disability in forecasts of healthy life expectancy, not sarcopenia coding. Searches for sarcopenia, M62.84, ICD-10 and related diagnostic terms found no passage addressing the claimed effects of the code’s introduction. (LLM, conf=0.76)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Levels of osteocalcin were increased in the diet-only group (36 ± 11.6%), yet its levels were no different than baseline in individuals on diet coupled with exercise;”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Risks of weight loss in older adults
What the sources say
- Supportedcites [320] Colleluori, G., Napoli, N., Phadnis, U., Armamento-Villareal, R. & Villareal, D. T. Effect of weight loss, exercise, or both on undercarboxylated osteocalcin and insulin secretion in frail, obese older adults. Oxid. Med. Cell. Longev. 2017, 4807046 (2017). source
Section 3.2 (Results) reports that serum undercarboxylated osteocalcin increased by 36.0 ± 11.6% at 12 months in the diet-only group and did not change in the diet-plus-exercise group. The quoted percentage refers specifically to undercarboxylated osteocalcin, rather than total osteocalcin. (LLM, conf=0.94)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The review included heterogeneous studies using different methodologies, training and vibration characteristics.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Whole-body vibration therapy.
What the sources say
- Supportedcites [370] Chen, H., Ma, J., Lu, B. & Ma, X. L. The effect of whole-body vibration training on lean mass: a PRISMA-compliant meta-analysis. Medicine (Baltimore) 96, e8390 (2017). source
The Methods (Statistical methods; page unavailable) identify differences in control interventions, vibration frequency, magnitude, acceleration, dose, and lean-mass measurement as sources of clinical heterogeneity. The Inclusion and exclusion criteria also allowed varied training positions, vibration settings, and study durations, supporting the characterization of the included studies as heterogeneous. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Adverse events associated with testosterone supplementation include polycythemia420, possible cardiovascular events421, venous thromboembolism422 and prostatism423.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Testosterone.
What the sources say
- Supportedcites [420] Ohlander, S. J., Varghese, B. & Pastuszak, A. W. Erythrocytosis following testosterone therapy. Sex. Med. Rev. 6, 77–85 (2018). source
Citation 420 is attached to “polycythemia,” not to the later adverse events, which have separate citations. The Abstract (Introduction) identifies polycythemia as a side effect of testosterone therapy, supporting the attributed claim. (LLM, conf=0.94)
- Not checked — no full text of the sourcecites [421] Albert, S. G. & Morley, J. E. Testosterone therapy, association with age, initiation and mode of therapy with cardiovascular events: a systematic review. Clin. Endocrinol. (Oxf.) 85, 436–443 (2016). source
- Supportedcites [422] Martinez, C. et al. Testosterone treatment and risk of venous thromboembolism: population based case-control study. BMJ 355, i5968 (2016). source
Citation 422 is attached specifically to venous thromboembolism, not the other listed adverse events. The Abstract reports that starting testosterone treatment was associated with increased venous thromboembolism risk, peaking within six months and declining thereafter (page not specified). (LLM, conf=0.93)
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Bariatric surgery leads to loss of fat mass394, alters gut hormones395 and can exacerbate weight loss-induced sarcopenia396–398 and osteoporosis399–402.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Bariatric surgery.
What the sources say
- Partly supportedcites [394] Cole, A. J. et al. Long-term body composition changes in women following roux-en-Y gastric bypass surgery. JPEN J. Parenter. Enteral Nutr. 41, 583–591 (2017). sourceExperimental — accuracy not yet measured
This source is cited for the sarcopenia portion of the sentence, not the separately cited claims about fat mass, gut hormones, or osteoporosis. The Results and Conclusions (pages unavailable) report continued lean-tissue loss and reduced handgrip strength after Roux-en-Y gastric bypass in five women. They do not establish that bariatric surgery generally exacerbates diagnosed, weight-loss-induced sarcopenia. (LLM, conf=0.82)
- Supportedcites [395] Anderwald, C. H. et al. Alterations in gastrointestinal, endocrine, and metabolic processes after bariatric Roux-en-Y gastric bypass surgery. Diabetes Care 35, 2580–2587 (2012). source
This source supports the ‘alters gut hormones’ clause, to which its citation is attached. The Final conclusions report augmented GLP-1 secretion after Roux-en-Y gastric bypass surgery. The separately cited claims about fat mass, sarcopenia, and osteoporosis are not attributed to this source. (LLM, conf=0.92)
- Not checked — no full text of the sourcecites [396] Lyytinen, T., Liikavainio, T., Paakkonen, M., Gylling, H. & Arokoski, J. P. Physical function and properties of quadriceps femoris muscle after bariatric surgery and subsequent weight loss. J. Musculoskelet. Neuronal Interact. 13, 329–338 (2013).
- Not checked — no full text of the sourcecites [397] Thibault, R., Huber, O., Azagury, D. E. & Pichard, C. Twelve key nutritional issues in bariatric surgery. Clin. Nutr. 35, 12–17 (2016). source
- Not checked — no full text of the sourcecites [398] Vaurs, C. et al. Determinants of changes in muscle mass after bariatric surgery. Diabetes Metab. 41, 416–421 (2015). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Over 56 weeks, testosterone-treated participants (mean age 53 years) had greater reductions in fat mass (mean between-group difference 2.9 kg; P = 0.04) and visceral fat (−2,678 mm2; P = 0.04) than controls.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Testosterone.
What the sources say
- Partly supportedcites [419] Ng Tang Fui, M. et al. Effects of testosterone treatment on body fat and lean mass in obese men on a hypocaloric diet: a randomised controlled trial. BMC Med. 14, 153 (2016). sourceExperimental — accuracy not yet measured
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Testosterone-treated participants also had greater lean mass regain during weight maintenance (mean between-group difference 3.4 kg; P = 0.002) following the very-low-energy diet, suggesting that weight loss was exclusively fat mass419.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Testosterone.
What the sources say
- Partly supportedcites [419] Ng Tang Fui, M. et al. Effects of testosterone treatment on body fat and lean mass in obese men on a hypocaloric diet: a randomised controlled trial. BMC Med. 14, 153 (2016). sourceExperimental — accuracy not yet measured
The Discussion reports greater lean-mass regain in testosterone-treated men after the very-low-energy diet. It says the 3.4 kg difference was measured at study end, not specifically as a between-group difference in regain during weight maintenance, and describes weight loss as 'almost exclusive' fat-mass loss rather than exclusively fat-mass loss. Page numbers are not available in the supplied passages. (LLM, conf=0.87)
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Conflicting data exist; in some studies, vitamin K antagonists demonstrate no differences in BMD or fracture rates461, while other data suggest lessening of steroid-induced BMD462 and sex-specific improvements in insulin sensitivity463.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Vitamin K.
What the sources say
- Not checked — no full text of the sourcecites [461] Jamal, S. A., Browner, W. S., Bauer, D. C. & Cummings, S. R. Warfarin use and risk for osteoporosis in elderly women. Study of Osteoporotic Fractures Research Group. Ann. Intern. Med. 128, 829–832 (1998). source
- Not checked — no full text of the sourcecites [462] Yonemura, K., Kimura, M., Miyaji, T. & Hishida, A. Short-term effect of vitamin K administration on prednisolone-induced loss of bone mineral density in patients with chronic glomerulonephritis. Calcif. Tissue Int. 66, 123–128 (2000). source
- Supportedcites [463] Yoshida, M. et al. Effect of vitamin K supplementation on insulin resistance in older men and women. Diabetes Care 31, 2092–2096 (2008). source
Split into 2 atoms — 2 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
plainconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Early trials demonstrated a greater total lean mass of 1.3 kg (P < 0.001), better physical function as measured by reduced stair climb time (P = 0.013), a trend towards lower blood levels of glucose of 6.9 ± 2.5 mg/dl (P = 0.052) and lower insulin sensitivity (−27.5% versus 2.6%; P = 0.013) with 3 mg per day of GTx-024 (an orally bioavailable nonsteroidal SARM) than with placebo429.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Selective androgen receptor modulators.
What the sources say
- Partly supportedcites [429] Dalton, J. T. et al. The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial. J. Cachexia Sarcopenia Muscle 2, 153–161 (2011). sourceExperimental — accuracy not yet measured
The Results report that 3 mg daily increased lean body mass by about 1.3 kg versus placebo (P < 0.001), and the paper reports improved Stair Climb Test performance (P = 0.013). But the Discussion says treatment decreased insulin resistance—a beneficial effect—not insulin sensitivity as the citing sentence claims. It also describes a significant reduction in fasting glucose rather than the claimed trend; the quoted glucose and percentage-change figures were not verified in the retrieved passages (page numbers unavailable). (LLM, conf=0.90)
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“In mice, transplantation of satellite cells into damaged muscle leads to self-renewal and muscle regeneration466,467.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Mesenchymal stem cells.
What the sources say
- Not checked — no full text of the sourcecites [466] Collins, C. A. et al. Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche. Cell 122, 289–301 (2005). source
- Supportedcites [467] Sacco, A., Doyonnas, R., Kraft, P., Vitorovic, S. & Blau, H. M. Self-renewal and expansion of single transplanted muscle stem cells. Nature 456, 502–506 (2008). source
The paper reports that transplanted mouse muscle stem cells self-renewed and contributed to muscle fibres (Abstract). It also reports that, after injury, donor-derived cells expanded alongside evidence of muscle regeneration. In the described experiment, cells were transplanted into irradiated muscle before the additional notexin injury, a timing detail the paraphrase compresses. (LLM, conf=0.90)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Enobosarm, a non-steroidal SARM, successfully increased muscle mass and physical function in patients without cancer and in those with advanced lung, colorectal or breast cancer or lymphoma427–429.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Selective androgen receptor modulators.
What the sources say
- Partly supportedcites [427] Crawford, J. et al. Study design and rationale for the phase 3 clinical development program of enobosarm, a selective androgen receptor modulator, for the prevention and treatment of muscle wasting in cancer patients (POWER Trials). Curr. Oncol. Rep. 18, 37 (2016). sourceExperimental — accuracy not yet measured
The “Novel Drug: Enobosarm” section reports improved lean body mass and physical function in people without cancer and in patients with the listed cancer types. It does not specify that the patients in the cancer study had advanced disease, so that qualifier is not supported by this copy. (LLM, conf=0.83)
- Partly supportedcites [428] Dobs, A. S. et al. Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial. Lancet Oncol. 14, 335–345 (2013). sourceExperimental — accuracy not yet measured
The Results and Discussion report increased lean body mass and stair-climb power with enobosarm in patients with cancer, including the non-small-cell lung and colorectal cancer groups. The Methods list breast cancer and lymphoma as eligible diagnoses, but the Discussion groups their outcomes under “other cancers” rather than demonstrating improvements for each separately. The paper also reports a previous study’s findings in people without cancer; that was not a population in this trial. (LLM, conf=0.82)
- Partly supportedcites [429] Dalton, J. T. et al. The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial. J. Cachexia Sarcopenia Muscle 2, 153–161 (2011). sourceExperimental — accuracy not yet measured
The Patients and methods section says the participants were healthy volunteers without evidence of disease, and the Results report increased lean body mass and improved physical function. This paper does not report those outcomes in patients with advanced lung, colorectal or breast cancer, or lymphoma. (LLM, conf=0.90)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“One study464 reported that over 3 years vitamin K supplementation was not implicated in the age-related changes in skeletal muscle or adipose tissue mass in older community-dwelling adults.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Vitamin K.
What the sources say
- Supportedcites [464] Shea, M. K., Dawson-Hughes, B., Gundberg, C. M. & Booth, S. L. Reducing undercarboxylated osteocalcin with vitamin k supplementation does not promote lean tissue loss or fat gain over 3 years in older women and men: a randomized controlled trial. J. Bone Miner. Res. 32, 243–249 (2017). source
The Methods describe a three-year trial in community-dwelling adults aged 60–80. The Results report no difference between vitamin K and control groups in three-year changes in appendicular lean mass or total fat mass in either women or men; the Discussion draws the same conclusion. (LLM, conf=0.93)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
- Supported
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Adiponectin is negatively correlated with age and obesity and counters the effects of leptin.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Biological pathways to sarcopenic obesity > Inflammatory pathways.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“A major subset of adults over the age of 65 is now classified as having sarcopenic obesity, a high-risk geriatric syndrome predominantly observed in an ageing population that is at risk of synergistic complications from both sarcopenia and obesity.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Abstract
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“All such secretory changes lead to insulin resistance, which is increased by muscle catabolism60, promoting gain in fat mass and a loss of muscle mass57.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Biological pathways to sarcopenic obesity > Inflammatory pathways.
What the sources say
- Not checked — no full text of the sourcecites [60] Zamboni, M., Mazzali, G., Fantin, F., Rossi, A. & Di Francesco, V. Sarcopenic obesity: a new category of obesity in the elderly. Nutr. Metab. Cardiovasc. Dis. 18, 388–395 (2008). source
- Not checked — no full text of the sourcecites [57] Schrager, M. A. et al. Sarcopenic obesity and inflammation in the InCHIANTI study. J. Appl. Physiol. (1985) 102, 919–925 (2007). This is an epidemiological study that shows that obesity directly affects inflammation and negatively affects muscle strength. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Ageing stimulates the infiltration of fat into muscle72,73, which might negatively affect sarcopenia74, as described below, and obesity promotes the deposition of fat in the liver, heart, pancreas and skeletal muscle (FIG. 1).”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Biological pathways to sarcopenic obesity > Myocellular mechanisms.
What the sources say
- Not checked — no full text of the sourcecites [72] Gallagher, D. et al. Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index. Am. J. Clin. Nutr. 72, 694–701 (2000). This study includes ethnically heterogeneous study populations, which allow the development of prediction formulas for healthy percentage body fat. source
- Not checked — no full text of the sourcecites [73] Goodpaster, B. H. et al. The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J. Gerontol. A Biol. Sci. Med. Sci. 61, 1059–1064 (2006). This study shows that loss of strength with ageing is much more rapid than the concomitant loss of muscle mass, suggesting a decline in muscle quality. source
- Not checked — no full text of the sourcecites [74] Visser, M. et al. Muscle mass, muscle strength, and muscle fat infiltration as predictors of incident mobility limitations in well-functioning older persons. J. Gerontol. A Biol. Sci. Med. Sci. 60, 324–333 (2005). This study shows that in sarcopenic obesity reflected by low cross-sectional thigh muscle area, greater fat infiltration into muscle is associated with mobility loss. source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Myostatin can be upregulated in skeletal muscle, inhibiting muscle genesis90.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Biological pathways to sarcopenic obesity > Myocellular mechanisms.
What the sources say
- Not checked — no full text of the sourcecites [90] Sakuma, K. et al. The adaptive responses in several mediators linked with hypertrophy and atrophy of skeletal muscle after lower limb unloading in humans. Acta Physiol. (Oxf.) 197, 151–159 (2009). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“A reduction in the number of mitochondria and elevated production of reactive oxygen species occur in muscle following the deposition of intramyocellular lipids. This process can impair muscle function and might reduce the oxidative capacity of muscle81.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Biological pathways to sarcopenic obesity > Myocellular mechanisms.
What the sources say
- Not checked — no full text of the sourcecites [81] Kohara, K. Sarcopenic obesity in aging population: current status and future directions for research. Endocrine 45, 15–25 (2014). source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“The deposition of intramyocellular lipids promotes lipotoxicity and inflammation and induces dedifferentiation of mesenchymal adipocyte-like progenitor cells that express fatty tissue genes75.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Biological pathways to sarcopenic obesity > Myocellular mechanisms.
What the sources say
- Not checked — no full text of the sourcecites [75] Sepe, A., Tchkonia, T., Thomou, T., Zamboni, M. & Kirkland, J. L. Aging and regional differences in fat cell progenitors — a mini-review. Gerontology 57, 66–75 (2011). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“This finding could be due to skeletal muscle preferentially depositing fat for a source of energy as opposed to glucose86,87.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Biological pathways to sarcopenic obesity > Myocellular mechanisms.
What the sources say
- Not checked — no full text of the sourcecites [86] Kusminski, C. M., Shetty, S., Orci, L., Unger, R. H. & Scherer, P. E. Diabetes and apoptosis: lipotoxicity. Apoptosis 14, 1484–1495 (2009). source
- Not checked — no full text of the sourcecites [87] Nilsson, M. I. et al. Abnormal protein turnover and anabolic resistance to exercise in sarcopenic obesity. FASEB J. 27, 3905–3916 (2013). source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Aerobic activity can improve the oxidative capacity of muscle by counteracting the negative effect of intra- myocellular lipids and accelerating lipolysis, which results in an increase in capillary density121.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Biological pathways to sarcopenic obesity > The role of exercise.
What the sources say
- Not checked — no full text of the sourcecites [121] Suetta, C. et al. Training-induced changes in muscle CSA, muscle strength, EMG, and rate of force development in elderly subjects after long-term unilateral disuse. J. Appl. Physiol. (1985) 97, 1954–1961 (2004). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“These mediators stimulate mitochondrial production, which promotes improved fatty acid metabolism124.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Biological pathways to sarcopenic obesity > The role of exercise.
What the sources say
- Not checked — no full text of the sourcecites [124] Marzetti, E. et al. Physical activity and exercise as countermeasures to physical frailty and sarcopenia. Aging Clin. Exp. Res. 29, 35–42 (2017). This study provides an overview of the interplay between physical activity, exercise and sarcopenia. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Reduced cytokine production can lead to improved glucose metabolism, insulin sensitivity and muscle protein synthesis, which might dampen the progression of sarcopenic obesity.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Biological pathways to sarcopenic obesity > The role of exercise.
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“One study reported an increase in intramyo cellular lipid deposition after young, healthy men and women aged 19–28 years were exposed to 30 days of leg disuse, which resulted in lower extremity muscle mass loss85.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Biological pathways to sarcopenic obesity > Myocellular mechanisms.
What the sources say
- Not checked — no full text of the sourcecites [85] Manini, T. M. et al. Reduced physical activity increases intermuscular adipose tissue in healthy young adults. Am. J. Clin. Nutr. 85, 377–384 (2007). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Circulating inflammatory biomarkers, including IL-6, C-reactive protein and TNF, are downregulated by aerobic exercise and strength training, although the relationship is less clear with combined aerobic and resistance activities114–118.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Biological pathways to sarcopenic obesity > The role of exercise.
What the sources say
- Not checked — no full text of the sourcecites [114] Bruunsgaard, H., Bjerregaard, E., Schroll, M. & Pedersen, B. K. Muscle strength after resistance training is inversely correlated with baseline levels of soluble tumor necrosis factor receptors in the oldest old. J. Am. Geriatr. Soc. 52, 237–241 (2004). source
- Not checked — no full text of the sourcecites [115] Kohut, M. L. et al. Aerobic exercise, but not flexibility/resistance exercise, reduces serum IL-18, CRP, and IL-6 independent of beta-blockers, BMI, and psychosocial factors in older adults. Brain Behav. Immun. 20, 201–209 (2006). source
- Not checked — no full text of the sourcecites [116] Forti, L. N. et al. Strength training reduces circulating interleukin-6 but not brain-derived neurotrophic factor in community-dwelling elderly individuals. Age (Dordr.) 36, 9704 (2014). source
- Not checked — no full text of the sourcecites [117] Beyer, I., Mets, T. & Bautmans, I. Chronic low-grade inflammation and age-related sarcopenia. Curr. Opin. Clin. Nutr. Metab. Care 15, 12–22 (2012). source
- Not checked — no full text of the sourcecites [118] Woods, J. A., Wilund, K. R., Martin, S. A. & Kistler, B. M. Exercise, inflammation and aging. Aging Dis. 3, 130–140 (2012).
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The term sarcopenia is defined differently throughout the literature (TABLE 1), leading to confusion in the medical community and preventing any inter-study comparisons.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > An evolving definition
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. It may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Cut-off points might not capture such determinants, particularly when levels of fat mass are high, which questions the utility of bioelectrical impedance for the assessment of body composition by professional societies169 who recommend adjustment to population-specific, age-appropriate equations169,176.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Assessing body composition
What the sources say
- Not checked — no full text of the sourcecites [169] Kyle, U. G. et al. Bioelectrical impedance analysis-part II: utilization in clinical practice. Clin. Nutr. 23, 1430–1453 (2004). This study demonstrates the application of bioelectrical impedance equations in clinical practice, as advocated by ESPEN. source
- Not checked — no full text of the sourcecites [176] Kyle, U. G. et al. Bioelectrical impedance analysis —part I: review of principles and methods. Clin. Nutr. 23, 1226–1243 (2004). source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Incremental metabolic changes over time promote fat deposition with a pro-inflammatory cascade of events.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Biological pathways to sarcopenic obesity > Summary of mechanisms.
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper may give no reason why it holds.
In the paper
“In a 2013 report by the International Society for Clinical Densitometry, the recommendation to perform DXA for assessing total body composition and for a regional analysis of fat and muscle in patients with muscle weakness or poor physical function was categorized as fair157.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Assessing body composition
What the sources say
- Not checked — no full text of the sourcecites [157] Kendler, D. L. et al. The Official Positions of the International Society for Clinical Densitometry: indications of use and reporting of DXA for body composition. J. Clin. Densitom. 16, 496–507 (2013). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Biological differences between different ethnic populations might influence the relationship between skeletal mass and resistance174.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Assessing body composition
What the sources say
- Not checked — no full text of the sourcecites [174] Chien, M. Y., Huang, T. Y. & Wu, Y. T. Prevalence of sarcopenia estimated using a bioelectrical impedance analysis prediction equation in community-dwelling elderly people in Taiwan. J. Am. Geriatr. Soc. 56, 1710–1715 (2008). source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The current definitions of sarcopenic obesity are based on the individual definitions of sarcopenia and obesity (TABLE 1), but presently there is no consensus that defines the cut-off points for either of these diseases, which makes arriving at an accurate diagnosis of sarcopenic obesity challenging.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > An evolving definition
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Calorie restriction and physical activity might impede and halt these processes.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Biological pathways to sarcopenic obesity > Summary of mechanisms.
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper may give no reason why it holds. It may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“DXA correlates well with gold standard measures of body composition, such as MRI, and with bioelectrical impedance, which can also measure fat and segmental muscle mass158–160.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Assessing body composition
What the sources say
- Not checked — no full text of the sourcecites [158] Fakhrawi, D. H. et al. Comparison of body composition by bioelectrical impedance and dual-energy x-ray absorptiometry in overweight/obese postmenopausal women. J. Clin. Densitom. 12, 238–244 (2009). source
- Not checked — no full text of the sourcecites [159] Bridge, P. et al. Validation of longitudinal DXA changes in body composition from pre- to mid-adolescence using MRI as reference. J. Clin. Densitom. 14, 340–347 (2011). source
- Not checked — no full text of the sourcecites [160] Xu, L. et al. Comparisons of body-composition prediction accuracy: a study of 2 bioelectric impedance consumer devices in healthy chinese persons using DXA and MRI as criteria methods. J. Clin. Densitom. 14, 458–464 (2011). source
boostedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Leptin and adiponectin stimulate and inhibit, respectively, the deposition of intramuscular lipids (Fig. 1); however, defining their precise roles in physical activity continues to be challenging.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Biological pathways to sarcopenic obesity > The role of exercise.
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“For instance, the concentration of leptin in the systemic circulation is suppressed following resistance exercise143 but also in individuals with overweight or obesity following a physical training intervention143–145.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Biological pathways to sarcopenic obesity > The role of exercise.
What the sources say
- Not checked — no full text of the sourcecites [143] Nindl, B. C. et al. Leptin concentrations experience a delayed reduction after resistance exercise in men. Med. Sci. Sports Exerc. 34, 608–613 (2002). source
- Not checked — no full text of the sourcecites [144] Bouassida, A. et al. Leptin, its implication in physical exercise and training: a short review. J. Sports Sci. Med. 5, 172–181 (2006).
- Not checked — no full text of the sourcecites [145] Fatouros, I. G. et al. Leptin and adiponectin responses in overweight inactive elderly following resistance training and detraining are intensity related. J. Clin. Endocrinol. Metab. 90, 5970–5977 (2005). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Other notable limitations include large standard errors and population specificity175.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Assessing body composition
What the sources say
- Not checked — no full text of the sourcecites [175] Roubenoff, R. Applications of bioelectrical impedance analysis for body composition to epidemiologic studies. Am J. Clin. Nutr. 64, 459S–462S (1996). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Reductions in muscle mass result in an increase in connective tissue164–166 that can interfere with the assessment of muscle mass.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Assessing body composition
What the sources say
- Not checked — no full text of the sourcecites [164] Das, S. K. et al. Body composition assessment in extreme obesity and after massive weight loss induced by gastric bypass surgery. Am. J. Physiol. Endocrinol. Metab. 284, E1080–E1088 (2003). source
- Not checked — no full text of the sourcecites [165] Schautz, B., Later, W., Heller, M., Muller, M. J. & Bosy-Westphal, A. Total and regional relationship between lean and fat mass with increasing adiposity — impact for the diagnosis of sarcopenic obesity. Eur. J. Clin. Nutr. 66, 1356–1361 (2012). source
- Not checked — no full text of the sourcecites [166] Bosy-Westphal, A. & Muller, M. J. Identification of skeletal muscle mass depletion across age and BMI groups in health and disease—there is need for a unified definition. Int. J. Obes. (Lond.) 39, 379–386 (2015). This review argues for the importance of standardized definitions in skeletal muscle mass. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Instead, cutoff points are premised on sex-specific, whole-body DXA.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > An evolving definition
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“As with sarcopenia, no consensus defines obesity cutoff points.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > An evolving definition
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“The American Association of Clinical Endocrinology187 recommends the use of the WHO body fat thresholds for the diagnosis of obesity — (men >25% body fat and women >35% body fat).”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > An evolving definition
What the sources say
- Not checked — no full text of the sourcecites [187] Garvey, W. T. et al. American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr. Pract. 22 (Suppl. 3), 1–203 (2016). Guidelines for the management of obesity by the AACE/ACE. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“The International Society of Clinical Densitometry, the American Heart Association and The Obesity Society all recognize the lack of specific thresholds, while the American College of Sports Medicine suggests cut-off points of 28% and 35% for men and women, respectively188,189.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > An evolving definition
What the sources say
- Not checked — no full text of the sourcecites [188] Bouchard, D. R., Dionne, I. J. & Brochu, M. Sarcopenic/obesity and physical capacity in older men and women: data from the Nutrition as a Determinant of Successful Aging (NuAge)-the Quebec longitudinal Study. Obesity (Silver Spring) 17, 2082–2088 (2009). source
- Not matchedcites [189] Durstine, J. in ACSM’s Exercise Management for Persons with Chronic Diseases and Disabilities 4th edn (eds Moore, G. E., Durstine, J. L. & Painter, P. L.) (Human Kinetics, 2016).
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“These definitions provide excellent negative percent agreements on the absence of sarcopenia; however, there is poor overlap in identifying individuals with sarcopenia183.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > An evolving definition
What the sources say
- Not checked — no full text of the sourcecites [183] Kemmler, W. et al. Prevalence of sarcopenia and sarcopenic obesity in older German men using recognized definitions: high accordance but low overlap! Osteoporos. Int. 28, 1881–1891 (2017). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Women with sarcopenia alone had higher scores than people with obesity without sarcopenia and than individuals with obesity and sarcopenia (P < 0.01).”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Consequences of sarcopenic obesity > Disability or impairments.
What the sources say
- Not checked — no full text of the sourcecites [188] Bouchard, D. R., Dionne, I. J. & Brochu, M. Sarcopenic/obesity and physical capacity in older men and women: data from the Nutrition as a Determinant of Successful Aging (NuAge)-the Quebec longitudinal Study. Obesity (Silver Spring) 17, 2082–2088 (2009). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“This prototype is not inconsistent with intramuscular fat accumulation, which contributes to inflammation, mitochondrial dysfunction and insulin resistance within muscle and reduces muscle protein synthesis74,195.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > An evolving definition
What the sources say
- Not checked — no full text of the sourcecites [74] Visser, M. et al. Muscle mass, muscle strength, and muscle fat infiltration as predictors of incident mobility limitations in well-functioning older persons. J. Gerontol. A Biol. Sci. Med. Sci. 60, 324–333 (2005). This study shows that in sarcopenic obesity reflected by low cross-sectional thigh muscle area, greater fat infiltration into muscle is associated with mobility loss. source
- Not checked — no full text of the sourcecites [195] Schrauwen-Hinderling, V. B., Hesselink, M. K., Schrauwen, P. & Kooi, M. E. Intramyocellular lipid content in human skeletal muscle. Obesity (Silver Spring) 14, 357–367 (2006). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“They suggested using handgrip strength and gait speed for initial testing and/or screening followed by the EWGSOP approach for muscle mass measurement, strength and physical performance, with different, lower, cut-off points (TABLE 1).”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > An evolving definition
What the sources say
- Not checked — no full text of the sourcecites [185] Chen, L. K. et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J. Am. Med. Dir. Assoc. 15, 95–101 (2014). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“found global physical capacity scores were no different between obese groups (sarcopenia versus non-sarcopenia (P = 0.14 in men and P = 0.19 in women)), but lower scores were observed than with the non-sarcopenic non-obese group (P < 0.05)188”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Consequences of sarcopenic obesity > Disability or impairments.
What the sources say
- Not checked — no full text of the sourcecites [188] Bouchard, D. R., Dionne, I. J. & Brochu, M. Sarcopenic/obesity and physical capacity in older men and women: data from the Nutrition as a Determinant of Successful Aging (NuAge)-the Quebec longitudinal Study. Obesity (Silver Spring) 17, 2082–2088 (2009). source
- Not checked — no full text of the sourcecites [191] Baumgartner, R. N. et al. Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly. Obes. Res. 12, 1995–2004 (2004). This study highlights the synergistic problems of sarcopenia and obesity that lead to impairments in instrumental activities of daily living. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“The Asian Working Group for Sarcopenia185 provided guidance for individuals of Asian descent.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > An evolving definition
What the sources say
- Not checked — no full text of the sourcecites [185] Chen, L. K. et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J. Am. Med. Dir. Assoc. 15, 95–101 (2014). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“As central fat accumulation predominates, and loss of muscle occurs peripherally, the prototype of sarcopenic obesity is easily recognized (‘fat frail’).”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > An evolving definition
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The prevalence of low muscle strength with obesity is less clear.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Prevalence of sarcopenic obesity
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The WHO thresholds also used BMI for obesity (≥30 kg/m2) or waist circumference (men ≥102 cm and women ≥88 cm) as a visceral fat surrogate.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > An evolving definition
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Midlife obesity also increases the risk of long-term care placement241, an association that persists in older adults with obesity242.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Consequences of sarcopenic obesity > Institutionalization and health-care utilization.
What the sources say
- Not checked — no full text of the sourcecites [241] Elkins, J. S. et al. Midlife obesity and long-term risk of nursing home admission. Obesity (Silver Spring) 14, 1472–1478 (2006). source
- Not checked — no full text of the sourcecites [242] Valiyeva, E., Russell, L. B., Miller, J. E. & Safford, M. M. Lifestyle-related risk factors and risk of future nursing home admission. Arch. Intern. Med. 166, 985–990 (2006). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“neither sarcopenia nor the components that define weakness increased the risk of hospitalization or short-term nursing facility stay”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Consequences of sarcopenic obesity > Institutionalization and health-care utilization.
What the sources say
- Not checked — no full text of the sourcecites [238] Cawthon, P. M. et al. Sarcopenia and health care utilization in older women. J. Gerontol. A Biol. Sci. Med. Sci. 72, 95–101 (2017). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“diets in patients with sarcopenic obesity lead to weight loss251, with adherence to a diet predicting weight loss success252”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Treatments for sarcopenic obesity > Dietary strategies: calorie restriction and protein supplementation.
What the sources say
- Not checked — no full text of the sourcecites [251] Johnston, B. C. et al. Comparison of weight loss among named diet programs in overweight and obese adults: a meta-analysis. JAMA 312, 923–933 (2014). source
- Not checked — no full text of the sourcecites [252] Dansinger, M. L., Gleason, J. A., Griffith, J. L., Selker, H. P. & Schaefer, E. J. Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial. JAMA 293, 43–53 (2005). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Tai chi and The Otago Exercise Programme (a home-based balance and strength fall prevention programme) have been shown to be effective at preventing falls and improving physical function, mobility and functional measures of lower extremity strength in older adults291.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Treatments for sarcopenic obesity > Resistance training and aerobic exercise.
What the sources say
- Not checked — no full text of the sourcecites [291] Son, N. K., Ryu, Y. U., Jeong, H. W., Jang, Y. H. & Kim, H. D. Comparison of 2 different exercise approaches: Tai Chi versus Otago, in community-dwelling older women. J. Geriatr. Phys. Ther. 39, 51–57 (2016). source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Even minimal resistance exercise improves muscle strength and mass279,280, and progressive resistance exercises counter sarcopenia by increasing strength.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Treatments for sarcopenic obesity > Resistance training and aerobic exercise.
What the sources say
- Not checked — no full text of the sourcecites [279] Taaffe, D. R., Duret, C., Wheeler, S. & Marcus, R. Once-weekly resistance exercise improves muscle strength and neuromuscular performance in older adults. J. Am. Geriatr. Soc. 47, 1208–1214 (1999). source
- Not checked — no full text of the sourcecites [280] Brown, A. B., McCartney, N. & Sale, D. G. Positive adaptations to weight-lifting training in the elderly. J. Appl. Physiol. (1985) 69, 1725–1733 (1990). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“High-velocity knee extension training at 240° of movement per second increases the expression of MYH6 and MYH9 mRNA and improves muscle enhancement138.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Treatments for sarcopenic obesity > Resistance training and aerobic exercise.
What the sources say
- Not checked — no full text of the sourcecites [138] Englund, D. A., Sharp, R. L., Selsby, J. T., Ganesan, S. S. & Franke, W. D. Resistance training performed at distinct angular velocities elicits velocity-specific alterations in muscle strength and mobility status in older adults. Exp. Gerontol. 91, 51–56 (2017). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“A total of 33 intervention studies lasting 8–24 weeks reported that unopposed calorie restriction without resistance training leads to the loss of muscle mass and loss of handgrip strength of up to 4.6% and 1.7 kg, respectively309.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Risks of weight loss in older adults
What the sources say
- Not checked — no full text of the sourcecites [309] Zibellini, J. et al. Effect of diet-induced weight loss on muscle strength in adults with overweight or obesity — a systematic review and meta-analysis of clinical trials. Obes. Rev. 17, 647–663 (2016). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“No specific interventions have tested diets for the treatment of sarcopenic obesity.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Dietary composition and restriction.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper may give no reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Assessing muscle strength (using handgrip dynamometry) and muscle mass (using DXA, bioelectrical impedance or other modalities) can fill a clinical gap in identifying sarcopenic obesity.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Integrating methods for analysing body composition into clinical practice.
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The most notable barrier to advancing the science in targeting this condition is the lack of a consistent definition for sarcopenic obesity.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Harmonizing a definition.
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
In the paper
“Separately, Ricky Lau and colleagues371 reviewed 13 trials of older adults and found significant treatment effects on knee extension dynamic strength (d = 0.63; P = 0.006), isometric strength (d = 0.57; P = 0.003) and functional measures such as sit-to-stand (d = 0.72; P < 0.001).”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Whole-body vibration therapy.
What the sources say
- Not checked — no full text of the sourcecites [371] Lau, R. W. et al. The effects of whole body vibration therapy on bone mineral density and leg muscle strength in older adults: a systematic review and meta-analysis. Clin. Rehabil. 25, 975–988 (2011). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Different populations, ethnicities and sexes require specific diagnostic thresholds; therefore, integrating highly accurate body composition measures into clinical settings will encourage clinical identification of sarcopenic obesity.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Harmonizing a definition.
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: fails — It may be too vague to check against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. It may be too vague to check against evidence.
In the paper
“Leptin might also be reduced further with periodized resistance training362.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Periodization strategies.
What the sources say
- Not checked — no full text of the sourcecites [362] Botero, J. P. et al. Effects of long-term periodized resistance training on body composition, leptin, resistin and muscle strength in elderly post-menopausal women. J. Sports Med. Phys. Fitness 53, 289–294 (2013).
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The disparate classification has impeded progress in this field.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Harmonizing a definition.
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
In the paper
“Linear periodization reduces training volume while increasing training intensity or load between cycles359.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Periodization strategies.
What the sources say
- Not checked — no full text of the sourcecites [359] Steele, J. Intensity; in-ten-si-ty; noun. 1. Often used ambiguously within resistance training. 2. Is it time to drop the term altogether? Br. J. Sports Med. 48, 1586–1588 (2014). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“While diets should be individualized, the composition of carbohydrates, fats and protein have differed in clinical trials.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Dietary composition and restriction.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“While the criteria for identifying and classifying subcutaneous or visceral adiposity are somewhat consistent, major progress is needed regarding the definition of sarcopenia.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Harmonizing a definition.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. It may state two separate claims as one.
In the paper
“For instance, DXA is routinely performed for screening and assessment of osteoporosis and is generally covered by insurance for this indication341.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Integrating methods for analysing body composition into clinical practice.
What the sources say
- Not checked — no full text of the sourcecites [341] U.S. Preventive Services Task Force. Screening for osteoporosis: U.S. preventive services task force recommendation statement. Ann. Intern. Med. 154, 356–364 (2011). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“This safe and convenient technique is associated with a low risk of injury363,364.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Whole-body vibration therapy.
What the sources say
- Not checked — no full text of the sourcecites [363] Ebersbach, G., Edler, D., Kaufhold, O. & Wissel, J. Whole body vibration versus conventional physiotherapy to improve balance and gait in Parkinson’s disease. Arch. Phys. Med. Rehabil. 89, 399–403 (2008). source
- Not checked — no full text of the sourcecites [364] Zhang, L. et al. Effect of whole-body vibration exercise on mobility, balance ability and general health status in frail elderly patients: a pilot randomized controlled trial. Clin. Rehabil. 28, 59–68 (2014). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Preliminary studies indicate that periodization results in increases in serum levels of irisin and decreases in IL-1β361.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Periodization strategies.
What the sources say
- Not checked — no full text of the sourcecites [361] Prestes, J. et al. Understanding the individual responsiveness to resistance training periodization. Age (Dordr.) 37, 9793 (2015). source
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Vitamin D deficiency is associated with an increased risk of falls and fractures, and reduced muscle mass and strength334–338, independent of obesity.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Risks of weight loss in older adults > Supplementation with calcium and vitamin D.
What the sources say
- Not checked — no full text of the sourcecites [334] American Geriatrics Society Workgroup on Vitamin D Supplementation for Older Adults. Recommendations abstracted from the American Geriatrics Society Consensus Statement on vitamin D for prevention of falls and their consequences. J. Am. Geriatr. Soc. 62, 147–152 (2014). source
- Not checked — no full text of the sourcecites [335] Bischoff-Ferrari, H. A. et al. Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged > or =60 y. Am. J. Clin. Nutr. 80, 752–758 (2004). source
- Not checked — no full text of the sourcecites [336] Scott, D. et al. A prospective study of the associations between 25-hydroxy-vitamin D, sarcopenia progression and physical activity in older adults. Clin. Endocrinol. (Oxf.) 73, 581–587 (2010). source
- Not checked — no full text of the sourcecites [337] Wicherts, I. S. et al. Vitamin D status predicts physical performance and its decline in older persons. J. Clin. Endocrinol. Metab. 92, 2058–2065 (2007). source
- Not checked — no full text of the sourcecites [338] Zittermann, A. et al. Vitamin D deficiency and mortality risk in the general population: a meta-analysis of prospective cohort studies. Am. J. Clin. Nutr. 95, 91–100 (2012). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Different populations, ethnicities and sexes require specific diagnostic thresholds; therefore, integrating highly accurate body composition measures into clinical settings will encourage clinical identification of sarcopenic obesity.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Harmonizing a definition.
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: fails — It may be too vague to check against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. It may be too vague to check against evidence.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Very-low energy or protein-sparing diets to induce rapid weight loss are not recommended owing to potential loss of muscle mass, strength and bone and risks of dramatic fluid, electrolyte and water shifts owing to protein shifts;”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Risks of weight loss in older adults
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Whole-body vibration therapy is a novel therapy that could increase muscle contraction efficiency and function with similar efficacy to resistance training, though data on its efficacy are mixed.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Whole-body vibration therapy.
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Bupropion can blunt olanzapine-associated weight gain without affecting bone metabolism387 and in combination with naltrexone can lead to a reduction in fat mass without altering lean mass388.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Weight loss medications.
What the sources say
- Not checked — no full text of the sourcecites [387] Gadde, K. M., Zhang, W. & Foust, M. S. Bupropion treatment of olanzapine-associated weight gain: an open-label, prospective trial. J. Clin. Psychopharmacol. 26, 409–413 (2006). source
- Not checked — no full text of the sourcecites [388] Smith, S. R. et al. Combination therapy with naltrexone and bupropion for obesity reduces total and visceral adiposity. Diabetes Obes. Metab. 15, 863–866 (2013). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Lorcaserin leads to more fat loss than placebo in patients with diabetes mellitus (−12.1% versus −5.9%; P = 0.008) and more trunk obesity (3.65% versus −0.36%).”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Weight loss medications.
What the sources say
- Not checked — no full text of the sourcecites [382] Apovian, C., Palmer, K., Fain, R., Perdomo, C. & Rubino, D. Effects of lorcaserin on fat and lean mass loss in obese and overweight patients without and with type 2 diabetes mellitus: the BLOSSOM and BLOOM-DM studies. Diabetes Obes. Metab. 18, 945–948 (2016). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Selective androgen receptor modulators (SARMs) target androgen receptors on muscle and bone but do not activate androgenic effects elsewhere.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Selective androgen receptor modulators.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Topiramate negatively affects BMD383 but might not affect lean mass384,385.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Weight loss medications.
What the sources say
- Not checked — no full text of the sourcecites [383] Simko, J. et al. The effect of topiramate and lamotrigine on rat bone mass, structure and metabolism. J. Neurol. Sci. 340, 80–85 (2014). source
- Not checked — no full text of the sourcecites [384] Eliasson, B. et al. Weight loss and metabolic effects of topiramate in overweight and obese type 2 diabetic patients: randomized double-blind placebo-controlled trial. Int. J. Obes. (Lond.) 31, 1140–1147 (2007). source
- Not checked — no full text of the sourcecites [385] Yaman, M. et al. Effects of topiramate use on body composition and resting metabolic rate in migraine patients. Neurol. Sci. 34, 225–229 (2013). source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Testosterone is an important regulator of body composition with ageing, as it increases muscle and bone mass, increases IGF1 levels, decreases inflammatory markers405 and alters biomarkers of bone turnover in adults with hypogonadism.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Testosterone.
What the sources say
- Not checked — no full text of the sourcecites [405] Nettleship, J. E., Pugh, P. J., Channer, K. S., Jones, T. & Jones, R. D. Inverse relationship between serum levels of interleukin-1beta and testosterone in men with stable coronary artery disease. Horm. Metab. Res. 39, 366–371 (2007). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“The population of participants had a mean age of 44 years, and no documented differences were observed in weight loss results or comorbidity resolution.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Bariatric surgery.
What the sources say
- Not checked — no full text of the sourcecites [393] Mastino, D. et al. Bariatric surgery outcomes in sarcopenic obesity. Obes. Surg. 26, 2355–2362 (2016). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Bariatric surgery improves weight and metabolic outcomes and reduces mortality.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Bariatric surgery.
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper may give no reason why it holds. It may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“A meta-analysis of testosterone supplementation found effect sizes of 0.47 (95% CI 0.12–0.84) for upper and 0.63 (95% CI 0.03–1.28) for lower extremity strength417, without sustained improvements in body composition418.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Testosterone.
What the sources say
- Not checked — no full text of the sourcecites [417] Ottenbacher, K. J., Ottenbacher, M. E., Ottenbacher, A. J., Acha, A. A. & Ostir, G. V. Androgen treatment and muscle strength in elderly men: a meta-analysis. J. Am. Geriatr. Soc. 54, 1666–1673 (2006). source
- Not checked — no full text of the sourcecites [418] O’Connell, M. D. et al. Do the effects of testosterone on muscle strength, physical function, body composition, and quality of life persist six months after treatment in intermediate-frail and frail elderly men? J. Clin. Endocrinol. Metab. 96, 454–458 (2011). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In nine older adults prescribed liraglutide, a weight decrease of 2.0 kg (−1.5 kg fat mass and −0.9% android fat) was observed, with a marginal improvement of 0.03 kg/m2 in skeletal muscle index (absolute muscle mass normalized by height squared)381.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Weight loss medications.
What the sources say
- Not checked — no full text of the sourcecites [381] Perna, S. et al. Liraglutide and obesity in elderly: efficacy in fat loss and safety in order to prevent sarcopenia. A perspective case series study. Aging Clin. Exp. Res. 28, 1251–1257 (2016). source
plaindirectn = 9- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Obesity negatively affects serum levels of testosterone and disrupts the actions of testosterone by increasing its aromatization to oestrogen403 and down regulating follicle-stimulating hormone and luteinizing hormone404, thus exacerbating hypogonadotropic hypogonadism.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Testosterone.
What the sources say
- Not checked — no full text of the sourcecites [403] Cohen, P. G. Obesity in men: the hypogonadal-estrogen receptor relationship and its effect on glucose homeostasis. Med. Hypotheses 70, 358–360 (2008). source
- Not checked — no full text of the sourcecites [404] Freeman, E. W., Sammel, M. D., Lin, H. & Gracia, C. R. Obesity and reproductive hormone levels in the transition to menopause. Menopause 17, 718–726 (2010). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“None of the six FDA-approved medications for weight loss are approved for use in older adults aged over 65 years, and few have been evaluated in terms of changes in body composition.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Weight loss medications.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“SARMs that have been developed in the past 5 years have not demonstrated adverse effects431 and have restored cortical and trabecular bone in orchidectomized mice432.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Selective androgen receptor modulators.
What the sources say
- Not checked — no full text of the sourcecites [431] Bhattacharya, I. et al. Safety, pharmacokinetic, and pharmacodynamic evaluation after single and multiple ascending doses of a novel selective androgen receptor modulator in healthy subjects. Clin. Ther. 38, 1401–1416 (2016). source
- Not checked — no full text of the sourcecites [432] Watanabe, K. et al. BA321, a novel carborane analog that binds to androgen and estrogen receptors, acts as a new selective androgen receptor modulator of bone in male mice. Biochem. Biophys. Res. Commun. 478, 279–285 (2016). source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Anamorelin is safe, well tolerated and stimulates appetite by promoting expression of GH, IGF1 and IGF-binding protein 3 (REFS435,436), which reverses muscle atrophy in mice437.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Anamorelin.
What the sources say
- Not checked — no full text of the sourcecites [435] Garcia, J. M. & Polvino, W. J. Pharmacodynamic hormonal effects of anamorelin, a novel oral ghrelin mimetic and growth hormone secretagogue in healthy volunteers. Growth Horm. IGF Res. 19, 267–273 (2009). source
- Not checked — no full text of the sourcecites [436] Garcia, J. M. & Polvino, W. J. Effect on body weight and safety of RC-1291, a novel, orally available ghrelin mimetic and growth hormone secretagogue: results of a phase I, randomized, placebo-controlled, multiple-dose study in healthy volunteers. Oncologist 12, 594–600 (2007). source
- Not checked — no full text of the sourcecites [437] Koshinaka, K. et al. Therapeutic potential of ghrelin treatment for unloading-induced muscle atrophy in mice. Biochem. Biophys. Res. Commun. 412, 296–301 (2011). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The growing challenges associated with sarcopenic obesity will probably worsen with the changing demographic distribution of our ageing population.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Conclusions
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: fails — It may be too vague to check against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. It may be too vague to check against evidence. The paper may give no reason why it holds.
In the paper
“Its expression drops following weight loss because it directly influences adipocyte metabolism448, and myostatin inhibitors can directly inhibit muscle loss.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Myostatin inhibitors.
What the sources say
- Not checked — no full text of the sourcecites [448] Buehring, B. & Binkley, N. Myostatin — the holy grail for muscle, bone, and fat? Curr. Osteoporos. Rep. 11, 407–414 (2013). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Muscle, bone and cartilage derived from mesenchymal cells share common precursor mesenchymal stem cells.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Mesenchymal stem cells.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Clarifying the mechanisms that contribute to sarcopenic obesity might elucidate novel therapies to improve function, quality of life and prevent institutionalization.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Conclusions
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: fails — It may be too vague to check against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. It may be too vague to check against evidence. The paper may give no reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Effective evidence based therapies can be helpful for improving physical function in older adults.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Conclusions
plainconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper may give no reason why it holds.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Vitamin K supplementation can restore serum levels of the vitamin458,459 and might increase bone resorption markers460.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Vitamin K.
What the sources say
- Not checked — no full text of the sourcecites [458] Caillot-Augusseau, A. et al. Space flight is associated with rapid decreases of undercarboxylated osteocalcin and increases of markers of bone resorption without changes in their circadian variation: observations in two cosmonauts. Clin. Chem. 46, 1136–1143 (2000). source
- Not checked — no full text of the sourcecites [459] Douglas, A. S. et al. Carboxylation of osteocalcin in post-menopausal osteoporotic women following vitamin K and D supplementation. Bone 17, 15–20 (1995). source
- Not checked — no full text of the sourcecites [460] Macdonald, H. M. et al. Vitamin K1 intake is associated with higher bone mineral density and reduced bone resorption in early postmenopausal Scottish women: no evidence of gene-nutrient interaction with apolipoprotein E polymorphisms. Am. J. Clin. Nutr. 87, 1513–1520 (2008). source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Myostatin is also expressed in adipose tissue and is inversely related to insulin resistance445.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Myostatin inhibitors.
What the sources say
- Not checked — no full text of the sourcecites [445] White, T. A. & LeBrasseur, N. K. Myostatin and sarcopenia: opportunities and challenges — a mini-review. Gerontology 60, 289–293 (2014). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Without being able to accurately identify populations of patients, there will be continued difficulties in targeting further obesity subtypes.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Conclusions
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: fails — It may be too vague to check against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. It may be too vague to check against evidence.
In the paper
“Myostatin inhibitors reduce expression of myostatin in both aerobic and resistance exercise449 and might be beneficial in treating sarcopenic obesity.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Myostatin inhibitors.
What the sources say
- Not checked — no full text of the sourcecites [449] Santos, A. R. et al. Different resistance-training regimens evoked a similar increase in myostatin inhibitors expression. Int. J. Sports Med. 36, 761–768 (2015). source
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“A review of four studies demonstrated high heterogeneity with improved symptom scores, and in three studies, improved lean mass was shown439.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Anamorelin.
What the sources say
- Not checked — no full text of the sourcecites [439] Bai, Y. et al. Anamorelin for cancer anorexia-cachexia syndrome: a systematic review and meta-analysis. Support. Care Cancer 25, 1651–1659 (2017). This is a meta-analysis of four randomized trials demonstrating that lean body mass improved with anamorelin, a novel ghrelin receptor agonist. source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Anamorelin improved lean mass in patients with cancer cachexia compared with placebo (2.09 kg, 95% CI 0.94–3.25; P = 0.0006)440 but failed to improve muscle power or handgrip strength in patients with inoperable nonsmall-cell lung cancer441.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Anamorelin.
What the sources say
- Not checked — no full text of the sourcecites [440] Garcia, J. M. et al. Anamorelin for patients with cancer cachexia: an integrated analysis of two phase 2, randomised, placebo-controlled, double-blind trials. Lancet Oncol. 16, 108–116 (2015). source
- Not checked — no full text of the sourcecites [441] Temel, J. S. et al. Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials. Lancet Oncol. 17, 519–531 (2016). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“A meta-analysis of 1,641 patients with cancer demonstrated improved total body weight, lean mass and quality of life (1.78, 95% CI 1.28–2.28, P < 0.001; 1.10, 95% CI 0.35–1.85, P = 0.004; 0.19, 95% CI 0.08–0.30, P = 0.0006, respectively)438.”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Anamorelin.
What the sources say
- Not checked — no full text of the sourcecites [438] Nishie, K., Yamamoto, S., Nagata, C., Koizumi, T. & Hanaoka, M. Anamorelin for advanced non-small-cell lung cancer with cachexia: systematic review and meta-analysis. Lung Cancer 112, 25–34 (2017). source
boosteddirectn = 1,641 ·- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The authors state this as an assumption.
For bioelectrical impedance to be valid, tissue hydration must be constant and the body must be cylindrical.
“To use bioelectrical impedance, tissue hydration must be constant and the body must be cylindrical168,169; both assumptions are challenged in sarcopenia and obesity.”
The paper relies on this without support.
Sarcopenia naturally occurs as part of ageing.
“Sarcopenia, which is the loss of muscle mass and strength or physical function, naturally occurs in ageing.”
The paper relies on this without support.
Exercising until failure can increase the risk of musculoskeletal injury.
“exercising until failure can increase the risk of musculoskeletal injury”
The paper relies on this without support.
Low muscle mass or strength is causally associated with long-term care placement.
“Low muscle mass or strength is causally associated with long-term care placement.”
The paper relies on this without support.
The effects of calorie restriction and weight loss on lean mass and bone observed in younger and middle-aged adults apply to older adults with sarcopenic obesity.
“Weight loss in younger adults (age 45–65 years) led to loss of lean mass after calorie restriction (4% reduction in lean mass; P < 0.0001), which was partially lessened by augmentation with aerobic activity (2% reduction in lean mass in participants who had augmented weight loss with aerobic activity; P = 0.05)311.”
“Loss of BMD in older adults with obesity seems to continue during long-term lifestyle change in the opposite direction to the weight changes321.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It is also not clear which calorie deficit is effective, in the context of a hypocaloric diet, to achieve a reduction in fat mass while preserving muscle mass.3”
From Nutritional and exercise interventions in individuals with sarcopenic obesity around retirement age: a systematic review and meta-analysis (2023) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Obesity is a risk factor in developing other diseases such as cardiovascular diseases (atherosclerosis, myocardial infarct, heart failure, and coronary disease), metabolic syndrome, T2DM, NAFLD, cirrhosis, cancer, osteoarthritis, pulmonary dysfunction (e.g., obstructive sleep apnea syndrome), reduced cognitive skills, urinary incontinence, and, more recently, coronavirus disease 2019 (COVID-19) [”
From The critical role of oxidative stress in sarcopenic obesity (2021) · cites this paper as [48]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“2) negative clinical interactions between obesity and sarcopenia, leading to a synergistically higher risk for metabolic disease and functional impairment compared to those caused by the cumulative risk from each separate condition [78,79].”
From Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement (2022) · cites this paper as [78]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The effect of adiposity amplifies all the pathophysiological mechanism of the inflammaging sustaining the lean mass loss [9,19].”
From A Narrative Review on GLP-1 Receptor Agonists for Obesity in Older Women: Maximizing Weight Loss While Preserving Lean Mass (2026) · cites this paper as [19]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although sarcopenia has classically been regarded as a manifestation of undernutrition, in recent decades—and especially in both industrialized and developing countries—it has become increasingly linked to obesity, establishing a self-sustaining vicious cycle between these two interrelated conditions [19].”
From A Narrative Review on GLP-1 Receptor Agonists for Obesity in Older Women: Maximizing Weight Loss While Preserving Lean Mass (2026) · cites this paper as [19]
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This reinforces the effectiveness of targeted resistance interventions in preserving muscle mass in older women with SO, as emphasized in recent clinical guidelines [30].”
From Efficacy of Power Training on Sarcopenic Obesity in Community-Dwelling Older Women: A 32-Week Randomized Clinical Trial (2025) · cites this paper as [30]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Obesity in aged individuals stimulates sarcopenia by altering skeletal muscle lipid metabolism, insulin resistance, and inflammatory pathways (139–141).”
From Health Consequences of Sarcopenic Obesity: A Narrative Review (2020) · cites this paper as [139]
The cited source says what the claim attributes to it.
In the citing paper
“1) bidirectional, pathogenic interaction between body FM accumulation and loss of skeletal muscle mass and function;”
From Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement (2022) · cites this paper as [78]
The cited source says what the claim attributes to it.
In the citing paper
“SO has been associated with mobility limitation, cardiometabolic complications, disability, lower quality of life and mortality risk, and these associations appear stronger when obesity-related metabolic burden and sarcopenia-related functional impairment coexist (4, 5).”
In the citing paper
“In sarcopenic obesity, muscle is present as type II muscle fiber atrophy and increased lipid deposition and adipocytes [13,22].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [13]
In the citing paper
“Aging is associated with changes in body composition, with fat mass typically increasing until about the seventh decade of life and, simultaneously, muscle mass decreasing from about the fifth decade of life onward.1–3”
From Nutritional and exercise interventions in individuals with sarcopenic obesity around retirement age: a systematic review and meta-analysis (2023) · cites this paper as [3]
In the citing paper
“As a result, the risk of older individuals to develop obesity, defined as abnormal or excessive fat accumulation, as well as sarcopenia, defined as the progressive and generalized loss of muscle mass and function, is high.3”
From Nutritional and exercise interventions in individuals with sarcopenic obesity around retirement age: a systematic review and meta-analysis (2023) · cites this paper as [3]
In the citing paper
“In individuals with sarcopenic obesity, it is likely that inflammatory processes, other myocellular mechanisms, or hormonal changes, as well as the presence of chronic diseases and pathological processes, lead to higher protein needs to maintain or even improve muscle mass, strength, and function.3,49”
From Nutritional and exercise interventions in individuals with sarcopenic obesity around retirement age: a systematic review and meta-analysis (2023) · cites this paper as [3]
In the citing paper
“prevalent in 10–20 % of older adults”
From Weighing the risk of GLP-1 treatment in older adults: Should we be concerned about sarcopenic obesity? (2025) · cites this paper as [7]
In the citing paper
“the levels of growth hormone (GH), another anabolic hormone involved in muscle mass through the PI3K-AKT/PKB-mTOR pathway, is reduced with aging and obesity and participates in the pathogenesis of sarcopenic obesity (33).”
From Sarcopenic obesity: epidemiology, pathophysiology, cardiovascular disease, mortality, and management (2023) · cites this paper as [33]
In the citing paper
“In postmenopausal women, the reduction in estradiol and increase in FSH levels promote body composition changes comprising an increase in adipose tissue and a decrease in muscle mass.”
From Sarcopenic obesity: epidemiology, pathophysiology, cardiovascular disease, mortality, and management (2023) · cites this paper as [33]
In the citing paper
“Presently, a very-low calorie intake must be avoided in older individuals with sarcopenic obesity, as this strategy can compromise overall health by inducing micronutrient and electrolyte deficiencies, have a deleterious impact on skeletal muscle mass, and reduce bone mineral density (33).”
From Sarcopenic obesity: epidemiology, pathophysiology, cardiovascular disease, mortality, and management (2023) · cites this paper as [33]
In the citing paper
“IL-6 is a myokine associated with sarcopenia and is upregulated in older persons [31, 38, 41, 44, 46–48].”
From The critical role of oxidative stress in sarcopenic obesity (2021) · cites this paper as [48]
In the citing paper
“Also, myosteatosis, typically displayed in aging, could impair muscle fiber, replace muscle tissue, decrease muscle protein synthesis, and impair new muscle tissue growth [48, 66, 118–120].”
From The critical role of oxidative stress in sarcopenic obesity (2021) · cites this paper as [48]
In the citing paper
“many professional organizations recommend that a combination of resistance training and aerobic training seems to be the most practical way to improve physical performance (165, 166).”
From Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments (2020) · cites this paper as [166]
In the citing paper
“Meanwhile, as resistance training can improve flexibility, muscle strength, and muscle hypertrophy, aerobic training focuses on increasing physical endurance of older people (166).”
From Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments (2020) · cites this paper as [166]
In the citing paper
“aging, inflammation, sedentary lifestyle, complex hormonal and metabolic derangements, genetics all seem to play a role [109, 110].”
From Critical appraisal of definitions and diagnostic criteria for sarcopenic obesity based on a systematic review (2020) · cites this paper as [110]
In the citing paper
“Sarcopenic obesity is treated with a range of management approaches, such as lifestyle interventions, exercise, nutrition and medical therapies.”
From Sarcopenic obesity in older adults: a clinical overview (2024) · cites this paper as [127]
In the citing paper
“which may present additional complications for the development of anabolic resistance and subsequent muscle loss.60”
From Reduced physical activity in young and older adults: Metabolic and musculoskeletal implications (2019) · cites this paper as [60]
In the citing paper
“Both sarcopenia and obesity can occur simultaneously and synergistically aggravate each other, resulting in sarcopenic obesity [5].”
From Effects of nutrition and exercise interventions on persons with sarcopenic obesity: an umbrella review of meta-analyses of randomised controlled trials (2023) · cites this paper as [5]
In the citing paper
“Several clinical trials have shown that nutrition interventions and physical exercise improve relevant parameters regarding sarcopenic obesity such as grip strength, body fat and muscle mass [5, 13–17].”
From Effects of nutrition and exercise interventions on persons with sarcopenic obesity: an umbrella review of meta-analyses of randomised controlled trials (2023) · cites this paper as [5]
In the citing paper
“As well as reducing the accompanied complications such as cardiovascular disease, the main goals when treating sarcopenic obesity are to decrease body fat and to support the build-up or preservation of muscle mass and muscle function [5, 11••, 12].”
From Effects of nutrition and exercise interventions on persons with sarcopenic obesity: an umbrella review of meta-analyses of randomised controlled trials (2023) · cites this paper as [5]
In the citing paper
“Furthermore, whole-body electromyostimulation (WB-EMS) has emerged in research as a useful treatment for sarcopenia [18] and sarcopenic obesity, showing promising effects due to its similarities to resistance training [5, 19, 20].”
From Effects of nutrition and exercise interventions on persons with sarcopenic obesity: an umbrella review of meta-analyses of randomised controlled trials (2023) · cites this paper as [5]
In the citing paper
“Consequently, with increasing age there is an increased risk of obesity, which is the excessive accumulation of fat [4], as well as the risk of sarcopenia, which is characterised by low muscle mass and muscle function [5].”
From Effects of nutrition and exercise interventions on persons with sarcopenic obesity: an umbrella review of meta-analyses of randomised controlled trials (2023) · cites this paper as [5]
In the citing paper
“It is worth noting that obesity gives rise to a state of mild inflammation, marked by the secretion of leptin, which elevates the levels of pro-inflammatory cytokines, resulting in a diminished anabolic response to IGF-1.”
From Exerkines and Sarcopenia: Unveiling the Mechanism Behind Exercise-Induced Mitochondrial Homeostasis (2025) · cites this paper as [83]
In the citing paper
“The ensuing inflammation further contributes to insulin resistance, exacerbated by muscle catabolism, thereby leading to increased fat accumulation and muscle loss [83,84].”
From Exerkines and Sarcopenia: Unveiling the Mechanism Behind Exercise-Induced Mitochondrial Homeostasis (2025) · cites this paper as [83]
In the citing paper
“In obesity, leptin resistance caused by hyperleptinemia can limit muscle fatty acid oxidation and reduce lipolysis of adipose tissue.”
From Adipokines, Myokines, and Hepatokines: Crosstalk and Metabolic Repercussions (2021) · cites this paper as [99]
In the citing paper
“Low ApN levels in these subjects may thus contribute to the reduction of lean mass, together with sex-specific hormonal changes, low-grade inflammation and increased intramyocellular triglyceride content [114].”
From Adiponectin and Its Mimics on Skeletal Muscle: Insulin Sensitizers, Fat Burners, Exercise Mimickers, Muscling Pills … or Everything Together? (2020) · cites this paper as [114]
In the citing paper
“There has been evidence from pre-clinical studies indicating that adipose tissue damages muscle homeostasis, resulting in muscle atrophy and regeneration capacity reduction (16, 17). This finding was regarded as the pathogenic mechanism of sarcopenic obesity (17).”
From The role of obesity in sarcopenia and the optimal body composition to prevent against sarcopenia and obesity (2023) · cites this paper as [17]
In the citing paper
“The excess accumulation of fat also affects muscle phenotypes metabolically (17).”
From The role of obesity in sarcopenia and the optimal body composition to prevent against sarcopenia and obesity (2023) · cites this paper as [17]
In the citing paper
“On the contrary, pre-clinical studies reported that obesity impaired muscle glucose tolerance, imbalanced protein synthesis and degradation, and oxidative stress which ultimately led to muscle atrophy, especially in old animals (16, 17).”
From The role of obesity in sarcopenia and the optimal body composition to prevent against sarcopenia and obesity (2023) · cites this paper as [17]
In the citing paper
“Although they had larger muscle storage, the muscle regeneration may be impaired (17).”
From The role of obesity in sarcopenia and the optimal body composition to prevent against sarcopenia and obesity (2023) · cites this paper as [17]
In the citing paper
“Individuals with SO had lower muscle mass, strength, and higher adiposity, as well as higher all-cause mortality and worse surgical prognosis (17, 32).”
From The role of obesity in sarcopenia and the optimal body composition to prevent against sarcopenia and obesity (2023) · cites this paper as [17]
In the citing paper
“In sarcopenic obesity, the combination of increased fat mass with reduced muscle mass or muscle strength significantly increases the risk of falls, fractures, and functional dependency.[ 9 ]”
From Exercise approaches in obese individuals with physical limitations (2026) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Treatments for sarcopenic obesity > Resistance training and aerobic exercise.
“High-speed circuit training was associated with nonsignificant improvements between groups in short performance physical battery (mean difference 1.1, 95% CI–0.1 to 2.4; P = 0.08) and power (mean difference 158 W, 95% CI 2–315; P = 0.01).”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Treatments for sarcopenic obesity > Resistance training and aerobic exercise.
“power (mean difference 158 W, 95% CI 2–315; P = 0.01)”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Selective androgen receptor modulators.
“Enobosarm significantly increased lean mass compared with baseline”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Selective androgen receptor modulators.
“(1.0 kg, 95% CI −4.8 to 11.5; P = 0.046)”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Selective androgen receptor modulators.
“Enobosarm significantly increased lean mass compared with baseline (1.0 kg, 95% CI −4.8 to 11.5; P = 0.046)”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Future directions and emerging therapies > Selective androgen receptor modulators.
“95% CI −4.8 to 11.5; P = 0.046”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Treatments for sarcopenic obesity > Resistance training and aerobic exercise.
“High-speed circuit training was associated with nonsignificant improvements between groups”
§ Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies > Treatments for sarcopenic obesity > Resistance training and aerobic exercise.
“power (mean difference 158 W, 95% CI 2–315; P = 0.01).”
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“Sato, Y., Honda, Y., Kuno, H. & Oizumi, K. Menatetrenone ameliorates osteopenia in disuse-affected limbs of vitamin D− and K-deficient stroke patients. Bone 23, 291–296 (1998).”
Cited work 10.1016/s8756-3282(98)00108-2 · retracted 2018-09-18 · notice 10.1016/s8756-3282(98)00108-2 · this paper published 2018-07-31
Citations
Cites
1 retracted
Sato, Y., Honda, Y., Kuno, H., & Oizumi, K. (1998) · Bone · doi:10.1016/s8756-3282(98)00108-2 · Cited by 77
RetractedWARE, J. E., KOSINSKI, M., & KELLER, S. D. (1996) · Medical Care · doi:10.1097/00005650-199603000-00003 · Cited by 17,392
Sarcopenia: European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., Martin, F. C., Michel, J.-P., Rolland, Y., Schneider, S. M., et al. (2010) · Age and Ageing · doi:10.1093/ageing/afq034 · Cited by 11,601
Garber, C. E., Blissmer, B., Deschenes, M. R., Franklin, B. A., Lamonte, M. J., Lee, I.-M., Nieman, D. C., & Swain, D. P. (2011) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e318213fefb · Cited by 9,319
The metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability
Guralnik, J. M., Ferrucci, L., Simonsick, E. M., Salive, M. E., & Wallace, R. B. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503023320902 · Cited by 4,083
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
Jensen, M. D., Ryan, D. H., Apovian, C. M., Ard, J. D., Comuzzie, A. G., Donato, K. A., Hu, F. B., Hubbard, V. S., Jakicic, J. M., Kushner, R. F., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.004 · Cited by 4,058
Sarcopenia in Asia: Consensus Report of the Asian Working Group for Sarcopenia
Chen, L.-K., Liu, L.-K., Woo, J., Assantachai, P., Auyeung, T.-W., Bahyah, K. S., Chou, M.-Y., Chen, L.-Y., Hsu, P.-S., Krairit, O., et al. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.11.025 · Cited by 4,051
Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member
McPherron, A. C., Lawler, A. M., & Lee, S.-J. (1997) · Nature · doi:10.1038/387083a0 · Cited by 4,013
Epidemiology of Sarcopenia among the Elderly in New Mexico
Baumgartner, R. N., Koehler, K. M., Gallagher, D., Romero, L., Heymsfield, S. B., Ross, R. R., Garry, P. J., & Lindeman, R. D. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009520 · Cited by 4,004
Cited by
Sorted by citations
Cruz-Jentoft, A. J., & Sayer, A. A. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31138-9 · Cited by 3,905
Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement
Donini, L. M., Busetto, L., Bischoff, S. C., Cederholm, T., Ballesteros-Pomar, M. D., Batsis, J. A., Bauer, J. M., Boirie, Y., Cruz-Jentoft, A. J., Dicker, D., et al. (2022) · Obesity Facts · doi:10.1159/000521241 · Cited by 1,019
Self-citationObesity in the critically ill: a narrative review
Schetz, M., JONG, A. D., Deane, A. M., Druml, W., Hemelaar, P., Pelosi, P. P., Pickkers, P., Blaser, A. R., Roberts, J. A., Sakr, Y. L., et al. (2019) · Intensive Care Medicine · doi:10.1007/s00134-019-05594-1 · Cited by 585
Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement
Donini, L. M., Busetto, L., Bischoff, S. C., Cederholm, T., Ballesteros-Pomar, M. D., Batsis, J. A., Bauer, J. M., Boirie, Y., Cruz-Jentoft, A. J., Dicker, D., et al. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2021.11.014 · Cited by 566
“…and loss of skeletal muscle mass and function; (2) negative clinical interactions between obesity and sarcopenia, leading to a synergistically higher risk for metabolic disease and functional impairment compared to those caused by the cumulative risk from each separate condition [78, 79].”
Self-citationMuscle, Bone, and Fat Crosstalk: The Biological Role of Myokines, Osteokines, and Adipokines
Kirk, B., Feehan, J., Lombardi, G., & Duque, G. (2020) · Current Osteoporosis Reports · doi:10.1007/s11914-020-00599-y · Cited by 510
Metadata
- Authors
- Batsis, J. A., & Villareal, D. T.
- Affiliations
- Dartmouth College (US)
- Michael E. DeBakey VA Medical Center (US)
- Corresponding author
- Batsis, John A.
- Venue
- Nature Reviews Endocrinology
- Published
- 2018-07-31
- Volume
- 14
- Issue
- 9
- Pages
- 513-537
- ISSN
- 1759-5029 (ISSN-L)
- 1759-5037
- PMC
- PMC6241236
- OpenAlex
- W2885711716
- Semantic Scholar
- 2aa7c67104ad71f61a29661d93854e1780cb40a8
- Cited by
- 1,382
- References
- 484
- Citations by year
- 2026: 199 · 2025: 232 · 2024: 221 · 2023: 225 · 2022: 186 · 2021: 144 · 2020: 123 · 2019: 44 · 2018: 5
- FWCI
- 10.38
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- U.S. Department of Veterans Affairs (I01 CX000906)
- National Institutes of Health (UL1TR001086)
- National Institute on Aging (K23AG051681, R01AG031176)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK109950)
- National Center for Chronic Disease Prevention and Health Promotion (U48DP005018)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Physiology (medical) › Body Composition Measurement Techniques
- Keywords
- sarcopenic obesity, sarcopenia, obesity, older adults, muscle mass and strength, sex differences, hormonal changes, inflammation, body composition assessment, prevalence, comorbidities, mortality, caloric restriction, protein supplementation, resistance training, aerobic exercise, testosterone, selective androgen receptor modulators, myostatin inhibitors, vitamin K, mesenchymal stem cell therapy
- MeSH terms
- Aged, Aged, 80 and over, Aging, Body Composition, Female, Follow-Up Studies, Humans, Male, Obesity, Quality of Life, Exercise, Comorbidity, Prevalence, Risk Assessment, Sarcopenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-09-28, under version 3 of the claim definition (prompt extract-v3).
A second model labelled each claim on 2026-09-28 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review